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ABSTRACT 
We have investigated the use of the E. coli lac operator-repressor 
system to regulate the expression of genes introduced into mammalian 
cells by gene transfer. We find that the bacterial lac repressor 
protein encoded in a suitable expression vector is synthesized in 
mammalian cells in culture, assembles into a tetramer, enters the 
nucleus to some extent, and represses expression of another gene that 
has one or several lac operator sequences inserted into any one of 
several sites in the promoter region of the gene. Derepression can be 
achieved by exposure of the cells to IPTG. From a practical point of 
view of an inducible genetic switch, this system confers an induction 
level of somewhere between 10- and 20-fold in most of the cases we 
have tested. That is not better than those that have been achieved with 
heat shock, mouse mammary tumor virus, and metallothionein promoters. 
There may, however, be some situations and some promoters for which the 
use of the lac operator system is advantageous. We have also shown that 
this lac control system can be used to regulate the expression of genes 
introduced into Xenopus oocytes by micro-injection. 
At present, we have been trying to revise this system by using a 
newly developed promoter containing a symmetric lac operator sequence 
inserted at the various strategic points within the human metallo-
thionein IIA promoter and enhancer regions, which consist of several 
positive control elements, in order to achieve induction ratios of a 
factor of 100 or more. We have also generated a new lac! gene which 
encodes a repressor containing at its carboxyl terminus the nuclear 
localization signal of the SV40 large-T antigen. Overall, by combining 
v 
the newly developed lac control promoters with the new repressor 
producing cell lines, we hope to generate an inducible expression 
system with large induction ratios that can be used as a general 
genetic switch in the future. 
In section II, the nucleotide sequence of the mouse skeletal 
muscle (a) actin gene is presented and discussed. 
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CHAPTER 1 
INTRODUCTION TO SECTION I 
The E. coli lac operator-repressor system is functional for control of 
gene expression in animal cells. 
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The specific aim of the first (and major) part of this thesis is 
to develop a new inducible eukaryotic expression system that can be 
used to achieve high levels of expression of gene products of interest, 
by gene transfer in animal cells and with a high induction ratio. There 
are two basic kinds of applications of this system that we foresee: (a) 
the direct usefulness for the controlled expression of gene products in 
animal cells, and (b) for the study of one aspect of the mechanism of 
enhancer function in eukaryotic cells. 
Reason (a) can be subdivided into two parts. First, for genetic 
engineering purposes, one often wishes to produce useful proteins, such 
as rare hormones or potent growth factors, by expression in animal 
systems. In some such cases, the gene product is toxic to the cells. An 
appropriate strategy then is to place the gene under the control of an 
inducible promoter, grow the cells up to large numbers while the gene 
is inactive, and then induce expression. Second, in basic science one 
would like to be able to study the mechanism of action of any 
endogenous gene product, especially regulatory molecules (including 
proto-oncogenes, kinases, growth factors, etc.) in a biological system 
of interest, by turning the gene on and off at will. For example, if 
one can block the expression, in a controlled manner, of a potent 
endogenous oncogene by inducible antisense RNA expression, one has the 
ideal control between plus and minus expression for observing effects 
of the oncogene. 
Explanation of the second motivation (b) requires some discussion 
of enhancers and of our present knowledge of their mechanism of 
function. One of the central problems to understand in eukaryotic 
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molecular biology is the mechanisms by which specific genes are 
expressed in a tissue-specific manner or are actived in response to 
extracellular inducers. Essentially, two DNA sequence elements are 
required for the regulation of gene transcription in eukaryotes: 
promoters (including proximal and distal elements), which are required 
for accurate and efficient initiation of transcription from genes, and 
enhancers, which are needed to increase the rate of transcription from 
promoters. Promoters are located immediately upstream from the start 
site of transcription, and act in a position-dependent fashion (for 
reviews, see Dynan and Tjian, 1985; McKnight and Tjian, 1986; Jones et 
al., 1988), whereas enhancers can act on cis-linked promoters at great 
distances (a few kilobases away) in an orientation-independent manner 
and can also function downstream from the transcription unit (for 
reviews, see Gluzman, 1985; Serfling et al., 1985; Ptashne, 1986). The 
available data are consistent with the current view that promoters and 
enhancers operate by trans-acting protein factors that specifically 
interact with these cis-acting sequence elements and stimulate 
transcription in vivo and in vitro (for reviews, see McKnight and 
Tjian, 1986; Maniatis et al., 1987; Jones et al., 1988). 
In recent years, inducible promoters and enhancers have been 
identified for a number of genes including genes for heat shock (Wu, 
1984; Topol et al., 1985; Bienz and Pelham, 1986), metallothionein 
(Mayo et al., 1982; Karin et al., 1984a, 1984b; Friedman and Stark, 
1985; Haslinger and Karin, 1985; Serfling et al., 1985; Imbra and 
Karin, 1987), interferon-a (Ryals et al., 1985) and -P (Fujita et al., 
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1985; Goodbourn et al., 1985), and c-fos (Treisman, 1985). In addition, 
steroid-inducible enhancers have been identified in the long terminal 
repeat sequences of the mouse mammary tumor virus (see Ringold, 1983, 
for review; Chandler et al., 1983; Ponta et al., 1985) and the Moloney 
murine sarcoma virus (DeFranco and Yamamoto, 1986; Miksicek et al., 
1986), and in association with many cellular genes (Karin et al., 1984; 
Renkawitz et al., 1984; Slater et al., 1985; Klein-Hitpass et al., 
1986; Seiler-Tuyns et al., 1986; Jantzen et al., 1987). Inducible 
enhancer elements are generally capable of activating heterologous 
promoters. In fact, usually only very short DNA sequences within 
enhancers are necessary for activation of transcription from nearby 
promoters. For instance, a 12-base pair DNA sequence element from the 
human metallo-thionein gene is sufficient to confer metal inducibility 
on a heterologous promoter (Searle et al., 1985), and a 14-base pair 
DNA sequence element from the Drosophila hsp70 gene is sufficient to 
confer heat inducibility on a heterologous promoter in mammalian cells 
(Pelham and Bienz, 1982). 
Numerous DNA binding and footprinting experiments have provided 
strong evidence that inducible enhancer elements specifically interact 
with cellular protein factors. For example, first, the best understood 
trans-acting regulatory factors in higher eukaryotes are the steroid 
receptor proteins that bind to the steroid-inducible enhancers and 
promote transcription (see Yamamoto et al., 1985, for review). It has 
been shown that cotransfection of plasmids expressing receptor proteins 
and a plasmid containing a steroid-inducible enhancer into receptor-
negative cell lines led to the activation of transcription (Miesfield 
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et al., 1986; Druege et al., 1986; Giguere et al., 1986), suggesting 
that binding of steroid receptor-hormone complex to the enhancer is 
required for steroid-dependent gene regulation. Second, a protein 
factor that is capable of binding heat-shock response elements (HSEs) 
has been identified in yeast (Wiederrecht et al., 1987), Drosophila 
(Parker and Topol, 1984; Wu, 1984), and man (Kingston et al., 1987). 
The HSE-binding factor has been highly purified and shown to stimulate 
transcription from the hsp70 promoter in vitro (Parker and Topol, 1984) 
and therefore has been designated the heat-shock transcription factor 
(HSTF). However, the mechanism by which trans-acting protein factors 
bind to enhancer elements and act on the transcriptional machinery, 
including RNA polymerase II, to activate transcription is not 
understood for any inducible enhancer. 
Let us assume that a specific protein binds to a distant enhancer 
element and then interacts with a protein complex, including RNA 
polymerase itself, at the promoter. Then there are two basic kinds of 
mechanisms by which the protein at the enhancer site can act at a 
distance on the promoter complex: (a) action through space via 
"looping", (b) action through the chain via "scanning". Ptashne (1986) 
has summarized the arguments for the looping model. This model has the 
advantage of intuitive plausibility. However, Courey et al. (1986) have 
offered evidence that enhancer function can be blocked by inserting a 
short segment of DNA containing intercalated photo-crosslinked psoralen 
molecules between enhancer and promoter, suggesting a through the chain 
mechanism (scanning model). 
Our idea is to place a lac operator sequence between the enhancer 
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and the promoter elements . If action is through the chain, then the 
presence of lac repressor binding to the operator should block the 
action of the enhancer. Addition of IPTG should reestablish communi-
cation between the enhancer and promoter elements. On the other hand, 
it is unlikely that a lac repressor bound to an operator would prevent 
interaction via a looping mechanism if all the elements are suitably 
spaced . Our specific plans are to investigate this problem by inserting 
the lac operator between the glucocorticoid responsive element (GRE, an 
inducible enhancer) and the promoter region of the human metallo-
thionein IIA gene (see below). 
Let us return to a more detailed discussion of the use of the lac 
operator-repressor system for control of eukaryotic gene expression 
after gene transfer. There are of course other already available 
eukaryotic inducible promoter/enhancer systems (described above). These 
have some disadvantages that make it worthwhile to test new approaches. 
For example, the metal-ion-inducible metallothionein promoter and the 
glucocorticoid-inducible mouse mammary tumor virus promoter suffer 
often from the existence of a relatively high level of constitutive 
expression, and with the addition of inducing agents, they suffer from 
a limited inducibility or are restricted to a relatively narrow range 
of host cells. Also, the inducing agents, which include heavy metals, 
steroid hormones, interferons, and heat treatment, may interfere with 
normal metabolism and cell proliferation. And, although the heat-shock 
promoter has been suggested to be a general method for inducibly 
expressing proteins in mammalian cells (Dreano et al . , 1986; Wurm et 
al., 1986), it has been reported recently that heat shock transiently 
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accelerates the degradation of the long-lived fraction of cellular 
proteins in some mammalian cells (Parag et al., 1987). 
The specific aim of the first section of this thesis is thus to 
establish a new eukaryotic expression system that can be optimally 
applied to the large-scale expression of gene products of interest in 
mammalian cells. The approach of this project is to use the E. coli lac 
repressor and the lac operator to control expression of genes 
introduced into mammalian cells by gene transfer. The general back-
ground of this approach is described by the following. In the E. coli 
lac operon, genes encoding enzymes essential for lactose metabolism are 
under the negative control of a tetramer repressor molecule consisting 
of four identical polypeptide chains, each of molecular weight 38 
kilodalton. The lac repressor can bind specfically to a cognate lac 
operator sequence downstream of the lac promoter. When bound to the 
operator, the repressor can completely inhibit transcription from the 
lac promoter in E. coli. Allolactose and its analogues, such as 
isopropyl P-D-thiogalactoside (IPTG), can bind to repressor protein and 
dramatically decrease the affinity of repressor to the operator so that 
they activate transcription of the lac promoter. Overall, the lac 
operator-repressor system is one of the most thoroughly studied and 
best understood examples of a protein-nucleic acid interaction that 
regulates transcrip-tion of a gene in prokaryotic systems (Beckwith and 
Zipser, 1970; Miller and Reznikoff, 1980). 
We show in Chapter 2 that the bacterial lac repressor protein 
encoded in a suitable expression vector is synthesized in mammalian 
cells in culture, assembles into a tetramer, enters the nucleus to some 
8 
extent, and represses expression of another gene that has one or 
several lac operator sequences inserted into any one of several sites 
in the promoter region of this plasmid. Derepression can be achieved by 
exposure of the cells to IPTG. Although a significant level of 
derepression (60%-80%) can be achieved with IPTG, it is not fully 
reversible. From a practical point of view of an inducible genetic 
switch, this system confers an induction ratio somewhere between 10-
and 20-fold in most of the cases we have tested. That is not better 
than those that have been achieved with heat shock, mouse mammary tumor 
virus, and metallothionein promoters. There may, however, be some 
situations and some promoters for which the use of the lac operator 
system is advantageous. At present, we have been trying to revise this 
system by combining it with other positive control elements so that we 
may get dynamic control over a factor of 100 or more (see below). 
Additionally, we have investigated the use of this lac control 
system to regulate the expression of genes introduced by microinjection 
into Xenopus laevis oocytes. A primary goal of this study was to 
demonstrate that this system could be used as a genetic switch in frog 
oocytes, just as in E. coli and in mammalian cells (Hu and Davidson, 
1987; Brown et al., 1987). The ability to control the transcription of 
a gene in oocytes by using the lac repressor and hybrid promoters 
containing the lac operator should be useful for a wide variety of 
purposes. Moreover, one potentially rewarding feature of this system is 
that it may provide a method the experimenter can use to control the 
expression of genes that play a role in early embryonic development. 
Ultimately, it may provide a method for the control of tissue-specific 
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gene expression in transgenic animals. 
As described in Chapter 3, with a single lac operator sequence 
inserted in a control region of the test plasmid injected into Xenopus 
oocytes, a high level of repression is achieved with the lac repressor. 
Repression can be achieved by premixing repressor with plasmid prior to 
nuclear injection, or by injection of repressor into the oocyte 
cytoplasm before injection of the plasmid into the oocyte nucleus. A 
low level of induction can be achieved by addition of the inducer IPTG 
to the external medium; a much higher level of induction is obtained by 
injection of IPTG into the oocyte cytoplasm. Furthermore, the repressor 
protein does not affect expression of a test plasmid that does not 
contain the operator sequence. 
It is clear that there is room for revision and improvement within 
this lac control system. First, we have been trying to introduce other 
positive control elements, including the metal responsive element (MRE) 
and the glucocorticoid responsive element {GRE), into this control 
system to achieve higher induction ratios upon the addition of the 
extracellular inducers (e.g. heavy metals + IPTG or dexamethasone + 
IPTG). The rationale of this approach is that by using a combination of 
a positive and negative control system, we likely will get multipli-
cative effects upon the addition of inducers because the positive 
activation should be able to occur independently and concurrently with 
the relief of repression from the negative control. The human metallo-
thionein IIA {hMT-IIA) gene provides a useful model for this purpose. 
This gene is actively expressed in most cell types, and its transcrip-
tion is regulated in response to a variety of environmental stimuli, 
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which includes heavy metal ions, steroid and polypeptide hormones, 
growth factors, cytokines, and phorbol ester tumor promoters (Karin et 
al . , 1984a, 1984b; Friedman and Stark, 1985; Imbra and Karin, 1987). 
These effects are mediated by specific regulatory proteins that 
interact with distinct cis-acting elements in the 5'-flanking region of 
the gene (Karin et al., 1984b; Lee et al., 1987a, 1987b; Angel et al., 
1987). In addition to one GRE and four MREs, the 5'-flanking region 
contains four other elements involved in controlling the basal level of 
expression : a TATA box, a GC box, and two basal level enhancer elements 
(BLEs) (Karin et al., 1987) . Recently, we have successfully constructed 
a number of new expression vectors which consist of the hMT-IIA 
promoter with a single symmetric lac operator sequence inserted at the 
various strategic points within the promoter and enhancer regions, as 
shown in Figure 1 (page 16). It should be noted that a perfectly 
symmetric lac operator segment (Sadler et al., 1983; Simons et al., 
1984) has been chosen for use here because it has been shown that it 
binds the lac repressor about 8 - 10 times more tightly than does the 
natural lac operator sequence , which has been used in our previous 
studies. Hopefully, further work may reveal that this new lac control 
system can achieve induction ratios of a factor of 100 or more . 
Second , as mentioned previously, since the majority (~90%) of the 
lac repressor synthesized in the mammalian cell line LI-1 which we have 
characterized is located in the cytoplasm, it is desirable to generate 
a new repressor that will localize primarily in the nucleus. In 
eukaryotes, most regulatory proteins (DNA-binding proteins) are 
transported from their cytoplasmic site of synthesis and are localized 
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primarily in the nucleus. This relatively strict nuclear accumulation 
is attributed to the presence in the protein of a distinctive stretch 
of amino acids that acts as a nuclear localization signal (see 
Dingwall, 1985, for review). Accordingly, as another venture of 
revising this lac control system, we have generated a new lac! gene 
that encodes a repressor containing at its carboxyl terminus the 
nuclear localization signal of the SV40 large-T antigen (Kalderon et 
al., 1984). As depicted in Figure 2 (page 17), a stretch of DNA 
sequence encoding the short amino acid sequence of Pro-Lys-Lys-Lys-Arg-
Lys-Val has been engineered on the 3' end of the wild type lac! gene by 
using oligonucleotide-directed mutagenesis (Zoller and Smith, 1984). 
This gene has been stably transfected into three mammalian cell lines, 
including mouse Ltk-, rat XC, and Rat-2(tk-) cells. Experiments are 
currently under way to isolate and characterize the cell lines that 
synthesize high levels of repressor protein . Moreover, the distribution 
between cytoplasm and nucleus of the engineered lac repressor 
containing the nuclear localization signal will be determined by the 
immuno-blot (Western-blot) analysis . Overall, by combining the newly 
developed lac control systems with the new repressor producing cell 
lines, we hope to generate an inducible expression system with large 
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Figure 1. Structure of the hMT-IIA control region . (A) Sequence 
of the hMT-IIA 5' control region from position +1 (the major start site 
of transcription) to position -300. (B) Schematic diagram of the lac 
operator insertions in the promoter region. BLE, basal level enhancer; 
GC, GC-box element; 0 , the lac operator. 
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Sequence 
lac! Wild Type 5'-- - CAG TGA GCG CAA CGC AAT TAA TGT---3' -Nucleotide 
Gln-stop -Amino Acid 
(Site-Directed Mutagenesis) 
lac! Mutant 5'---CCG AAA AAG AAA CGC AAA GTA TGA---3' -Nucleotide 
Pro-Lys-Lys-Lys-Arg-Lys-Val-stop -Amino Acid 
(the nuclear localization signal 
of the SV40 large-T antigen) 
Figure 2. Oligonucleotide-directed mutagenesis of the lac! gene. The 
mutant lac! gene encodes a repressor containing at its carboxyl 
terminus the nuclear localization signal of the SV40 large-T antigen. 
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CHAPTER 2 
The inducible lac operator-repressor system is functional in mammalian 
cells. 
Mickey C-T. Hu and Norman Davidson 
Cell 48:555-566 (1987) 
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The Inducible lac Operator-Repressor System 
Is Functional in Mammalian Cells 
Mickey C.-T. Hu and Norman Davidson 
Division of Chemistry 
California Institute of Technology 
Pasadena, California 91125 
Summary 
We have investigated the use of the Escherichia coli 
lac operator-repressor system to regulate expression 
of transfected genes in mammalian cells. We show 
that lac repressor produced in mouse L cells by trans-
fection of a lac/ expression vector blocks transcription 
of an MSV-CAT fusion gene when the /ac operator is 
inserted at any one of the following sites within the 
promoter region: between the initiation codon (ATG) 
and the transcription start site; between the transcrip-
tion start and TATA box regions; or upstream of the 
TATA box region. This last result suggests that the 
repressor may prevent protein-protein interactions in-
volved in transcription activation . The inducer IPTG 
causes a marked derepression of CAT expression. The 
lac repressor-operator complex may be useful as an 
on/off "switch" in the regulation of gene expression for 
gene transfer experiments. 
Introduction 
Emerging evidence indicates that one of the major mech-
anisms for control of gene expression in eukaryotes, just 
as in prokaryotes, involves binding of a regulatory protein 
to a specific DNA sequence that it recognizes (for reviews 
see Dynan and Tjian, 1985; McKnight and Tjian, 1986). 
Generally speaking , these regulatory mechanisms are 
somewhat more complex in eukaryotes than in prokary-
otes in that they more frequently involve interactions be-
tween several different proteins each binding to a distinct 
short sequence in the regulatory region of the gene 
(Ptashne, 1986; Davidson et al. , 1986). 
Repression by binding of the lac repressor to the lac 
operator and derepression by action of inducers such as 
isopropyl 13-D-thiogalactoside (IPTG) is one of the most 
thoroughly studied and best understood examples of a 
protein-nucleic acid interaction that regulates transcrip-
tion of a gene in Escherichia coli (Beckwith and Zipser, 
1970; Miller and Reznikoff, 1980). The goal of the present 
research was to determine whether a suitably engineered 
lac repressor-operator system would be functional in ani-
mal cells just as in E. coli. If effective, such a system would 
be a useful addition to the several eukaryotic inducible 
promoter systems now used for achieving regulated ex-
pression of genes introduced into eukaryotic cells by gene 
transfer. These latter include heat shock inducible pro-
moters fY'/u, 1984; Topol et al., 1985), the glucocorti-
coid-inducible mouse mammary tumor virus long terminal 
repeat (LTR) (see Ringold, 1983, for review), the metal-ion-
inducible metallothionein promoter (Mayo et al., 1982), 
and poly(IC)-inducible interferon promoters (Goodbourn 
et al., 1985; Ryals et al., 1985). In addition , information 
about steric interactions between two eukaryotic regula-
tory proteins, each binding to its specific sequence in a 
promoter region, might be provided by observing the ef-
fects of lac repressor binding to an operator sequence in-
serted in the vicinity of the two interacting regulating 
sequences. 
The lac repressor is a homotetramer containing four 
polypeptide chains, each of molecular weight 38 kd . To be 
functional in a eukaryotic ceil , this protein would have to 
self-assemble after synthesis of the monomer units in the 
cytoplasm, migrate to the nucleus, and bind to an operator 
sequence that was present in some sort of a chromatin 
structure characteristic of eukaryotic DNA. To be useful 
the system would have to be inducible by IPTG added 
to the external medium. It was not known beforehand 
whether ail this would occur. To our knowledge, the only 
instance in which a prokaryotic regulatory protein has 
been shown to bind to its specific recognition sequence 
in a eukaryotic ceil is for the E. coli lexA protein to bind 
to its operator in yeast (Brent and Ptashne, 1984). 
Results 
Overview 
Our overall strategy is depicted in Figure 1. By mutation 
of the initiator GTG to ATG , the lac/ coding sequence has 
been modified so that it is expected to be translated in a 
eukaryotic cell . It was then inserted into a eukaryotic ex-
pression vector driven by the Reus sarcoma virus LTR 
(RSV LTR) as a promoter. A mouse L ceil line denoted Ll-1, 
in which functional repressor is expressed at moderate 
levels, was selected (Figure 1A). 
The lac operator sequence has been inserted into 
selected sites around the promoter element or transcrip-
tion start site of a standard DNA construction, pSM12, in 
which the chloramphenicol acetyltransferase (CAT) cod-
ing sequence is transcribed under the control of a chi-
meric promoter consisting of part of the SV40 early pro-
moter coupled to the Moloney sarcoma virus (MSV) 
enhancer (Laimins et al., 1984). SV40 RNA processing 
signals are provided at the 3' end of the gene. This particu-
lar construction was chosen because the effect of the 
MSV enhancer in augmenting expression had already 
been studied. Furthermore, a series of plasmids with the 
enhancer in different positions relative to the promoter 
has been made and studied by Laimins et al. (1984); we 
anticipate, in future studies, measuring the effect of the 
position of the lac operator relative to the enhancer and 
the promoter in these several constructions. 
As summarized in Figure 1B, we have studied CAT gene 
expression , both by enzyme assays and RNA blot analy-
sis, after introducing the plasm ids by a transient transfec-
tion method into the repressor-positive Ll-1 cells and , as 
a control , into the parental L cells. The effect of the inducer 











Figure 1. Schematic Representation of the Ex-
pression of lac Repressor and Its Functional 
Assay 
~;?AI 1 Cal•aosfect•an ~~;;,:: • ..,!)~ . 
~ / Tronsfec110n 
(A) An expression vector containing an altered 
lac/ gene under the control of the RSV LTR was 
cotransfected into LTK- cells with a plasmid 
pTK-5, wh ich carries the HSV-1 tk gene. The 
transfected cells were cultured in HAT selective 
medium, and clonal isolates were screened for 
the presence of stably expressed lac/ mANA 
and repressor protein (see Experimental Pro-
cedures) . (B) In the functional assay, an 
MSV-CAT fusion gene or its derivatives con-
taining lac operator sequence was transfected 
into the repressor producing cells (LI-1). The 
cells were subsequently cultured in the pres-
ence or absence of IPTG. The transient expres-
sion of the CAT gene was monitored by the CAT 
assay and RNA blot analysis, and nuclear DNA 
uptake was quantitated by Southern blot 
analysis. 
~~~ LTK-cells 
1 Selec,an '"' TK+ ~~~LI - Icells 
1 T<ealmenl HAT 
enmg for repressor• 
cell I me) 
RNA Western 
+ I- IPTG 




dot CAT blot OS!.Oy 
blot essay 
160 
A B c 
Cell clones a 
c 
E 120 LIIB I-
';;; 
LIIB 3- u 
Ll185- . • >- 80 ~ 
(Li-I)Lil87- · • u 0 Q 
L TK•- " 0 
Contra{ 0:: 
L TK--
oo 10 30 50 0 
LI -I Cell Ext ract E 
(fL I ) 
lions have been studied. As noted above, the parental 
plasmid, pSM12, contains a gene consisting of an MSV 
enhancer, the SV40 promoter, the CAT coding region, the 
SV40 small t intron, and an SV40 poly(A) addition site. This 
construction is expected to be transcriptionally active in 
repressor-positive cells because it does not carry the lac 
operator sequence. The constructions with an operator in-
sert contain : one or several tandem operator insertions 
10 20 30 
Figure 2. Expression of lac/ mANA and lac 
Repressor Protein 
colt lac Repressor 
(A) RNA dot-blot analyses were performed 
using total cytoplasmic RNA extracted from L 
cells (HAT-resistant clones) that had been 
transfected 2 weeks (a) and 2 months (b) previ-
ously with the plasmids pRSV-1 and pTK-5. RNA 
extracted from nontransfected LTK- cells and 
those transfected with pTK-5 plasmid (TK• 
cells) were also performed as controls. Equal 
amounts (4 11g per dot) of each RNA sample 
were transferred to a filter and were subse-
quently hybridized with an SP6-generated an-
tisense lac/ probe. (B) Aliquots of crude cyto-
plasmic extracts (approximately 2.4 mg/ml) 
from Ll-1 cells and 32P-end-labeled 40 bp 
operator DNA (2 x 10-12 M) were equilibrated 
in the presence of 20 11Qiml sonicated calf thy-
mus DNA in standard binding buller at room 
temperature (Lin and Riggs, 1972). The reac-
tion was divided into three portions. and each 
sample was filtered through a nitrocellulose 
membrane filter (BASS, Schleicher & Schuell); 
the filters were washed with buller and counted 
for radioactivity. No background radioactivity 
has been subtracted. (e) No IPTG; (0 ) in the 
presence of 5 mM JPTG; (.6.) cellular extracts 
from LTK- cells used as a control in the ab-
sence of IPTG . (C) Standard binding curve for 
E. coli lac repressor (approximately 27 ng/ml) 
and operator DNA. The binding assay was per-
formed as described above. No background ra-
dioactivity has been subtracted. (e) No JPTG; 
(0 ) in the presence of 5 mM JPTG . 
(fLI) 
between the initiation codon and the transcription start 
point, designated as pSMA01, pSMA02, etc.; one or 
several tandem operator inserts between the transcrip-
tion start point and the TATA box region , designated as 
pSMB01 , pSMB02, etc. ; or one or two inserts between 
the TATA box region and upstream elements (SV40 21 bp 
repeats) , designated as pSMC01 and pSMC02, respec-
tively. 
It seemed plausible on general grounds that two or 
more tandem operator insertions might have a greater ef-
fect on gene expression than would a single sequence. 
This expectation is strengthened by the report that the 
half-lives of complexes of repressor bound to operator-
containing plasm ids increase with increasing numbers of 
tandem operators per plasmid (Sadler et al., 1980). 
Functional lac Repressor Can Be Expressed 
in Mouse L Cells 
The initiation codon of the E. coli lac/ gene is GTG (Steege, 
1977) and is not expected to function in eukaryotes. (It is 
of interest to note that changing the GTG initiation codon 
of a lacZ fusion gene into ATG actually results in a higher 
level of expression in E. coli in vivo and in vitro systems 
[Looman and van Knippenberg , 1986).) Therefore, in or-
der to achieve a moderately high level of expression of the 
lac repressor in animal cells, we have converted the initia-
tion codon of the lac/ gene to ATG by site directed muta-
genesis, and inserted the coding region into a eukaryotic 
expression vector driven by the RSV LTR and followed by 
SV40 splicing and polyadenylation signals, to give the 
plasmid pRSV-1 (see Experimental Procedures). 
Mouse LTK- cells were cotransfected with a plasmid 
(pTK-5) encoding the herpes simplex virus-1 thymidine 
kinase gene (tk) plus a 50-fold excess of pRSV-1 by the 
standard calcium phosphate coprecipitation procedure 
(Wigler et al., 1979; see Experimental Procedures). Stable 
transfectants were selected by growth in HAT-medium 
(see Experimental Procedures; Szybalska and Szybalski, 
1962). Clonal isolates were screened for the presence of 
stably expressed lac/ mANA and repressor protein. Many 
clones expressed the repressor gene by these criteria. 
RNA dot-blot data for several clones and appropriate 
negative controls are shown in Figure 2A. Further studies 
have been confined to the cell line Ll-1, which is the 
highest level expresser of the clones isolated. 
The tetramer repressor protein produced in E. coli is 
capable of binding to the operator sequence in vitro. To de-
termine whether repressor that is functional by this cri-
terion is produced in the transfected animal cells, we per-
formed a filter-binding assay for repressor-operator DNA 
complexes (Lin and Riggs, 1972). Crude extracts prepared 
from the cotransformed clones were incubated with the 
purified 32P-end-labeled operator fragment (40 bp), in the 
presence or absence of IPTG, prior to filtering through a 
nitrocellulose filter. In addition, purified lac repressor pro-
tein was used to standardize the operator-binding curve. 
Figure 29 shows a filter-binding assay of cell extracts from 
the lacf+ Ll-1 cells, and demonstrates that these cells 
synthesize functional repressor protein that specifically 
binds the operator fragment in the presence of a vast ex-
cess of calf thymus DNA just as does the purified E. coli 
protein. By comparison of the linear binding curves of the 
extracts and of the purified protein, we estimate that there 
are 2.5 (±0.5) x 104 functional repressor molecules per 
cell. The molecular weight of the tetramer is 150 kd (Gil-
bert and Muller-Hill, 1970); therefore, assuming 10 - 9 
gram of protein per cell, the functional repressor consti-
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Figure 3. Quantitative Western Blot Analysis of /sc Repressor in LI-t 
Cells 
Crude cytoplasmic and nuclear extracts from LI-t and LTK- cells (2 x 
t06) were electrophoresed through an 50S-polyacrylamide gel and 
were transferred to nitrocellulose. The blot was probed with anti-
repressor monoclonal antibody B-2 (Sams et al. , t985) followed by 
1251-labeled sheep anti-mouse immunoglobulin. After autoradiogra-
phy, the bands were quantitated by densitometric scanning. The 
migration of lac repressor monomer (P38) is indicated. The positions 
of 14C-Iabeled molecular weight standards are shown in the left mar-
gin. Cyt ., cytoplasmic fraction ; Nuc., nuclear fraction ; M, marker pro-
teins. 
The lac Repressor Is Distributed Between 
Cytoplasm and Nucleus 
Although the lac repressor is a well-characterized DNA-
binding and regulatory protein in E. coli, it was not known 
whether it could penetrate the nuclear envelope and how 
it would distribute between cytoplasm and nucleus in ani-
mal cells. To address this question, Western blot analyses 
were performed on extracts of separated cytoplasmic and 
nuclear fractions of Ll-1 cells, using a repressor-specific 
monoclonal antibody B-2 (Sams et al., 1985; see Ex-
perimental Procedures). 
The immunoblots in Figure 3 show that a repressor 
polypeptide of approximately 38 kd comigrating on an 
SDS gel with the monomer derived from purified E. coli 
repressor is present in Ll-1 cells but not in LTK- cells. 
About 10% of the total repressor was found in the nuclear 
fraction and 90% in the cytoplasm. The estimates from 
these gels of total repressor polypeptide present agree 
well with the amount found by operator binding; thus, 
most of the repressor polypeptide in Ll-1 cells is present 
as functional tetramer. We therefore estimate that about 
2500 repressor molecules are present in the nucleus, 
where they might be able to act as negative regulatory 
molecules. 
The measured ratio of nuclear to cytoplasmic repressor 
could be quantitatively distorted by nuclear leakage or dis-
ruption and/or by adherence of cytoplasmic material to the 
external nuclear surface. The gene expression experi-
ments reported below, as well as experiments with stable 
transformants and experiments by Xenopus oocyte injec-
tion methods (unpublished results), all show that there is 
some biologically active repressor in the nucleus. 
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Figure 4. Structural and Functional Properties of Operator Insertions 
in the Promoter Regions 
The organ ization of the SV40 early promoter region in parental plas-
mids (pSM12 and pSM11) and in their derivatives containing operator 
insertions is depicted. The hatched boxes to the left of the SV40 pro-
moter illustrate the MSV enhancer (the 73172 bp tandem repeats; Lai-
mins et al. , 1984). The SV40 21 bp repeats, TATA box , transcription start 
point (tsp), initiation codon (ATG), CAT-coding sequences (boxed re-
gion), and poly(A) addition site are indicated. The positions of single 
and multiple tandem operators (denoted as horizontal arrows) are 
shown as triangular inserts, and the copy number of the operator insert 
is ind icated at the top of each triangle: 0 1 (one operator), 0 2 (two tan-
dem operators). 0 3 (three tandem operators). 0 4 (four tandem opera-
tors). Individual cultu ces of LTK- cells were transfected with 4 ~g (at 
2 ~glml) of the indicated plasmid DNA by using the DEAE-dextran 
method, and cell extracts were prepared for assaying CAT activity at 
48 hr after transfection . CAT assays were performed at least three 
times, using equal amount of protein from the cell extracts, under linear 
assay conditions. The relative CAT activity is quantified as percentage 
of parental plasmid pSM12 CAT activity. The standard deviations 
shown on the right were calculated using data from four independent 
transfection experiments. Transfections and assays were repeated by 
using two different preparations of the plasm ids that showed less than 
50% CAT activity in transient expression in LTK- cells. The control 
CAT expression was also performed using pA 10CAT, the plasmid that 
contains the SV40 promoter elements but no enhancer sequences. 
The finite but low level of expression observed from this control plas-
mid has been observed by others (N. Fregien , personal communica-
tion). In our hands, the expression ratio for pA10CAT relat ive to pSM12 
varies with amount of DNA and with host cell type. We suspect that 
transcription from pA10CAT may be due to a cryptic promoter within 
the vector, as we observe for pUCOCAT (constructed by N. Fregien) , 
wh ich has no eukaryotic promoter (see also Lopata et al. , 1986; and 
Fregien and Davidson, 1986). 
Effects of Operator Insertions on Gene Expression 
in the Absence of Repressor 
Before studying the possible effects of repressor binding 
to operator sequences in the several plasmid construc-
tions in vivo. it was necessary to ~etermine the extent to 
which operator inserts affect gene expression in the 
22 
absence of repressor. Accordingly, transient expression 
studies were carried out with these plasmids in LTK-
cells. Figure 4 shows that insertion of a single operator be-
tween the initiation codon and the transcription start 
(pSMA01 and pSMD01) caused a 4S%-48% decrease in 
CAT activity with respect to the parental plasmid (pSM12 
and pSM11, respectively) ; two tandem operators 
(pSMA02 and pSMD02) caused a 72%-83% decrease in 
CAT activity; and three tandem operators (pSMA03 and 
pSMD03) almost eliminated CAT activity. Similarly, inser-
tion of a single operator between the transcription start 
and the TATA box (pSMB01 and pSME01) decreased CAT 
activity approximately 20%-30%; two tandem operators 
(pSMB02 and pSME02) decreased CAT activity about 
70%; and three tandem operators (pSMB03 and pSME03) 
decreased CAT activity about 80%-90%. In contrast. in-
sertion of a single operator between the TATA box and the 
upstream SV40 21 bp repeats (pSME01 and pSMF01) 
resulted in a 77%-8S% reduction in CAT activity. These 
latter results are in agreement with a previous study show-
ing that insertion of DNA segments of increasing length 
between 21 bp repeats and the TATA box region leads to 
a significant decrease in the amount of RNA transcript ini-
tiated at the major early-early start sites (Takahashi et al. , 
1986). (It may be noted, in Figure 4, that we have studied 
operator insertions into constructions pSM11 and pSM12 
of Laimins et al. (1984) with both orientations of the en-
hancer relative to the transcription direction. Our later 
studies in Ll-1 cells have been restricted to a subset of 
these plasmids.) 
The lac Repressor-Operator Complex Functions 
As a Regulatable Switch in Animal Cells 
To examine the functional capability of the expressed 
repressor as a negative transcription regulator in mam-
malian cells, we performed CAT assays with extracts of Ll-
1 cells obtained after transfection with the reporter genes 
(see Experimental Procedures). As shown in Figure SA, 
derivatives of the parental plasmid pSM12 containing a 
single operator between the initiation codon and the 
transcription start (pSMA01 , lane 2). between the tran-
scription start and the TATA box regions (pSMB01 , 1ane 4), 
and between the TATA box and the SV40 21 bp repeats 
(pSMC01 , lane 6) were repressed 8-12-fold in the repress-
or-positive Ll-1 cells relative to the same plasmids in the 
repressor-negative L cells. All pSM12 promoter deriv-
atives containing two tandem operators (Figure SA, 
pSMA02 and pSMB02) were repressed more efficiently 
(about 30-fold) than corresponding derivatives that con-
tained only a single operator. In summary, in the presence 
of repressor, CAT enzymatic activity was reduced by 
87%-92% for the single-operator-inserted genes and by 
96%-98% for the two-operator-inserted genes. 
To determine whether CAT gene expression was regu-
lated at the level of transcription, we isolated total cyto-
plasmic RNA from transiently transfected Ll-1 cells and 
determined the concentrations of CAT RNA by RNA dot-
blot hybridization (Figure 68). The relative amounts of 
CAT-specific RNA paralleled the levels of CAT enzyme ac-
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Figure 5. Repression and Induction of CAT Activity in Repressor-Producing Cells (LI·1) 
Subconfluent Ll-1 cells were translected with 411g (at 2 11glml) of plasmid DNA, as indicated in each lane, by using the DEAE-dextran protocol. After 
transfection , cells were cultured for 48 hr in galatose-substituted DME media (see Results and Experimental Procedures) under the following condi· 
l ions: (A) no IPTG was included; (B) IPTG was added to a 20 mM final concentration at 36 hr after translection, and cells were continuously cultured 
lor 12 hr; (C) IPTG added at 24 hr alter translection, and cells were cultured for another 24 hrs; (D) IPTG added at 12 hr after translection, and cells 
were cultured for additional 36 hr; and (E) IPTG added right alter translection , and cells were cultured lor 48 hr. Analyses of CAT activity were carried 
out 48 hr following translection as previously described. The relative CAT activity is normalized as a percentage of the parental plasmid's (pSM12) 
CAT activity in LTK- cells. Shown to the right of these CAT assays (A-E), the level of CAT expression from the indicated plasmid constructs in Ll-1 
cells (hatched bars) was compared with that in LTK- (empty bars) which is shown in Figure 4. The magnitude of induction in 48 hr as shown in 
(E) was individually quantified by dividing the % CAT activity of each in (E) by that observed in (A) in Ll-1 cells. As an additional negative control , 
when the operator was inserted downstream of the poly(A) site within the vector, CAT expression was not repressed in Ll-1 cells. 
These experiments are most plausibly interpreted as 
showing that binding of the repressor to an operator se-
quence inserted upstream of the transcription start point 
at the several sites that we have used inhibits either bind-
ing of RNA polymerase II or successful initiation of tran-
scription. Inhibition by repressor bound to the operator at 
a site that begins 42 nucleotides downstream of the start 
point may be due to steric interference with initiation or, 
more plausibly, may interfere with propagation of the tran-
scription complex. The latter view is consistent with the 
evidence that the lac repressor-operator complex is an ef· 
ficient terminator of transcription both in vivo and in vitro 
in a prokaryotic expression system (Deuschle et al. , 1986). 
In E. coli the p-galactoside IPTG is an efficient inducer 
of lac gene expression from the repressed state. Since we 
have shown that repressor protein can act on operator se-
quences in animal cells, we next asked whether IPTG in 
the external medium can relieve this repression. We there-
fore measured CAT enzyme activity as a function of time 
after the addition of IPTG to the medium. Transfected Ll-1 
cells were grown in the galactose-substituted DME me-
dium (see below) in the presence of 20 mM IPTG for 12 
to 48 hr. At various times thereafter, cytoplasmic extracts 
were prepared , and CAT enzyme activity was measured. 
As shown in Figures 5B-5E, treatment of the transfected 
cells with IPTG induces expression of CAT activity. Induc-
tion occurred rather slowly, being half-maximal after 12 hr 
(Figure 58) and nearing plateau by 24 hr (Figure 5C) . The 
level of induction is ca. 5-fold for the construct pSMA01 
(Figure 5E, lane 2) , 14-fold for pSMA02 (lane 3), 10-fold 
for pSMB01 (lane 4), 16-fold for pSMB02 (lane 5) , and 8-
fold for pSMC01 (lane 6). However, induction levels never 
returned to the fully derepressed level estimated from ex-
pression in LTK- cells. These experiments were carried 
out with galactose rather than glucose in the tissue culture 
medium, because galactose is a weak inducer of lac 
repressor whereas glucose is a weak anti-inducer in bac-
teria and in vitro (Barkley and Bourgeois, 1980; Riggs et 
al., 1970). The magnitude of induction in the presence of 
a given concentration of IPTG in the galactose-substituted 
DME media was about 2-fold higher than that in the 
glucose-containing DME media. There was no detectable 
induction in the galactose-substituted DME media in the 
absence of IPTG. In addition, we note that IPTG had no ef-
fect on the growth of Ll-1 or LTK- cells. 
The effects of IPTG were also monitored by measuring 
CAT mANA levels. The RNA dot-blot hybridizations (Fig-
ure 6C) show that the amounts of CAT-specific RNA in-
duced corresponded well with the levels of the CAT en-
zyme induced in transfected cells. The induction ratios in 
cells transfected with plasmids containing two tandem 
operators (pSMA02 and pSMB02) are greater than those 
for cells transfected with plasmids containing a single 
operator (pSMA01 and pSMB01). As previously noted, 
the repressed levels of expression are always lower for the 
plasmids containing two inserted operators than for the 
ones with a single operator. In neither case, however, 
does the maximally induced state reach the level ob-
served for the same plasmids in LTK- cells, where there 
is no repressor. 
In summary, these results show that the several 
MSV-CAT fusion genes carrying lac operators at different 
positions within the promoter regions were repressed by 
the lac repressor expressed in Ll-1 cells in the absence of 
IPTG and were derepressed by induction with IPTG . 
Operator Inserts Immediately Downstream of the 
TATA Box Shift the Transcription Start Site 
The current view on the function of the TATA element in 
higher eukaryotes is that it acts as a selector for transcrip-
tional initiation sites by defining a fixed number of base 
pairs downstream at which RNA polymerase begins tran-
scription . Consistent with this view, deletions of the TATA 
element result in heterogeneous initiation, and deletions 
that remove sequences downstream from a TATA element 
result in mANA initiated from a new site (Grosschedl and 
Birnsteil , 1980; BEmoist and Chambon, 1981; Mathis and 
Cham bon , 1981; Dierks et al. , 1981 ; Ghosh et al., 1981; Ka-
men et al., 1982; McKnight and Kingsbury, 1982; Dierks 
et al. , 1983). (Note, however, that it has been recently 
reported that yeast mANA initiation sites are determined 
primarily by specific sequences, not by the distance from 
the TATA element [Chen and Struhl, 1985; Hahn et al., 
1985).) 
It was therefore important to determine whether the 
operator insertions in the plasmids studied here would in-
fluence the choice of the transcription start site. We there-
fore performed CAT-specific primer extension experi-
ments with cytoplasmic RNA extracted from LTK- cells 
that had been stably transfected with each MSV-CAT fu-
sion gene tested . (Stable transfectants were used be-
cause of the greater specific activity of the CAT RNA in 
these samples.) We used as primer a 36 nucleotide 5'-
end-labeled oligonucleotide complementary to a se-
quence within the CAT gene (see Experimental Proce-
dures). With RNA from cells transfected with the parental 
plasmid pSM12, the primer extension product was ex-
tended to a length of 144 nucleotides, as expected (Figure 
7A, lane 3; the relevant sequences are shown in the leg-
end). In the plasmid pSMA01, an operator segment of 
24 
A B %CAT C %CAT D CAT RNA RNA RNA 
0 - pSMCOt - 2 pSMCOI - . 14 pSMCOI - • 
0.01- pSMB02- I p5>.'802- • 16 p$~2- • 
0.1 - • pSMBOI - 6pS~I - • 60 pSMBOI- • 
I - • pSMA02- 2 pSMA02- • 13 pSMA02 - • 
10 • pSMAOI - . 8 pSMAOI - • 40 pSMAOI - • 
100 - • p$Mt2 - • tOO pSMI2 - • 90 pSMI2 - • (ng) 
L_____j 
Probe CAT Ac l tn 
Figure 6. Analysis of CAT RNA Synthesized in the Absence or Pres-
ence of IPTG in LI-t Cells 
RNA dot-blot analyses were performed using RNA extracted from LI-t 
cells that had been transfected 48 hr previously with the indicated plas-
mid constructs. RNA samples (4 ~g per dot) were transferred to filters 
and were subsequently hybridized with an SP6-generated antisense 
CAT probe that hybridizes only to CAT-coding sequences or with an 
SP6-generated antisense actin probe (Hu et al. , t986) . (A) Nontrans-
fected LTK- cell RNA (2 ~g) plus 0, O.Dt , O.t , t, tO, or tOO ng of CAT 
RNA that was made by transcription in vitro of an SP6 clone (p64-CAT, 
which gives sense-strand RNA). (B) RNA from transfected LI-t cells 
cultured in the absence of IPTG . (C) From a differenttransfection , RNA 
from LI-t cells cultured in the presence of IPTG as described for Figure 
5E. (D) A control experiment of (B) that was probed with an SP6-
generated antisense actin probe. Controls show that the amount of to-
tal cellular RNA used per dot contributes negligibly to the signal in this 
assay. The relative CAT RNA in the respective transfectants was calcu-
lated after scintillation counting of each sample and comparing the 
radioactivities to that of the parental plasmid's CAT RNA. 
length 40 bp had been substituted for a 17 bp Stui-Hindlll 
fragment between the initiation codon and the transcrip-
tion start site. With the resulting RNA, the DNA primer was 
extended to about 168 nucleotides (Figure 7A, lane 4). 
Thus, the distance between the TATA region and the start 
site of RNA synthesis in this plasmid was the same as that 
in the parental plasmid pSM12. Furthermore, Figure 7B 
shows that mANA from the plasmid pSMC01 (lane 2), car-
rying one operator between the TATA region and the SV40 
21 bp repeats, has the same 5' end as the mANA from the 
parental plasmid pSM12. Therefore operator insertions 
downstream of the transcription start site or upstream of 
the TATA box do not affect the position of the transcription 
start site. However, when RNA from cells transfected with 
pSMB01 , containing one operator insertion between the 
transcription start site and the TATA box, was used as tem-
plate, the same primer was extended to 184 nucleotides 
(Figure 7A, lane 2, and see legend). This corresponds to 
a new start site at a T residue within the operator se-
quence. This new start site is 25 bp downstream of the res-
idue T15 of the TATA box (numbering as shown in Taka-
hashi et al. , 1986). Thus, these results support the view 
that the TATA region has a "fixing" function for the initiation 
of transcription in mammalian cells. 
Transfected Supercoiled DNA Becomes Nicked in 
LTK- Cells but Remains Mostly Intact in Ll-1 Cells 
We sought to confirm that the apparent repressor-
mediated repression of operator-containing MSV-CAT 
promoters was not caused by variation in plasmid copy 
number in the transiently transfected cells. Accordingly, 
total DNA was isolated from nuclei from transfected Ll-1 
cells by the Hirt procedure (Hirt, 1967) and was analyzed 
by electrophoresis on 1% agarose gels and subsequent 
blot hybridization to a 32P-Iabeled CAT probe. Results 
presented in Figure 8 show that the yields of the various 
CAT plasmid DNAs, as determined by Southern blotting, 
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Figure 7. Primer Extension Analysis of Cytoplasmic RNAs Produced 
by the MSV-CAT Fusion Genes Containing Operator Insertions 
(A) The 5'-32P-Iabeled 36 nucleotide synthetic oligonucleotide com· 
plementary to the CAT coding sequence (see Experimental Proce· 
dures) was hybridized to approximately 70 l'g total cytoplasmic RNA 
from LTK- cells transfected with the indicated plasmid constructs. The 
primer was then extended with unlabeled dNTPs with reverse tran-
scriptase, and the products were fractionated on a 6% polyacrylamide 
sequencing gel. As control experiments, the same primer was hybrid-
ized to either the same amount of total cytoplasmic RNA from non· 
transfected LTK- cells (lane 5) or no RNA (lane 6) . (B) The same 
primer was hybridized to approximately 70 11g total cytoplasmic RNA 
from LTK- cells transfected with pSMC01 (lane 2) and then extended 
as described above. The extended product is displayed on a 6% poly· 
acrylamide sequencing gel. The control experiments were performed 
as described above (lane 3, RNA from nontransfected LTK- cells; lane 
4, no RNA). 32P-Iabeled Hpallfragments of pBR322 served as nucleo-
tide size markers (M) . which are marked in the left margins. The band 
due to the extended product is identified by an arrow, and its length 
is indicated in the right margin of each panel. 
Synthesis of the observed eDNA products is depicted schematically 
below the figure. Symbols are the same as described in the legend to 
Figure 4. The 40 bp of the lac operator insertions is indicated by the 
hatched box. The primer is shown as a thin line, and extension prod· 
ucts as thick arrows. The relevant sequences are shown below: 
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could not account for the differences in RNA expression 
or CAT enzyme levels. It was quite surprising that most of 
the transfected supercoiled DNA remained intact after 48 
hr in the repressor-producing cells Ll-1 . Previous studies 
have shown that in transfection experiments, extracellular 
DNA that is not washed out when the culture medium is 
changed is completely degraded over a 22 hr period fol-
lowing transfection (Alwine, 1985). Therefore the DNA 
studied here, as isolated by the Hirt (1967) procedure, had 
been incorporated into the cells. In contrast, in other 
studies it has been reported that most of the transfected 
supercoiled DNA becomes nicked or linearized during the 
course of transfection (Weintraub et al., 1986). To inves-
tigate this further, we analyzed DNA from transfected 
LTK- cells by Southern blotting as described above. Fig-
ure 9 shows that after 48 hr the input supercoiled DNA 
was largely nicked (27%-62%), but only a small fraction 
(8%-13%) of DNA became linearized. (Nicked molecules 
were not distinguished from closed-circular relaxed 
molecules since they comigrated under the electrophore-
sis conditions used.) Moreover, some transfected DNA 
(10%-50%) became concatenated. We note that we did 
not see concatenation of transfected DNA in Ll-1 cells 
(Figure 8), probably because most of the DNA did not be-
come linearized. Thus there is less nicking and cutting of 
the plasmid DNA in the repressor-positive Ll-1 cells than 
in the repressor-negative LTK- cells. This phenomenon 
does not depend on the presence of an operator se-
quence in the plasmid; it was observed for pSM12 also. 
A plausible but speculative interpretation of these results 
is that the plasmids picked up a protective coat of lac 
repressor protein-because of its nonspecific DNA-bind-
ing properties (Lin and Riggs, 1972)-during their pas-
sage through the cytoplasm to the nucleus, where they 
became packaged into chromatin as minichromosomes 
(Cereghini and Yaniv, 1984; Reeves et al., 1985; Wein-
traub et al. , 1986). Furthermore, transfected DNA was 
found to be mostly unintegrated in LTK- and in Ll-1 cells 
in accordance with a previous report (Weintraub et al. , 
1986). The results presented in Figure 9 also indicate that 
thE1 quantity of transfected DNA taken up and persisting 
in nuclei was approximately the same for each plasmid, 
(Opuetor) 
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Figure 8. Southern Blot Analysis of Transfected DNA in the Nuclear 
Fraction of Ll-1 Cells 
Total DNA was isolated from nuclei from Ll-1 cells transfected 48 hr pre-
viously with the indicated plasmids in the absence of IPTG; DNA was 
analyzed by electrophoresis on 1% agarose gels and subsequent blot 
hybridization to an SPS-generated CAT probe (from p64-CAT, which 
gives sense-strand RNA). (A) DNA was undigested; (B) DNA was 
digested with Bam HI prior to electrophoresis. The lanes marked uncut 
(lane 1) and cut (lane 2) are samples of standard plasmid (0.1 l'g of 
pSM12), either intact or after digestion with BamHI , respectively. Ap-
proximately equal amounts of DNA were loaded in each lane. The form 
of the input DNA is indicated (nick. , nicked; lin., linearized; sc., super-
coiled), and the relative amount of DNA, as shown below (A), was 
quantitated by densitometric scanning and then normalized as a per-
centage of the total CAT DNA. 
and thus could not account for the differences in CAT ex-
pression between the operator-containing derivatives and 
the parental plasmids. 
Discussion 
Our overall result is that the bacterial lac repressor protein 
encoded in a suitable expression vector can be synthe-
sized in animal cells, assemble into a tetramer, enter the 
nucleus, and repress expression of another gene that has 
one or several lac operator sequences inserted into any 
one of several sites in the promoter region of th is plasmid. 
Derepression can be achieved by exposure of the cells to 
IPTG. 
In eukaryotes, most regulatory proteins are transported 
from their cytoplasmic site of synthesis and are localized 
primarily in the nucleus. This relatively strict nuclear ac-
cumulation is attributed to the presence in the protein of 
a distinctive stretch of amino acids that acts as a nuclear-
localization signal (Goldfarb et al., 1986; Richardson et 
al. , 1986; and also see Dingwall, 1985, for review). 
We observe that about 10% of the total lac repressor in 
Ll-1 cells, or about 2500 molecules, is located in the nu-
cleus. Since the nuclear volume is about 6% of the total 
cell volume in a mammalian cell (Alberts et al., 1983), the 
average concentration of repressor is about the same in 
the nucleus and cytoplasm. While this result can be ra-
tionalized in a number of ways, we find it rather surprising 
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Figure 9. Topology of Transfected DNA in Isolated Nuclei of LTK-
Cells 
Total DNA was isolated from nuclei from transfected LTK- cells at 48 
hr after transfection and then analyzed and quantitated as described 
in Figure 8. (A) Uncut DNA; (B) DNA digested with Bam HI before being 
separated on 1% agarose gels. High molecular weight DNA is indi-
cated as hmw. All other symbols are the same as in Figure 8. 
properties of repressor. In any case, with a diploid genome 
size of 6 x 109 bp, Ll-1 cells contain approximately one 
repressor per 2 x 106 bp of DNA. In E. coli, with a ge-
nome size of 4.2 x 106 bp and perhaps two chromo-
somes per cell, and with ca. 10 repressor molecules per 
cell (Muller-Hill et al., 1968), there is ca. one repressor per 
4.2 x 105 bp. These numbers are not greatly different. It 
is of interest to note that Chao et al. (1980) have reported 
that, in vitro, assembly of lac operator-containing DNA 
into nucleosomes with qctameric histone cores does not 
affect specific sequence recognition by repressor, or 
IPTG-induced dissociation, but that nonspecific binding of 
repressor to DNA is considerably diminished. Specific 
recognition presumably shows that the repressor-binding 
surface of the operator DNA faces outward on the nucleo-
some. Our results showing specific gene regulation by lac 
repressor but limited overall nuclear localization are totally 
consistent with their results. We note further that Silver et 
al. (1986) have reported very recently that the DNA-bind-
ing protein lexA and a lexA chimeric DNA regulatory pro-
tein are localized predominantly in the cytoplasm in yeast 
cells. 
The data in Figure 8 show that 48 hr after transfection, 
there are about 150 6 kb plasmid molecules per nucleus, 
corresponding to an additional 9 x 105 bp. These DNA 
molecules have entered the nucleus by passage through 
the cytoplasm. They may have thus acquired an addi-
tional coating of repressor, as suggested by the apparent 
protection against nicking observed in the Ll-1 cells. (How-
ever, our preliminary results with cells in which some of 
the plasmids derived here have been stably transfected 
into the chromosomal DNA of Ll-1 cells are that the levels 
of repression are about the same. Thus, the phenomena 
of repression are not dependent on recent exposure of the 
DNA to the cytoplasm.) 
By comparison of the expression levels of the plasm ids 
in repressor-positive Ll-1 cells and repressor negative 
LTK- cells, we deduce repression levels of 8--12-fold for 
a single operator insert and 24-48-fold for two in tandem. 
This is substantially less than the ratio of induced to 
repressed expression of the lac operon in E. coli, which 
may be as high as 1000-fold (Gilbert and Muller-Hill, 1970). 
The reasons for this are unknown. They may be related 
to the different molecular environments of the operator 
DNA sequence in eukaryotic chromatin and in a bacterial 
cell. However, our results are concordant with recent ex-
periments that show approximately 10-fold repression, by 
the mechanism of transcription termination, where the lac 
operator sequence is inserted downstream of coliphage 
T5 promoter and assayed in E. coli (Deuschle et al. , 1986). 
Whether the extent of repression could be augmented by 
increasing the overall level of expression of repressor pro-
tein or by adding a eukaryotic nuclear localization signal 
at an appropriate point in the protein is not known at 
present. 
Furthermore, we note that while a significant level of 
derepression (60%-80%) can be achieved with IPTG, it is 
not fully reversible, and it occurs slowly (ca. 24 hr). This 
limited induction may be related to the limited permeabil-
ity of the eukaryotic plasma membrane to IPTG, but we 
have no data bearing on this question. In E. coli , IPTG nor-
mally enters through the inducible lac permease system 
(Kennedy, 1970); nevertheless, permease-negative mu-
tants are still inducible for lacZ by IPTG, although the in-
ducer uptake rate is reduced (Herzenberg, 1959). 
From a practical point of view of an inducible genetic 
switch , the induction ratios achieved at present with the 
lac operator system are not better than those that have 
been achieved with heat shock, mouse mammary tumor 
virus, and metallothionein promoters. There may, how-
ever, be some situations and some promoters for which 
the use of the lac operator system is advantageous. Fur-
ther work may reveal methods for achieving higher induc-
tion ratios. It will be of interest to test whether the induction 
ratios observed here can be increased by applying gluco-
corticoids, since it has been recently reported that the ex-
pression of genes fused downstream of the MSV LTR is 
stimulated 3- to 5-fold by hormone treatment (DeFranco 
and Yamamoto, 1986). 
Our results on the effects of operator insertions and 
repressor binding on transcript levels have interesting im-
plications for general mechanisms of regulation of gene 
expression. Specific cases are discussed below. We ob-
serve that inserting either one or two copies of the 40 bp 
operator sequence between the TATA box and the 21 bp 
repeats reduces expression by a factor of approximately 
5 (pSMC01 and pSMC02, Figure 4). Specific transcrip-
tion factors related to the SP1 factor are believed to bind 
to the 21 bp repeats and contact a protein bound to the 
TATA box (for review, see Dynan and Tjian, 1985); the lat-
ter, in turn , interacts with RNA polymerase II to activate the 
transcriptional machinery. When this SP1 factor and the 
TATA box factor are separated by one or two lac operators, 
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transcription rates are reduced. The interactions must 
now require interaction at a distance-for example, by 
looping (Ptashne, 1986). Binding of repressor to the oper-
ator sequence in this position greatly inhibits transcrip-
tion; presumably the lac repressor protein presents a 
steric block to the normal protein-protein interactions. 
Takahashi et al. (1986) have tested the effects of altering 
the stereospecific relationships of SV40 promoter ele-
ments by constructing insertions of 4 or 15 bp between the 
21 bp repeats and the TATA box region. These insertions 
decrease transcription in vivo more drastically than inser-
tions of 10 or 21 bp because they place the interacting pro-
teins on opposite sides of the DNA helix. The lac operator 
sequence used by us is 40 bp in length , which is approxi-
mately an integral number of turns. Thus the effects ob-
served here in the absence of repressor are mainly due 
to increased distance, not opposite orientation relative to 
the helix axis. 
In agreement with earlier studies, we observed that 
placement of a 40 bp operator segment between the TATA 
box and the normal transcription start point changes the 
start point to a new site, which is again about 25 nucleo-
tides from the TATA box (see legend to Figure 7). In the 
presence of the repressor, transcription is reduced by a 
factor of about 12. We were unable to map the start point 
in the repressed state because of the amount of RNA pro-
duced; if it is the same, we assume that the binding of a 
protein to the TATA box or of RNA polymerase II close to 
the transcription start point can displace the binding of 
repressor to the operator. 
Finally, binding of repressor to an operator inserted 
downstream of the transcription start point also inhibits 
transcription . This is most plausibly interpreted as a block 
to passage of the transcription complex, in agreement 
with recent results for E. coli RNA polymerase in vivo and 
in vitro (Deuschle et al., 1986). In addition , we note that 
insertion of operator sequences between the transcription 
start point and the initiation codon may result in the forma-
tion of a hairpin structure in the 5'-untranslated region of 
the mANA, thus affecting translation initiation. The lac 
operator sequence has extensive bilateral symmetry 
(Barkley and Bourgeois, 1980). This hypothesis is sup-
ported by recent experiments in which hairpin structures 
were generated upstream of the initiator codon by oligonu-
cleotide insertion, thus leading to a drastic reduction in 
translation (Kozak, 1986). 
Experimental Procedures 
Site-Directed Mutagenesis of the lac/ Gene 
The /acf'l gene contained in plasmid piO (J. L. Betz, unpublished 
results) was excised by EcoRI and Hincll digestions, and subcloned 
into the EcoRI and Hincll sites of the vector M13mp19 (Yanisch-Perron 
et al. , 1985). The oligonucleotide 5'-TGGTGAATATGAAACCAG-3' was 
employed as a mismatched primer to introduce a G-to-A mutation of 
the GTG initiator codon . The 5'-phosphorylated mutagenic primer 
and the M13 primer 5'-ATGCCCCCTGCCTATTTCGG-3' (nucleotides 
2054-2073 of M13mp19) were simultaneously annealed to a single-
stranded noncoding template of the /ac/-M13 clone, extended with 
E. coli DNA polymerase I large fragment (Kienow) , and ligated essen-
tially as described by Zoller and Smith (1984) . Following transformation 
into strain JM101 and screening for the mutant template, single-
stranded DNA of the mutated lacl (/ac/'")-M13 was prepared, and the 
entire DNA insert was sequenced by the dideoxy chain-terminating 
method (Sanger et al. , 1977; Biggin et al. , 1963). Double-stranded (M13 
AI form) DNA for the mutant lac/"' gene was excised with EcoRI and 
Hincll and was reintroduced into the corresponding sites of an SP62 
vector together with the 0.6 kb Hincii-EcoRI DNA fragment of the 3' 
portion of the lac/ gene. This mutant plasmid was designated 
plmSP62. To delete the operator sequence downstream of the termi-
nation codon of the lac/ gene, plmSP62 DNA was digested with 
BamHI and Sphl , thus generating a 3'-protruding end that protected 
the remainder of the vector from exonuclease Ill attack, and unidirec-
tionally deleted by exonuclease Ill (Henikoff, 1964). This DNA was ren-
dered blunt-ended with T4 DNA polymerase, ligated with T4 DNA li-
gase, and used to transform the MC1061 .2 strain of E. coli. 
Subsequently, these plasmids were excised by EcoRI and Sail diges-
tions, and the mutant /ac/m-containing fragments were cloned into the 
corresponding sites of the M13mp16 vector. Single-stranded DNA was 
prepared from a plaque-purified phage, and the DNA sequence at the 
deletion junction was determined using the dideoxy chain-terminating 
method (Sanger et al., 1977; Biggin et al., 1963). 
Construction of the /ac/ Expression Vector pRSV-1 
The plasmid plmSP62, carrying the entire sequence of the lac/ gene 
(from 30 nucleotides upstream of the primary translation initiation site 
to 16 nucleotides downstream of the termination codon) was digested 
with EcoRI , blunt-ended with Klenow fragment in the presence of 
dNTPs, annealed with Hindi! I linker, ligated with T4 DNA ligase, and 
digested with Hindi! I. The 1.3 kb Hindiii-Sall fragment was purified by 
electrophoresis in low-gelling-temperature agarose (1 .0°Al SeaPiaque 
agarose; FMC Corporation , Marine Colloids Division) and was sub-
cloned into pRSV-CAT (Gorman et al., 1962b). This plasmid was 
digested with Hpal, annealed with Sail linker, ligated with T4 DNA li-
gase, and then redigested with Sail and Hindi! I. The 3.5 kb Hindiii-Sall 
fragment was gel-isolated and then ligated with the 1.3 kb Hindiii-Sall 
fragment of /actm and then used to transform MC1061 .2. In the result-
ing plasmid, designated pRSV-1 , a /act-encoding region is installed un-
der transcriptional control of the RSV LTR. This plasmid carried an 
SV40 poly(A) addition signal and was used for the expression of the 
lac repressor protein in LTK- cells (see below). 
Construction of CAT Plasmlds Containing Operator Inserts 
Plasmid p0E101 , carrying 12 tandem copies of the lac operator (Sadler 
et al. , 1960), was partially digested with EcoRI. The ends of the opera-
tor monomer and oligomers were then repaired with Klenow fragment 
in the presence of dNTPs. Operator-inserted CAT plasmids were con-
structed by the following procedures. First, for insertion between the 
initiation codon (ATG) and the transcription start point, parental plas-
mids pSM11 and pSM12 (containing the MSVenhancer in the opposite 
orientations, respectively, and also containing the SV40 21 bp repeats 
and its promoter, the coding sequences from the CAT gene, and the 
SV40 poly[A) addition signal ; Laimins et al. , 1964) were linearized by 
digestion with Stu I and Hind Ill. The DNA molecules were fractionated 
by agarose gel electrophoresis, and the linearized large fragments 
(about 6 kb) of the plasmids were extracted and purified . The ends of 
the DNA fragments were repaired with Klenow fragment in the pres-
ence of dNTPs, and the blunt-ended operator monomer and oligomers 
mixture was then added and ligated with T4 DNA ligase. Thus, the 
Stui-Hindlll segment (17 bp) of each parental plasmid was replaced 
by single or multiple tandem operator sequences in the resultant plas-
mids. Second, for insertion between the transcription start point and 
the TATA box region , pSM11 and pSM12 was digested with Bgll, 
repaired with Klenow fragment in the presence of dNTPs, incubated 
with the blunt-ended operator monomer and oligomer mixture, and 
simultaneously ligated with T4 DNA ligase and used to transform 
MC1061 .2. The resultant plasmids thus contained single or multiple 
tandem operator sequences between the transcription start and the 
TATA box regions. Third , for insertion between the TATA box and SV40 
21 bp repeats regions, pSM11 or pSM12 was partially digested with 
Ncol , and the full-length linearized plasmid DNA was fractionated by 
agarose gel electrophoresis. The ends of the DNA were filled in with 
Klenow fragment in the presence of dNTPs, the blunt-ended operator 
monomer and oligomers were added, and the DNA mixture was ligated 
with T4 DNA ligase. The resultant plasmids tnerefore included single 
or multiple tandem operator sequences between the TATA box and the 
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SV40 21 bp repeat regions. Subsequently, all of the operator-
containing plasmids were excised by EcoRI and Sail digestion and 
were cloned into the corresponding sites of M13mp16. That single or 
multiple tandem operator sequences were in fact introduced into the 
CAT plasm ids at the sites indicated was verified by DNA sequencing 
(Sanger et al., 1977; Biggin et al., 1963). 
Cell Culture and Stable Transfectants 
Mouse LTK- cells were grown in Dulbecco's modified Eagle's (DME) 
medium supplemented with 10% fetal calf serum. Cells to be trans-
fected were plated on the day before transfection at a density of 1.0 x 
106 cells per 60 mM dish . LTK- cells were cotransfected with a 50:1 
molar ratio of pRSV-1 and pTK-5 (Roach et al., 1964), which carries the 
3.5-kb tk-coding Bam HI fragment of the herpes simplex virus type 1 tk 
gene. Calcium phosphate precipitates of the plasmid DNA were pre-
pared as described elsewhere (Gorman et al., 1962a). The precipitate 
was left on the cells for 16 hr, a fresh aliquot of medium was supplied , 
and the cells were incubated without selection for 24 hr prior to addi-
tion of HAT medium (DME medium containing 10°Al fetal calf serum, 
0.1 mM hypoxanthine, 0.4 ~M aminopterin , 16.0 ~M thymidine) . Resis-
tant colonies were isolated and expanded after 14 days. Transfectants 
expressing the lac/ gene were initially identified by RNA dot blots and 
were then characterized by an operator-binding assay to quantitate the 
amount of functional repressor protein (see below). In addition, the lev-
els of repressor protein in the nucleus and in the cytoplasm were quan-
titated and estimated by Western blotting and radiographic detection 
with antibody. 
Transient Transfection and CAT Assay 
LTK- cells and lac repressor-producing cells (LI-1) were grown in 
DME supplemented with 100,t, fetal calf serum and in HAT medium, 
respectively. Cells to be transfected were plated on the day prior to 
transfection at a density of 1.2 x 106 cells per 60 mM dish. DEAE-
dextran transfections were performed by washing the cells twice with 
DME without serum and then adding 500 ~g/ml DEAE-dextran (Sigma 
Chemical Co., MW 500,000) in DME with the appropriate DNA in the 
presence of chloroquine (2 ~g/ml) . Incubations were for 4 hr at 37"C 
including 1 hr of initial incubation in 20A> C02 and 3 hr of incubation 
in 5°Al C02 as described by Sussman and Milman (1964). The cells 
were shocked with dimethyl sulfoxide for 2 min at 37"C according to 
Sussman and Milman (1964); the media were replaced, either with or 
without IPTG (20m M final concentration), and the cells were incubated 
for 46 hr before harvesting. Each plasmid preparation used for trans-
fection was purified through two CsCI-ethidium bromide equilibrium 
gradients. After transfection, the CAT extractions and assay were per-
formed using equal amounts of protein from the cellular extracts ac-
cording to Gorman et al. (1962a). 
Isolation and Analysis of Plasmid DNA from Transfected Cells 
Total DNA was isolated from nuclei from transfected cells by the 
method of Hirt (1967). The supernatants were phenol-extracted twice, 
chloroform-extracted once, and the DNA was ethanol-precipitated. The 
pellets were washed with 75% ethanol, dried, and dissolved in 20 ~I 
of TE (10 mM Tris-HCI , 1 mM EOTA). Equivalent portions of each sam-
ple were digested with BamHI. The digests and an equivalent portion 
of each undigested sample were electrophoresed on 1% agarose gels 
and then blotted to Zeta-probe (Bio-Rad) or Hybond-N (Amersham) 
membranes, and plasmid DNA was visualized by hybridization with 
32P-Iabeled SP6-CAT RNA. After autoradiography, the resultant bands 
were quantitated by densitometric scanning and comparison with the 
intensities of bands of known amounts of purified plasmid DNA. 
Isolation and Analysis of RNA from Transfected Calls 
Cytoplasmic RNA was isolated from mouse LTK- or Ll-1 cells. Trans-
fected cells were washed with PBS (phosphate-buffered saline), 
scraped off with 5 ml of PBS, and centrifuged. The pellet was 
resuspended in 0.1 ml of 0.25 M Tris-HCI, and the cell suspension was 
frozen and quickly rethawed four times on dry ice. Nuclei were re-
moved by centrifugation in an Eppendorf microfuge for 15 min (4°C), 
and RNA was isolated from the resulting supernatant according to Gor-
man et al. (1962b) . An equal volume of a solution of 7 M urea, 0.35 M 
NaCI, 10 mM Tris-HCI (pH 6.0), 10 mM EOTA, 1% SDS and about 40 
~g of tRNA per ml were added. The mixture was extracted twice with 
phenol-chloroform-isoamyl alcohol (20:20:1 (v/v]) and twice with chlo-
roform-isoamyl alcohol. After precipitation with ethanol the RNA was 
collected by centrifugation and was resuspended in 10 mM Tris-HCI , 
0.1 mM EDTA, 0.1% SDS. Equivalent portions of each RNA sample 
were assayed by dot-blot analysis using an SP6-generated antisense 
lac/ probe. an SP6-generated antisense CAT probe, or an SP6-
generated antisense actin probe (Hu et al. , 1986). Approximately 70 ~g 
of each cytoplasmic RNA preparation was used for each primer exten-
sion experiment, and the 36 nucleotide 32P-Iabeled oligonucleotide 5'-
TGCCATffiGGATATATCAACGGffiGTATATCCAGTG-3' (complemen -
tary to a region of the CAT mRNA started at 12 nucleotides downstream 
of the initiation codon AUG) was used as primer. Primer extension was 
performed as previously described (Hu et al.. 1986) except that the 
cloned Moloney murine leukemia virus reverse transcriptase (BRL) 
was used in extension . 
Western Blot Analysis 
Crude cytoplasmic and nuclear extracts from Ll-1 and LTK- cells were 
prepared from two 100 mM dishes near confluence. The cells were 
washed with PBS. scraped off with 5 ml of PBS, and centrifuged. The 
pellet was resuspended in 0.1 ml of cold lysis buffer containing 0.2 M 
potassium phosphate (K2HP04 :KH2P04 : 5:1, pH 7.4). 0.1 mM EDTA. 
0.3 mM DTT, 5°/o (w/v) glucose. 25 ~M leupeptin, 1 ~g/ml bestatin . 10 
~g/ml trypsin inhibitor, and 1 mM PMSF. The cell suspension was 
freeze-thawed four times on dry ice, and the nuclei and the cell debris 
were sedimented . The supernatant was used for Western blot analysis 
and for the repressor-operator filter-binding assay (see below) . The 
nuclear pellet was resuspended in 0.1 ml of homogenization buffer 
(0.5% NP40, 0.2 mM EDTA) and homogenized. The homogenate was 
treated with DNAase I (1 mg/ml final concentration) for 1 hr at 37"C and 
then mixed with the electrophoresis sample solution (2x ESS: 20 mM 
Tris-HCI , 5 mM EDTA. 4% SDS, 20% glycerol , 10% P-mercaptoeth-
anol . 0.5 mg/ml bromophenol blue (pH 7.0] ). Equal amounts of protein 
from cytoplasmic extracts of Ll-1 and LTK- cells ("'2 x 106) were also 
mixed with equal volumes of 2x ESS. In addition , 14C-Iabeled 
molecular weight standards (BRL) were included. The samples were 
subjected to SDS-10% polyacrylamide gel electrophoresis and then 
transferred to nitrocellulose according to Burnette (1981). The filter was 
probed with anti-repressor monoclonal antibody B-2 (Sams et al. , 
1985) followed by 1251-labeled sheep anti-mouse immunoglobulin 
(Amersham). air-dried, and exposed to X-ray film . The amount of 
repressor protein was quantitated by scanning the autoradiograph. 
Other Methods 
Nucleic acid manipulations and blot hybridizations were according to 
standard procedures (Maniatis et al. , 1982; Reed and Mann, 1985). In 
vitro transcription with SP6 polymerase employed methods and rea-
gents as described by Melton et al. (1984) . The filter-binding assay of 
repressor-operator complexes was performed essentially as de-
scribed by Lin and Riggs (1972) except that the DNA probe used was 
a gel-purified 32P-end-labeled operator fragment of 40 bp. Protein 
content of cellular extracts was measured by the method of Bradford 
(1976). 
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of expression of injected DNA in Xenopus oocytes. 
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SUMMARY 
We have investigated the use of the Escherichia coli lac operator-repressor system to regulate the expression 
of genes introduced by microinjection into Xenopus laevis oocytes. We observe that expression of an MSV-cat 
fusion gene, in which the lac operator was inserted between the TAT A box and the transcription start point 
(tsp ), or between the tsp and the start codon (ATG }, is completely repressed when the lac repressor protein 
is added to the plasmid suspension prior to injection. The lac repressor had no detectable effect on the 
expression of a coinjected HSV-1 tk gene that had no operator insertion (or on an MSV-cat gene without an 
operator), indicating that the nonspecific DNA-binding properties of the repressor do not inhibit transcription. 
CAT activity expressed from the operator-containing MSV -cat genes transcribed in the oocyte nucleus was also 
inhibited by repressor injected into the oocyte cytoplasm, showing that biologically active repressor proteins 
can enter the nucleus from the cytoplasm. Injection of the inducer IPTG into the oocyte cytoplasm markedly 
derepressed the repressed cat genes but not the HSV-1 tk gene coinjected as an internal control. Overall, our 
results show that the lac operator-repressor system can be useful as a genetic switch in the regulation of gene 
expression of injected DNA in frog oocytes. Finally, our observations on the vectors used in this work show 
that the MSV enhancer significantly activates transcription from the SV40 early promoter in frog oocytes, 
although previous studies have indicated that the MSV enhancer is not necessary for the activity of the MSV 
promoter in oocytes [Graves et al., Mol. Cell. Bioi. 5 ( 1985) 1945-1958). 
Co"espondence to: Dr. N. Davidson, Church Chemical Labora-
tories, 164-30, California Institute of Technology, Pasadena, CA 
91125 (U.S.A.) Tel. (818)356-6055. 
Abbreviations: bp, base pair(s); BSA, bovine serum albumin; 
buffers B, R, ND-96, see MATERIALS AND METHODS, 
section b: CAT, Cm acetyltransferase; cat, gene coding for CAT; 
Cm, chloramphenicol; dNTP, deoxynucleoside triphosphate; 
DTT, dithiothreitol; HSV, Herpes simplex virus; IPTG, isopro-
pyl-P-o-thiogalactopyranoside; LTR, long terminal repeat; 
MSV, Moloney murine sarcoma virus; nt, nucleotide(s); ori, 
origin of DNA replication; PA, polyacrylamide; RSV, Rous sar-
coma virus; SDS, sodium dodecyl sulfate; SV, simian virus; tk, 
thymidine kinase gene; tsp, transcription start point. 
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INTRODUCTION 
The control of gene expression can occur, in prin-
ciple, at a number of levels, the most basic of which 
is transcription initiation. Repression by binding of 
the lac repressor to the lac operator and derepression 
by action of inducers such as IPTG is one of the 
most thoroughly studied and best understood 
examples of a protein-nucleic acid interaction that 
regulates transcription of a gene in prokaryotic sys-
tems (for reviews, see Beckwith and Zipser, 1970; 
Miller and Reznikoff, 1980). Recently, we and others 
have reported that the lac operator-repressor system 
is functional in mammalian cells in culture and 
can be used as an inducible genetic switch for gene 
transfer experiments (Hu and Davidson, 1987; 
Brown et al., 1987). 
We report here the results of our concurrent 
studies of the properties of the lac operator-repressor 
system for control of the expression of genes intro-
duced by microinjection into Xenopus oocytes. The 
oocyte system has certain advantages over, and 
certain differences from, mammalian cells for studies 
of problems in gene expression . (For general reviews 
of expression of injected genes in Xenopus oocytes, 
see Gurdon and Melton, 1981; Gurdon and 
Wickens, 1983; Colman, 1984a.) First, in oocytes, 
genes can be introduced in controlled quantities and 
in a controlled physical state (e.g., supercoiled, 
linearized, etc.) by microinjection. By contrast, in 
transient expression gene transfer experiments in 
mammalian cells, the copy number of transfected 
genes per cell is greatly variable with time and quite 
heterogenous, and the level of expression is quite 
variable from cell to cell (Domen et al., 1986; 
Alwine, 1985; Spandidos and Wilkie, 1984). Second, 
regulatory molecules can be introduced into an 
oocyte in a controlled manner, but there is no con-
venient controllable way of introducing a defined 
amount of a regulatory protein or an inducer into a 
mammalian cell. Third, the effects of transcriptional 
enhancers on gene expression are sometimes differ-
ent in oocytes than in mammalian cells . We antici-
pate that the present system will be useful as a tool 
for the study of the mechanism of enhancer function 
and hence of these differences. 
33 
MATERIALS AND METHODS 
(a) Plasmid constructions 
Plasmid constructions of operator-carrying cat 
plasmids have been described previously (Hu and 
Davidson, 1987). Plasmid pSME01 was con-
structed by inserting one operator sequence (40 bp) 
into the Bgll site of pSM II, between the tsp and the 
TATA box region. Plasmid pSMDOI was con-
structed by replacing the Stui-Hindiii segment 
(21 bp), between the tsp and the start codon (ATG), 
by one operator sequence (40 bp). Plasmid pTK-5 
(Roach et al., 1984) was constructed by inserting the 
3.5-kb BamHI fragment containing the tk gene of 
HSV-1 (McKnight, 1980; Wagner et al., 1981) into 
the Bam HI site of pBR322. 
(b) Oocyte preparation and injection 
Adult female Xenopus laevis were purchased from 
N asco (Ft. Atkinson, WI), anesthetized by im-
mersion in MS-222 (Sigma), and an ovarian frag-
ment was excised as described (White et al., 1985; 
Colman, 1984b). Stage-Y and stage-VI oocytes (Du-
mont, 1972) were isolated from the ovarian tissue by 
collagenase treatment (White et al., 1985) and placed 
in ND-96 buffer (96 mM NaCI, 2 mM KCI, 1.8 mM 
CaC12, I mM MgCI2 , 5 mM Hepes/NaOH, pH 7.6) 
supplemented with 2.5 mM sodium pyruvate at 
20 ° C. In preparation for injection, CsCl-density-
gradient-purified plasmid DNA was dissolved at a 
concentration of 350 J.Lgfml in B buffer (10 mM 
Tris · HCl, pH 7.4, 3 mM magnesium acetate, 
0.1 mM EDTA, 0.1 mM DTT, 50 J.Lgfm! BSA). 
About 10-20 nl of this solution was injected into the 
nucleus of each oocyte as described by Gurdon and 
Wickens (1983) and Colman (1984a). The purified 
E. coli lac repressor (kindly provided by Sheldon 
York, University of Colorado) was dissolved in R 
buffer (0.2 M potassium phosphate, pH 7.4, 0.1 mM 
EDTA, 0.3 mM DTT, 5% [w/v] glucose, 50 J.Lgfml 
PMSF). The repressor solution was diluted into B 
buffer at a final concentration of0.14 mgjm! prior to 
injection into the oocyte nucleus. In experiments 
where the repressor was injected into the cytoplasm, 
about 50 nl of the repressor solution (1.35 mg/ml) 
was injected into the cytoplasm of each oocyte. 
When it was necessary to give oocytes a second 
InJection in a specific location with respect to the 
first, only oocytes showing a trace of the first in-
jection site were used (the injection site is very 
frequently marked by a concentration of pigment). In 
some experiments where the inducer IPTG was 
injected, about 20 nl of0.5 M IPTG (in sterile water) 
solution was injected into the cytoplasm of each 
oocyte. Groups of 30 to 60 oocytes were injected in 
each experiment and then incubated in ND-96 buffer 
supplemented with 10 Jlg/ml penicillin and 10 Jlg/ml 
streptomycin for 48 h at 20 °C. Batches of ten 
healthy-looking oocytes were taken for analysis of 
RNA or enzyme activity. 
(c) Extract preparation and CAT assay 
Microinjected oocytes were washed briefly in ND-
96 buffer, suspended in 200 Jll of homogenization 
buffer (100 mM NaCI, 20 mM Tris · HCI, pH 7.6, 
I % Triton X-100, I mM PMSF), homogenized and 
centrifuged (12000 x g, 15 min) in a microcentrifuge 
to pellet insoluble material. The cytoplasmic extract 
was then removed carefully to avoid lipid contami-
nation, and a 20-Jll portion was incubated with a 
solution of 100 Jll of 250 mM Tris · HCI (pH 7.8), 
20 Jll of 4mM acetyl coenzyme A, and 10 Jll of 14C-
Iabeled Cm (0.2 11Ci, approx. 50 mCi/mmol ; Amer-
sham Corp.) for 2h at 37 °C. E. coli CAT (P-L 
Biochemicals Inc.) was used as a control. Cm was 
then extracted with I ml of cold ethyl acetate and 
chromatographed as described by Gorman et al. 
(1982a). For quantitation of CAT activity, reactions 
were in the linear range (no more than 40 % Cm 
acetylated). 
(d) RNA isolation and analysis 
Total RNA was extracted from pooled injected 
oocytes and digested with proteinase K primarily as 
described (Probst et al., 1979; Colman, 1984a). Ho-
mogenate was extracted twice with phenol-chloro-
form-isoamyl alcohol (20 : 20 : 1, v/v) and once 
with chloroform-isoamyl alcohol. After precipi-
tation with ethanol, the RNA was collected by cen-
trifugation and resuspended in 10 mM Tris · HCI 
(pH 7.4), 0.1 mM EDTA, 0.1% SDS. 
Primer extension analyses were performed as pre-
viously described (Hu et al ., 1986) ~o detect accumu-
lated tk transcripts in total RNA purified from 
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injected oocytes. The 33-nt 32P-Iabeled synthetic 
oligodeoxynucleotide 5' -dGTGCGGGAGTIT-
CACGCCACCAAGATCTGCGGC-3 ' (synthe-
sized by S. Horvath, Caltech, on an automated 
DNA synthesizer) was used as primer to hybridize 
to RNA transcribed from the pTK-5 template. The 
synthetic oligodeoxynucleotide is complementary to 
a region of the tk mRNA started at 44 nt down-
stream from the tk mRNA cap site. Therefore, the 
primer extension product observed from RNA tran-
scribed from the pTK-5 template is 77 nt in length. 
Extension products were sized by electrophoresis on 
a 9% PA-8 M urea sequencing gel in Tris-borate-
EDT A buffer, and detected by autoradiography of 
the dried gel. Primer extension mapping of RNA 
transcribed from the MSV-cat template was per-
formed as previously described (Hu and Davidson, 
1987). 
RES ULTS 
(a) The lac operator-repressor complex functions as 
a regulatable switch in Xenopus oocytes 
The transcriptional units used in these experi-
ments (Fig. lA) were also used by us in our recent 
studies of the lac operator-repressor system in mam-
malian cells (Hu and Davidson, 1987). In these con-
structions, the lac operator sequence has been in-
serted into a selected site in the region of the 
promoter ortsp of a plasmid, pSMil. In pSMII, the 
E . coli cat gene coding sequence is transcribed under 
the control of a chimeric promoter consisting of part 
of the SV40 early promoter, coupled to the MSV 
enhancer (Laimins et al. , 1984). SV40 RNA pro-
cessing signals, the small-t intron and early poly( A)-
addition signal, are provided at the 3' end of the 
gene. This particular construction was useful since 
the effect of the MSV enhancer in augmenting ex-
pression in mammalian cells had already been re-
ported (Laimins et al., 1984 ). 
As can be seen in Fig. lA, in the plasmid 
pSMEOI an operator sequence has been inserted 
16 n t down stream from the second A of the TAT A 
box and therefore 9 nt upstream from the tsp. In the 
plasmid pSMDOI, the operator is inserted 40 nt 






















Fig. I. Schematic representation of structure of operator insertions in the promoter regions and plasmid pTK5. {A) The organization 
of the SV40 early promoter region in parental plasmid {pSMII) and in its derivatives containing the lac operator insertions is depicted. 
The hatched boxes to the left of the SV40 promoter (21, 21, 22) illustrate the MSV enhancer (the 73/72 bp tandem repeats; Laimins 
et a!., 1984 ). The SV40 21-bp repeats, T A TA box, tsp , start codon (A TG ), CAT-coding sequences {boxed region), the SV40 small-t intron 
(intron) and early poly (A)-addition signal are indicated. The positions of the lac operator (0) insertion are shown as triangular inserts. 
Plasmid pSMEOI carries one operator insertion between the TATA box region and the tsp, whereas plasmid pSMDOI carries one 
operator insertion between the tsp and the start codon {ATG). As a control for the activity of the MSV enhancer in Xenopus oocytes, 
the plasmid pA 10CAT that contains the SV40 promoter elements but no enhancer sequences is used. (B) Structure of plasmid pTK-5. 
The 3.5-kb Bam HI fragment containing the HSV-1 tk gene (stippled box) is inserted into the Bam HI site of pBR322 vector. Amp', 
ampicillin-resistance (bla) gene. Ori, origin of DNA replication. 
from the A of the cat gene initiator (ATG). We first 
tested whether CAT enzyme activity could be detect-
ed in Xenopus oocytes after injection of these plas-
mids into the nucleus under the usual conditions 
(5 ngofeach DNA injected per oocyte)(Gurdon and 
Melton, 1981; Gurdon and Wickens, 1983). As a 
control (see below), the plasmid pTK-5 (Fig. 1B) 
containing a HSV-1 tk gene was coinjected with the 
pSM plasmids. As shown in Fig. 2A, Exp. 1 (each set 
of two Janes shows duplicate experiments) and in 
Fig. 3A, Exp. 1, extracts prepared from pSME01-
injected oocytes and from pSMD01-injected 
oocytes, respectively, contained readily detected 
amounts of CAT enzyme. When the same mixture of 
either plasmid was premixed with the purified E. coli 
lac repressor protein (at a ten-fold molar excess over 
the pSM plasmid), and injected into the oocyte 
nucleus, cat gene expression was undetectable 
(Fig. 2A, Exp. 2 [the second set of two lanes]; and 
Fig. 3A, Exp. 2). No CAT enzyme activity was 
detected in uninjected oocytes, confirming the obser-
vation by Jones et al. (1983) that Xenopus oocytes are 
devoid of endogenous CAT activity. It should be 
noted that oocytes from different frogs have a high 
degree of variability in their ability to synthesize the 
CAT enzyme (Jones et al., 1983). Thus, the CAT 
activities from these two experiments (pSMEO 1 and 
pSMD01) are not directly comparable. 
In E. coli, IPTG added to the external medium is 
an efficient inducer of lac gene expression from the 
repressed state, we therefore tested whether IPTG 
would also relieve repression in oocytes. As shown 
in Fig. 2A, Exp. 4 (the fourth set of two lanes), and 
Fig. 3A, Exp. 4, injection of DNA plus repressor 
into oocyte nuclei, followed by incubation in an 
external medium containing 20 mM IPTG for about 
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Fig. 2. Effect of lac repressor on the cat expression from plasmid pSMEOI and mapping of transcripts. (A) CAT synthesis in the absence 
or presence of the lac repressor in injected oocytes. Groups of 40 oocytes isolated from a single female frog were each coinjected with 
plasmids pSMEOI and pTK-5 (5 ng of each DNA per oocyte). After 48 h of incubation, total extracts were isolated from two batches 
of pooled oocytes (ten oocytes per batch) and the extracts from each batch equivalent to one oocyte were assayed for CAT activity 
(experiments 1-5). Specifically, in Exp. I, plasmids pSMEOI and pTK-5 were injected into the oocyte nucleus. In Exp. 2 plasmids 
pSMEOI and pTK-5 were coinjected with the E. coli lac repressor (at a ten-fold molar excess over the pSM plasmid) into the oocyte 
nucleus. In Exp. 3, the lac repressor (at approx. 70 ng protein per oocyte) was first injected into the oocyte cytoplasm and, 2 h later, 
plasmids pSMEO I and pTK-5 were injected into the nucleus of the previously injected oocytes. In Exp. 4, oocytes were injected as 
described in Exp. 2 and subsequently incubated in the buffer containing 20 mM IPTG. In Exp. 5, oocytes were first injected as described 
in Exp. 2 and, 12 h later, IPTG was injected into the cytoplasm (to a final concentration about 20 mM in oocyte) of previously injected 
oocytes. CAT assays were performed under linear assay conditions. CAT assays with extracts from uninjected oocytes and with the 
purified E. coli CAT enzyme were performed as negative and positive controls, respectively. The figure shows an autoradiograph of 
thin-layer chromatography plates used to analyze the products of the reaction. The migration position of the starting material, Cm is 
indicated (row C). The migration position of acetylated Cm is indicated (row AC). The number below each lane indicates the % 
conversion of Cm to its acetylated forms, as quantified by liquid scintillation counting. The diagram shown in the lower panel is the 
relative CAT activity which is normalized as percentage of plasmid pSMEO I CAT activity in injected oocytes in Exp. I. The background 
radioactivity of CAT assays, as shown in the negative control, has been subtracted. (B) Primer-extension mapping of transcripts 
synthesized in injected oocytes by the HSV -1 tk gene. All injections are described above. After 48 h of incubation, total RNAs were 
isolated from two batches of pooled oocytes (10 oocytes per batch) and the RNAs equivalent to one oocyte were analyzed for tk 
transcripts by primer extension. The HSV-1 tk gene produced a transcript that resulted in the 33-nt tk specific primer being extended 
to a leng1h of77 nt (see MATERIALS AND METHODS, section d). Extension products were sized on a 9% PA-8 M urea sequencing 
gel and autoradiographed. As a control, the same primer extension experiment was performed by using total RNA isolated from pooled 
uninjected oocytes. 32P-Iabeled Hpa II fragments of pBR322 served as nt size markers (M), which are marked in the right margin. The 
bands corresponding to the tk transcript-specific products are indicated by an arrow on the left margin. Nuc, nucleus; Cyto, cytoplasm; 
Buffer, ND-96 buffer containing 20 mM IPTG; Uninjected, uninjected oocytes; PRIMER, the 33-nt tic-specific primer. 
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Fig. 3. Eflfect of lac repressor on the cat expression from plasmid pSMDO I and mapping of transcripts. (A) CAT synthesis in the absence 
or presence of the lac repressor in injected oocytes. Groups of 40 oocytes isolated from another single female frog were each coinjected 
with plasmids pSMDOI and pTK-5 (5 ng of each DNA per oocyte). Experimental procedures and CAT assays with extracts isolated 
from two batches of pooled oocytes of each experiment were performed as described in the legend to Fig. 2A. Specifically, in Exp. I, 
plasmids pSMDOJ and pTK-5 were injected into the oocyte nucleus. In Exp. 2, plasmids pSMDOJ and pTK-5 were coinjected with 
the purified lac repressor (at a ten-fold molar excess over the pSM plasmid) into the oocyte nucleus. In Exp. 3, the lac repressor was 
first injected into the oocyte cytoplasm (at approx. 70 ng per oocyte) and, 2 h later, plasmids pSMDOI and pTK-5 were injected into 
the previously injected oocyte nucleus. In Exp. 4, oocytes were injected as described in Exp. 2 and subsequently incubated in the buffer 
containing 20 mM lPTG. In Exp. 5, oocytes were first injected as described in the Exp. 2 and, 12 h later, IPTG was injected into the 
cytoplasm of the previously injected oocytes (to a final concentration of approx. 20 mM in oocyte). CAT assays were performed under 
linear assay conditions. All symbols and the diagram of the relative CAT activity shown in the lower panel are the same as in Fig. 2A. 
(B) Primer extension mapping of transcripts synthesized in injected oocytes by the HSV-1 tk gene. All injections are described above. 
Experimental procedures and primer extension analyses for the tk-specific transcripts were performed as described in the legend to 
Fig. 28. Symbols are the same as in Fig. 28. 
48 h, induced expression of CAT activity of 
pSME01 to approx. 19% and CAT activity of 
pSMD01 to approx. 8% of the unrepressed level. 
Thus, some relief of repression was achieved. We 
suspected that this limited induction was due to 
limited permeability of the oocyte membrane to the 
inducer IPTG. Therefore, 12 h after the pSM 
plasmid DNAs plus repressor were injected into the 
nucleus, IPTG was injected into the cytoplasm (to a 
final average concentration of 20 mM in the oocyte). 
This protocol was chosen to ensure that any IPTG 
induction was due to an effect on operator-bound 
repressor, rather than inhibition of the initial binding 
of repressor to operator. As shown in Fig. 2A, Exp. 5 
(the fifth set of two lanes), and Fig. 3A, Exp. 5, 
injection of IPTG into the cytoplasm induced ex-
pression of cat gene by pSMEOl up to 57 %, and by 
pSMDOI up to 44 %, of the unrepressed level. To 
increase the induction level to 100 %, we have tried 
to inject more IPTG into the cytoplasm (up to a final 
concentration of 50 mM), but these concentrations 
had an adverse effect on the health of the oocyte. 
Thus, while the present results show that IPTG can 
significantly relieve repression, we have not yet been 
able to induce complete dissociation of operator-
bound repressor molecules by IPTG. IPTG does not 
have non-specific effects on the expression of the 
HSV-1 tk gene (Figs. 2B and 3B). 
(b) Functional lac repressor can enter the oocyte 
nucleus 
Athough the lac repressor is a well-characterized 
DNA-binding and regulatory protein in E. coli, it 
was not known whether it could penetrate the oocyte 
nuclear envelope and bind to any operator con-
taining sequences therein . To address this question, 
we injected the lac repressor into the cytoplasm of 
oocytes (at approx. 70 ng protein per oocyte), and 
then 2 h later, injected plasmids pSMEOl and pTK-
5 (5 ng of each DNA per oocyte) into the nucleus of 
these cells. As shown in Fig. 2A, Exp. 3 (the third set 
of two lanes), and Fig. 3A, Exp. 3, injection of 
repressor proteins into the oocyte cytoplasm prior to 
injection of DNAs into the oocyte nucleus reduced 
expression of CAT activity of pSMEO I by 98 % and 
CAT activity of pSMDOl by 96 %. The present 
experiments therefore show that a sufficient quantity 
of repressor can enter the nucleus and bind to the 
operator sequence to give nearly complete re-
pression. 
(c) The nonspecific DNA-binding properties of the 
lac repressor do not contribute to transcriptional 
inhibition 
It is known from previous studies (Lin and Riggs, 
1972 ; 1975; von Hippe! et al., 1974) that the lac 
repressor can bind nonspecifically to DNA. There-
fore it was important to determine whether any such 
nonspecific binding would affect gene expression in 
our system. These tests were conducted by 
coinjecting the HSV-1 tk gene into the oocyte nu-
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cleus along with the pSM plasmids in the absence, 
and presence, of repressor protein. After 48 h of 
incubation, the amount of tk-specific RNA mole-
cules were measured by primer extension (see legend 
to Fig. 2B). As shown in Figs. 2B and 3B (each set 
of two lanes showing duplicate experiments), there 
was no significant difference in the amount of tk-
transcripts synthesized between oocytes injected 
with and without the lac repressor. Thus, the non-
specific DNA-binding properties of the repressor do 
not have an inhibitory effect on transcription of a 
gene introduced by injection. 
In separate injections, we also tested that expres-
sion from the parental plasmid, pSM11, that 
contains no lac operator insert, was not inhibited by 
lac repressor (not shown). Because of the variability 
of oocyte injection experiments, we prefer to use 
internal controls, i.e., the HSV-1 tk gene (Figs . 2B 
and 3B). 
(d) Effects of operator insertions on gene expression 
in Xenopus oocytes 
As a further control, it was important to determine 






~ 0 Cl) 
80 a. 0 
>. ~ - Cl) ·:;: a. 
:;:; 60 (.) 
<( 
~ 40 (.) 
cfi 
20 
Fig. 4. Effects of the lac operator insertions on gene expression 
in the absence of repressor in oocytes. Groups of 20 oocytes 
isolated from a single female frog were each injected (5 ng of 
DNA per oocyte) with one of these plasmids pSMII (lane 1), 
pSMEOI (lane 2), and pSMDOI (lane 3). CAT assays with 
extracts isolated from pooled injected oocytes of each experi-
ment were performed as described in the legend to Fig. 2A. The 
relative CAT activity is normalized as % of parental plasmid 
pSM II CAT activity in injected oocytes. 
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Fig. 5. Primer extension mapping of transcripts synthesized in injected oocytes from MSV-cat fusion genes containing operator 
insertions. After 48 h of incubation, total RNAs were isolated from ten pooled injected oocytes, and the RNAs equivalent to five oocytes 
were analyzed for cat gene transcripts by primer extension. The 5' -32P-labeled 36-nt synthetic oligodeoxynucleotide complementary to 
the CAT -coding sequence (Hu and Davidson, 1987) was hybridized to the RNA and then extended with unlabeled dNTPs with reverse 
stream from the cat gene affects transcnptwn in 
Xenopus oocytes in the absence of repressor. Such an 
analysis was provided by comparison of expression 
in the absence of repressor by the plasmids 
pSME01 and pSMD01, which contain an operator 
insert, with the parental plasmid pSM 11 which 
contains no operator insert. As shown in Fig. 4, the 
plasmids pSME01 and pSMDOl show a reduction 
of approx. 2S % and 38 %, respectively, relative to 
CAT activity expression by the plasmid pSM 11, 
which contains no operator sequence. Thus, the 
operator sequence itself has a modest reducing effect 
on the levels of cat gene expression in Xenopus 
oocytes. This is similar to our previous results in 
mammalian cells (Hu and Davidson, 1987). 
(e) Operator insert immediately downstream of the 
TAT A box shifts the transcription start point of an 
injected gene in Xenopus oocytes 
Whenever one inserts a new DNA segment close 
to the TAT A box or the tsp, and then observes 
changes in gene expression, it is important to show 
whether or not the tsp has changed. It was, therefore, 
desirable to determine whether the operator in-
sertions in the plasmids studied here would influence 
the choice of the tsp in Xenopus oocytes. 
To test this, we performed cat-specific primer ex-
tension mapping with total RNA extracted from in-
jected oocytes with each MSV -cat fusion gene tested. 
We used as primer a 36-nt S' -end-labeled oligo-
deoxynucleotide complementary to a sequence 
within the cat gene, as previously described (Hu and 
Davidson, 1987). As shown in Fig. SA (lane 2), with 
RNA from oocytes injected with the parental plas-
mid pSM 11, the DNA primer was extended to a 
length of 144 nt. However, when RNA from oocytes 
injected with the plasmid pSME01, containing one 
operator segment of length 40-bp insertion between 
the TAT A box and the tsp, the same primer was 
extended to 184 nt (Fig. SB, lane 3). This corre-
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sponds to a new tsp at a T residue, 25 bp down-
stream from the second A of the TAT A box, within 
the operator sequence. In the plasmid pSMD01, an 
operator segment of length 40 bp had been sub-
stituted for a 21-bp fragment between the tsp and the 
start codon ATG (see MATERIALS AND METHODS, 
section a). With RNA from oocytes injected with the 
plasmid pSMD01, the primer extension products 
were extended to approx. 162 and 1S8 nt (Fig. SA, 
lane 3). The latter extension product (1S8 nt) may be 
due to a small secondary structure in the S' -untrans-
Iated region of the mRNA (or it may be a nearby 
alternate tsp), but the fragment of length 162 nt 
corresponds to the same tsp as for the parental plas-
mid. We therefore conclude that an operator 
insertion downstream from the normal tsp does not 
affect the position of the actual tsp in oocytes. It 
should be noted that the relative intensities of these 
extended products are not comparable, since these 
injected oocytes were not from the same frog. 
(f) The MSV enhancer has an activating effect on an 
enhancerless SV 40 early promoter expression in 
Xenopus oocytes 
The MSV enhancer was first discovered by its 
ability to functionally replace the SV40 enhancer 
(72-bp repeats) during viral infection (Levinson 
et al., 1982). Later it was demonstrated that, 
although the MSV enhancer is capable of enhancing 
gene activity, both from its own promoter (Laimins 
et al., 1984; Graves et al., 198S) and from a 
heterologous (SV40) promoter .in mammalian cells 
(Laimins et al., 1982; 1984 ), it does not contribute to 
transcriptional expression from its own promoter in 
Xenopus oocytes (Graves et al., 198S). The failure of 
the MSV enhancer to enhance its own promoter in 
Xenopus oocytes was interpreted to reflect a species 
and cell-type specificity limit of enhancer function 
(for reviews, see Gluzman, 198S; and Serfling et al., 
1985). However, it has been demonstrated that the 
transcriptase. Extended products were sized on a 6% PA sequencing gel (Maxam and Gilbert, 1980) and autoradiographed. As a control, 
the same primer was hybridized to the total RNA isolated from pooled uninjected oocytes. (A) Lanes : I, control : RNA from uninjected 
oocytes; 2, RNA from oocytes injected with pSM II; 3, RNA from oocytes injected with pSMDOI; 4, 32P-labeled Hpaii fragments of 
pBR322 served as nt size markers (M), which are inidicated. (B). Lanes: I, nt size markers; 2, control: RNA from uninjected oocytes; 
3, RNA from oocytes injected with pSMEOI. The band due to the extended product is identified by an arrow, and its length is indicated. 
Synthesis of the observed eDNA products is depicted schematically below the figure. Symbols are the same as in the legend to Fig. I, 
except that the lac operator insertion (Op) is indicated by a hatched box. The primer is shown as a thin line, and extension products 
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Fig. 6. Activating effect of the MSV enhancer on an enhancer-
less SV40 early-promoter expression and strong expression of 
the RSV LTR in injected oocytes. Groups of 40 oocytes isolated 
from a single female frog were each injected with plasmid DNA 
(5 ng DNA per oocyte) as indicated in each lane. After 48 h 
incubation, total extracts were isolated from two batches of 
pooled injected oocytes (ten oocytes per batch) and the extracts 
from each batch equivalent to one oocyte were assayed for CAT 
activity. CAT assays were performed under linear assay condi-
tions. CAT assays with extracts from uninjected oocytes were 
performed as negative controls. Symbols are as described in the 
legend to Fig. 2A. The number below each lane indicates the % 
conversion of Cm to its acetylated forms, as quantified by liquid 
scintillation counting. The number shown in the bottom row is 
the relative CAT activity which is normalized as % of plasmid 
pSM II CAT activity in injected oocytes. The background 
radioactivity of CAT assays (as shown in negative controls: lanes 
marked uninjected) has been subtracted. 
SV40 enhancer is able to activate transcription about 
100-fold from the SV40 early promoter in Xenopus 
oocytes (Spinelli and Ciliberto, 1985). Since the 
SV40 enhancer is known to be active in a wide 
variety of tissues and species, it was of interest to 
examine whether or not the MSV enhancer can 
functionally replace the SV40 enhancer to activate 
transcription from the SV40 early promoter in 
Xenopus oocytes. We therefore compared cat gene 
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expression in injected oocytes from the MSV-cat 
fusion plasmid pSMll with that from the plasmid 
pA10CAT, containing the SV40 early promoter 
elements but no enhancer. To test whether the RSV 
L TR is an efficient promoter for gene expression in 
frog oocytes, we also performed CAT assays with 
extracts from oocytes injected with the plasmid 
pRSVCA T, in which the cat gene is placed under 
RSV LTR control (Gorman et al., 1982b). CAT 
assays with extracts from uninjected oocytes were 
performed as a negative control. As shown in Fig. 6 
(with extracts from pooled oocytes, and again with 
each set of two lanes showing duplicate experi-
ments), the level of cat gene expression from plasmid 
pSM 11 was nine times higher than that from plasmid 
pA 10CAT, and CAT activity of pRSVCAT was 
about 14 times higher than that of pA10CAT. There-
fore, we conclude that the MSV enhancer has a 
significant activating effect on SV40 early promoter 
expression, and that the RSV L TR is indeed a strong 
promoter for gene expression in Xenopus oocytes. 
DISCUSSION 
We have shown that with a single lac operator 
sequence inserted in a control region of the test plas-
mid injected into Xenopus oocytes, a high level of 
repression is achieved with the lac repressor. 
Repression can be achieved by premixing repressor 
with plasmid prior to nuclear injection, or by 
injection of repressor into the oocyte cytoplasm 
before injection of the plasmid into the oocyte 
nucleus. A low level of induction can be achieved by 
addition of the inducer IPTG to the external 
medium; a much higher level of induction is obtained 
by injection ofiPTG into the oocyte cytoplasm. The 
repressor protein does not affect expression of a test 
plasmid that does not contain the operator sequence. 
These points are discussed in greater detail below. 
A primary goal of this study was to demonstrate 
that the inducible lac operator-repressor system 
could be used as a genetic switch in frog oocytes, just 
as it is in E . coli and in mammalian cells (Hu and 
Davidson, 1987; 'Brown. et al., 1987). The ability to 
control the transcription of a gene in oocytes by using 
the lac repressor and hybrid promoters containing 
the lac operator should be useful for a wide variety 
of purposes. For example, it is often desirable to 
regulate the expression of a protein in an inducible 
manner rather than rely on constitutive expression 
since the expression of high levels of proteins may 
have deleterious effects on the growth of the cells 
(Kaufman eta!., 1985). Furthermore, one potentially 
rewarding feature of this system is that it may 
provide a method for the experimenter to control the 
expression of genes that play a role in early 
embryonic development. 
Our previous studies and those of Brown et a! . 
(1987) showed that in mammalian cells, the lac 
repressor synthesized in the cytoplasm could enter 
the nucleus; the concentration of repressor was ap-
proximately equal between nucleus and cytoplasm 
(Hu and Davidson, 1987). The present results show 
that lac repressor protein injected into the oocyte 
cytoplasm can migrate into the nucleus and cause 
repression . In this instance, it was impracticable to 
determine the distribution of repressor between the 
cytoplasm and the nucleus, thus our results do not 
indicate whether or not specific binding increases the 
repressor concentration in a specific nuclear or cellu-
lar compartment. 
A significant and potentially useful difference 
between the oocyte experiments and those in mam-
malian cells (Hu and Davidson, 1987) is the higher 
level of repression achieved in oocytes. This is 
probably due to a higher concentration of repressor 
protein in injected oocytes. Since the volume of a 
Xenopus oocyte and a mammalian cell are approxi-
mately 0.54 J.!l (Gurdon and Wickens, 1983) and 
4 x 10 - 6 J.!l (Alberts eta! ., 1983), respectively, we 
estimate that we have introduced about an 83 times 
higher concentration of repressor in an oocyte 
(approx. 830 nM) than that in a repressor-producing 
LI-1 cell (approx. 10 nM) (the repressor-expressing 
L cells studied in Hu and Davidson, 1987). The 
average concentration of plasmid DNA in an 
injected oocyte nucleus (approx. 30 nM) is about 30 
times higher than that transfected into a nucleus of 
the LI-1 cell (approx. 1 nM). Thus, the molar ratio 
of repressor versus plasmid DNA in injected oocytes 
is approx. three times higher than that in our transient 
expression gene transfer experiments in LI-1 cells. 
This would suggest that higher levels of repression 
may be achieved by increasing the total concen-
tration of repressor in an animal c~ll over that in the 
LI-1 cell line. 
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We wish to discuss the interpretation of the obser-
vation that the lac repressor does not affect tran-
scription from a gene that does not contain an 
operator sequence. This fact may be due to the rela-
tive weakness of the nonspecific binding, so that 
RNA polymerase can displace nonspecifically 
bound repressor or it may indicate that the lac 
repressor simply does not bind nonspecifically to 
DNA in nucleosomes. The latter interpretation is 
supported by the observations of Chao et a!. (1980). 
They have shown that assembly of lac operator-
containing DNA into nucleosomes with octameric 
histone cores in vitro does not affect specific 
sequence recognition by repressor, or IPTG-induced 
dissociation, but that nonspecific binding of re-
pressor to DNA is considerably diminished. On the 
other hand, the specific repression results show that 
the repressor can bind to operator DNA in an oocyte 
nucleus . We think it is possible that this result means 
that for an operator segment in a nucleosome, the 
major groove of the operator sequence faces outward 
and is available for recognition by repressor, 
although the minor groove is interacting with the 
histone core. The alternative possibility that operator 
sequences are not organized in nucleosomes in 
oocytes has not been investigated by us. 
In agreement with our earlier results with mam-
malian cells, binding of repressor to an operator 
inserted downstream from the tsp inhibits tran-
scription. This is probably not due to a direct inhi-
bition of binding of RNA polymerase (see below), 
but rather, to a block of the propagating tran-
scription complex. The latter interpretation is sup-
ported by observations in E. coli that the operator-
bound repressor can block transcribing RNA poly-
merase and terminate transcription (Deuschle et a!., 
1986; Besse eta!., 1986; Sellitti eta!., 1987). In the 
E . coli lac operon, the operator overlaps downstream 
with the promoter element. When repressor is bound 
to the operator, RNA polymerase can still bind to the 
promoter but can not initiate transcription (Schmitz 
and Galas, 1979). In the expression plasmid we have 
studied here, pSMDO 1, the operator is inserted at 
40 bp downstream from the normal tsp (65 bp down-
stream from the TAT A box). By occupying this 
downstream operator, the repressor is less likely to 
provide any steric hindrance and to prevent the pro-
moter from being recognized by RNA polymerase. 
However, we do not have data to show where an 
operator-bound repressor forces the transcribing 
RNA polymerase to stop and to release the nascent 
transcript. From the standpoint of basic tran-
scription studies, one exciting feature of this system 
is that it provides for the potential study of how 
various distant control elements, such as enhancers, 
communicate with the promoter and the tsp of a 
eukaryotic gene. 
We wish to discuss an incidental but important set 
of observations about the activity of the MSV 
enhancer that were made in the course of this work. 
Previously, it has been reported that the MSV 
enhancer does not appear to be recognized or utilized 
to enhance transcription from its own promoter in 
Xenopus oocytes (Graves eta!., 1985). In contrast, 
our results show that the MSV enhancer placed 
upstream from an enhancerless SV40 early promoter 
does activate transcription in Xenopus oocytes. Thus, 
Xenopus oocytes do contain a trans-acting factor(s) 
that can act on the MSV enhancer to enhance ex-
pression from some cis-located promoters. In-
terestingly, it has been shown recently that in human 
293 cells the SV40 enhancer has only a minor effect 
on transcription from the SV40 early promoter, but 
that it has a strong activating effect on transcription 
from the HSV tk promoter (Robbins eta!., 1986). 
Overall these results, taken together, support the 
view that the interactions between an enhancer, a 
promoter, and other cis-acting DNA elements will 
vary with the particular trans-acting factor( s) that are 
present in the cell of interest, but will also depend on 
the particular permutation of cis-acting DNA ele-
ments present in the total promoter cassette. 
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CHAPTER 4 
INTRODUCTION TO SECTION II 
Molecular cloning and characterization of the mouse skeletal 
a-actin gene. 
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The actin genes represent a multigene family whose individual 
members are expressed in a developmentally regulated and tissue-
specific manner (Saborio et al., 1979; Vandekerckhove and Weber, 1979; 
Ordahl et al., 1980; Bruskin et al., 1981; Schwartz and Rothblum, 1981; 
Minty et al., 1982; Fyrberg et al., 1983; Garcia et al., 1984; 
Vandekerckhove and Weber, 1984; Nudel et al., 1985). During differenti-
ation of muscle tissue, the P- and 1-cytoskeletal actins are down-
regulated, whereas the sarcomeric a-cardiac and a-skeletal actins are 
up-regulated, synthesized in large amounts, but with distinct tissue-
specific and developmental patterns of expression (Devlin and Emerson, 
1979; Minty et al., 1982; Gunning et al., 1983; Bains et al., 1984; 
Mohun et al., 1986; Nudel et al., 1986). 
During the terminal development of skeletal muscle cells, 
proliferating mononucleated myoblasts stop dividing and fuse to form 
multinucleated myotubes. Coincident with this transition, the relative 
level of skeletal a-actin mRNA is induced at least 25-fold over its 
level in perfusion myoblasts both in vivo and in vitro (Hayward and 
Schwartz, 1986). It is therefore of particular interest to investigate 
the molecular mechanisms underlying the selective induction of the 
skeletal a-actin gene family member in the course of muscle cell 
development. 
What might be the molecular mechanism(s) governing the control of 
the skeletal a-actin gene regulation in myogenic and nonmyogenic cells? 
One approach to answering this question is the molecular cloning and 
characterization of the genes coding for the skeletal a-actin proteins. 
By studying the structural organization of the skeletal a-actin gene, 
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we can begin to look for the controlling elements which modulate the 
expression of this gene during muscle cell development. Hence, we have 
isolated and characterized the genomic clone of the mouse skeletal a-
actin gene from BALB/c mouse sperm DNA. 
In this section, we will report on the molecular cloning and 
characterization of this gene. As described in Chapter 5, the structure 
and the complete nucleotide sequence of the single genomic copy of the 
mouse skeletal a-actin gene has been determined. A comparison of the 
nucleotide sequences of several vertebrate skeletal a-actin genes 
reveals several highly conserved sequences in the 5'-flanking region 
and in both 5'- and 3'-untranslated regions. Additionally, two poten-
tial inverted repeat sequences, partially within the conserved regions, 
have been identified within the large first intron of rodent skeletal 
a-actin genes. It has been reported that a tissue-specific tran-
scriptional enhancer is located in the first intron of a heavy-chain 
immunoglobulin gene (Gillies et al., 1983). Moreover, a tissue-specific 
transcriptional enhancer has been identified very recently within the 
large first intron of the human P-actin gene (Kawamoto et al., 1988). 
Therefore, in the future it will be interesting to investigate whether 
or not these partially conserved inverted repeat sequences in the first 
intron of mammalian skeletal a-actin genes serve as regulatory 
elements, such as enhancers, in differentiated muscle cells. 
In Chapter 6, a new mapping technique for determining transcrip-
tion start sites on cloned genomic DNA has been developed. We have 
successfully used this approach to map the transcription start site of 
the mouse skeletal a-actin gene. 
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The complete nucleotide sequence of a genomic clone encoding the mouse skeletal a-actin gene has been 
determined. This single-copy gene codes for a protein identical in primary sequence to the rabbit skeletal 
a-actin. It has a large intron in the 5' -untranslated region 12 nucleotides upstream from the initiator A TG and 
five small introns in the coding region at codons specifying amino acids 41/42, 150, 204, 267, and 327/328. These 
intron positions are identical to those for the corresponding genes of chickens and rats. Similar to other skeletal 
a-actin genes, the nucleotide sequence codes for two amino acids, Met-Cys, preceding the known N-terminal 
Asp of the mature protein. Comparison of the nucleotide sequences of rat, mouse, chicken, and human skeletal 
muscle a-actin genes reveals conserved sequences (some not previously noted) outside of the protein-coding 
region. Furthermore, several inverted repeat sequences, partially within these conserved regions, have been 
identified. These sequences are not present in the vertebrate cytoskeletalj3-actin genes. The strong conservation 
of the inverted repeat sequences suggests that they may have a role in the tissue-specific expression of skeletal 
a-actin genes. 
The actins represent a multigene family of highly con-
served proteins found in all eucaryotes. Differences in amino 
acid sequence among the various actins have shown that at 
least six different isoforms are expressed in vertebrates (52, 
53). Two striated muscle isoforms, skeletal a and cardiac a 
(52), and two smooth muscle isoforms (53) are found in the 
contractile apparatus of muscle fibers , whereas two cyto-
skeletal isoforms, 13 and "f , are present in the cytoskeleton of 
all cells (51). These actin proteins are extremely conserved 
in amino acid sequence. 
Actin gene expression is tissue specific and developmen-
tally regulated (27, 29, 32, 35) . By studying the structural 
organization of the actin gene family, one can begin to look 
for the controlling elements which modulate the expression 
of these genes during development . Here we present the 
complete nucleotide sequence of the single genomic copy of 
the mouse skeletal a-actin gene. The coding region of this 
gene is interrupted by five introns which are located in the 
same positions as introns previously identified in other 
vertebrate skeletal a-actin genes (13, 54) . A comparison of 
the nucleotide sequences of several vertebrate skeletal a-
actin genes reveals several blocks of highly conserved 
sequences in the 5'-flanking region and in both the 5'- and 
3'-untranslated regions . Interestingly, the conserved se-
quences in the 5'-flanking region and within the first 
untranslated exon can potentially form several hairpin loops 
by base pairing between adjacent inverted complementary 
sequences. These regions do not correspond to the potential 
hairpin structure in the corresponding portion of the rat 
cytoskeletalj3-actin gene (33). Furthermore, it is possible to 
form long hairpin loops within the first intron and one stem 
loop in the 3'-untranslated region upstream from the putative 
polyadenylation signal A TT AAA. These interesting second-
ary structures are apparently not present in the vertebrate 
cytoskeletalj3-actin genes. To our knowledge, this is the first 
description of potential secondary structures in the first 
• Corresponding author. 
intron and among the highly conserved sequences in the 
5'-flanking region and both the 5'- and 3'-untranslated re-
gions of vertebrate skeletal a-actin genes . Since the species 
compared (avian and mammalian) have been separated for 
more than 250 million years (12) , these results indicate a 
strong selective constraint to conserve these sequences and 
suggest that they may have an important role in the tissue-
specific expression of the skeletal a-actin genes. 
MATERIALS AND METHODS 
Materials. Restriction endonucleases, T4 DNA ligase, T4 
polynucleotide kinase, Escherichia coli exonuclease VII, and 
E . coli DNA polymerase I large fragment (Klenow) were 
purchased from Bethesda Research Laboratories, Boehr-
inger Mannheim Biochemicals, or New England BioLabs. 
Avian myeloblastosis virus reverse transcriptase was 
obtained from Life Sciences, Inc . Sp6 RNA polymerase and 
placental RNasin were obtained from Promega Biotec. 
Radioactively labeled nucleotides were purchased from 
Amersham Corp. or New England Nuclear Corp. Unlabeled 
nucleotides were obtained from P-L Biochemicals, Inc. 
Synthetic oligonucleotides were synthesized by S. Horvath, 
Caltech, on an automated DNA synthesizer (21) and purified 
by electrophoresis through a 20% polyacrylamide-8 M urea 
preparative gel in Tris borate-EDT A buffer. BALB/c genomic 
DNA was provided by T . Hunkapiller. The Drosophila actin 
genomic clone DmA2 (Dm5C in reference 14) and a 
3'-untranslated region of rat skeletal a-actin eDNA (15) were 
provided by B. Bond and L. Garfinkel, respectively. 
Isolation of genomic actin clones and restriction mapping. A 
cosmid genomic library of BALB/c mouse sperm DNA, 
constructed and kindly provided by M. Steinmetz at Cal-
tech, was screened by colony hybridization (49) by using an 
actin-coding region probe isolated from the Drosophila actin 
genomic clone DmA2 (Dm5C). From 16 positive clones, 1 
was tentatively identified to contain the skeletal a-actin gene 
by hybridization with the conserved (29), isotype-specific 
(37), 3'-untranslated region of a rat skeletal a-actin eDNA. 
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FIG . 1. Structure of the mouse skeletal a-actin gene. (A) Cosinid clone containing the genomic DNA encoding the mouse skeletal a-actin 
gene . (B) Restriction endonuclease map of the 6.8-kb EcoR! DNA fragment. One squiggly arrow represents an SP6 antisense transcript of a 
BamH!-EcoRl fragment thai was subcloned from che 6.8-kb EcoRl fragment. (C) Detailed restriction map of the mouse skeletal a-actin gene 
and flanking DNA. Fragmenls were subcloned inco M13 veccors and sequenced by dideoxy chain cerrnination as indicated by arrows. (D) 
Schematic represencacion of the struccure of the mouse skeletal a-accin gene. Solid boxes represent coding exons, open boxes indicate 
cranscribed uncranslaled regions , and solid lines coincide with inlrons and flanking DNA . Numbers above the exons correspond to codon 
posilions (Fig. 2). The squiggly line represents che SP6 antisense transcript as mentioned above. 
Southern blot (48) analysis with the Drosophila actin probe 
localized the mouse a-actin-coding region to a single 6.8-
kilobase (kb) EcoRl fragment in the cosmid clone. This 
fragment was subcloned into the EcoRl site of plasmid 
pSP62-PL (28), provided by D. Melton , Harvard University. 
The restriction endonuclease map of the 6.8-kb EcoRl 
fragment was determined by single and double enzyme 
digests. Subsequently, the 3.9-kb BamHl-EcoRl fragment 
was subcloned into the BamHl and EcoRl sites of the 
plasmid pSP62-PL (see Fig. 18) and mapped in finer detail 
by digestion with more restriction endonucleases. 
Localization of the promoter region of the a-actin gene. 
Several different restriction endonuclease digests of the 
6.8-kb EcoRl fragment were probed with a 20-base oligonu-
cleotide (5' -GCCCAACACCCAAATATGGC-3') containing 
the sequence of the CAA T promoter homology, highly 
conserved between the skeletal a-actin genes of chickens 
and rats (34). The oligonucleotide was 5' end labeled with 
polynucleotide kinase and [-y-32P]A TP, and hybridization 
was performed directly in the dried agarose gel as described 
previously (39). A linearized chicken skeletal a-actin ge-
nomic clone (provided by C. Ordahl [13]) and EcoRI-
linearized SP6 vector were used as positive and negative 
controls, respectively . 
Ml3 cloning and DNA sequencing. Appropriate restriction 
fragments from the 6.8- and 3.9-kb inserts were subcloned, 
in opposite orientations, into the multiple cloning sites of 
M13 mp18 and M13 mp19 RF vectors, transforming first into 
E. coli JM101 for high efficiency and replating with £. coli 
JM109 (recA -) to prevent sequence changes. 
Single-stranded M13 templates were sequenced by the 
dideoxy chain termination procedure (41) with an [a-
3sS]dA TP (500 Cilmmol) label as described by Biggin et al. 
(3), with the following modifications, (i) The synthetic 
pentadecanucleotide (5'-TCCCAGTCACGACGT-3') and 
the hexadecanucleotide (5'-GGGTAACGCCAGGGTT-3') 
were used as sequencing primers . (ii) The dideoxy sequence 
reactions were carried out in 50 mM NaCl-7 mM Tris 
hydrochloride (pH 7.4)-10 mM MgClr3 mM dithiothreitol. 
(iii) The final concentrations of unlabeled nucleotides in each 
sequence reaction were as follows: A reaction , 25 I'-M dCTP, 
25 !LM dGTP, 25 I'-M dTTP, 20 I'-M ddATP; C reaction, 81'-M 
dCTP, 32 I'-M dGTP, 32 I'-M dTTP, 50 I'-M ddCTP; G 
reaction, 32 !LM dCTP, 8 I'-M dGTP, 32 ILM dTTP, 50 I'-M 
ddGTP; T reaction , 32 I'-M dCTP, 321'-M dGTP, 81'-M dTTP, 
50 I'-M ddTTP. (iv) After electrophoresis, the gel was imme-
diately dried , without fixing, for 1 h at sooc and autoradio-
graphed. 
Computer analysis of sequence homology was done as 
described by Hunkapiller et al. (21). 
Primer extension analysis. Polyadenylated [poly(A)+] 
RNA from a differentiated culture of the mouse myogenic 
cell line BC3H-1 (42) was isolated by guanidine thiocyanate 
extraction (9) and two cycles of oligo(dT)-ceUulose chroma-
tography (1). A synthetic 42-base oligonucleotide 
(5'- AGAGCCGTTGTCACACACAAGAGCGGTGGTCTC 
GTCTTCGTC-3') complementary to a portion of the coding 
sequence, spanning positions 1038 through 1079 in exon 2, 
was 5' end labeled with polynucleotide kinase and [-y-
32P]ATP (3,000 Cilmmol) and used as an extension primer. 
One picomole of the labeled oligonucleotide (106 cpm/1'-g) 
was denatured by heating at 80°C for 10 min in 40 ILl of 98% 
formamide containing 1 ILl of 0 .5 M EDT A. Five micrograms 
of poly(A)+ RNA in 10 ILl of 200 mM sodium piperazine-
N,N'-bis(2-ethanesulfonic acid) (pH 6.4)-2 M NaCI-5 mM 
EDTA was added, and the mixture was incubated at 37°C for 
12 h. The nucleic acids were ethanol precipitated from 
ammonium acetate and reprecipitated from sodium acetate. 
The dried pellet was suspended in 25 ILl of 100 mM 
Trishydrochloride (pH 8.3)-40 mM KCl-20 mM MgClr10 
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341 Ill L l u Al• Ser L e u S er- Tnr- Pne Gin Gin Mit 1ro lie Tnr- Lya Gin Glu Tyr Asp Glu Al• G l y Pr-o S er- lie V• l Hts Ar- 'il Lys C¥a 373 Eaan 7 
2607 AT C ClG GCC TCG CTG TCC ACC TTC C AG C AG AT G TGG ATC ACC AA G C AG G AG lAC GAC GAG GCT GGC CCC TCC All GTG C AC CGC TGC 2696 
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FIG. 2. Nucleotide sequence of the mouse skeletal a -actin gene . Numbers in the left and right margins, respectivel y. refer to the first and 
last nucleotides or a mino acids in each line . Negative numbers indicate nucleotide positions upstream from the transcription start site . The 
deduced amino acid sequences encoded by the exons are indicated above the nucleotide sequence in the three-letter amino acid code and 
numbered as described previously (23 , 52) . An as terisk indicates an "extra" serine residue between codons 234 and 235 , which has been 
designated position 234a (23 , 52). A hatched box represe nts a splice junction border, and a vertical arrow denote s the cap si te which is 
assigned as nucleotide number 1. The CAAAT, TATA , and putative polyadenylation signal AITAAA are indicated by the boxes . The 5'- and 
3'-untranslated gene regions are underlined, and a G + T-rich stretch downstream from the putative polyadenylation site (16 , 26) is 
underscored with a broken line. The restriction si tes used for the exonuclease Vll mappi ng described in the legend to Fig. 3 are marked and 
underlined . Abbreviations : Trm, termination codon; 3'UT, 3'-untranslated region. 
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FIG. 3. Exonuclease VII mapping of the mouse skeletal a-actin gene. Total RNA (50 fLg) from a differentiated culture of BC3H-1 cells was 
hybridized at 60 or 65°C with approximately 5 ng of each probe as shown in the schematic diagram (lower panel) . The hybridized samples were 
treated with 3 U of exonuclease VII (1 h, 4SOC), electrophoresed on an alkaline agarose gel (A) or a 5% polyacrylamide--8 M urea sequencing 
gel (B, C), and autoradiographed. (A) Lanes: 1, size markers , Hindiil fragments of-y DNA; 2, size markers, Haem fragments of cj>X174 DNA; 
3, undigested probe of 1,750-nucleotide Bglll-Bglll fragment; 4 and 5, protected products from samples hybridized at 60 and 65°C, 
respectively. (B) Lanes: 1, size markers, Haeiil fragments of cj>X174 DNA; 2, size markers, Hpaii fragments of PBR 322; 3, undigested probe 
of 580-nucleotide Sph!-Bglll fragment; 4 and 5, protected products from samples hybridized at 60 and 65°C, respectively. (C) Lanes: 1 and 
2, protected products from samples hybridized at 65 and 60°C, respectively ; 3, undigested probe of 391-nucleotide BamH!-BamH! fragment; 
4, size markers, Haem fragments of cj>X174 DNA ; 5, size markers , Hpaii fragments of PBR 322. nt, Nucleotide. 
mM dithiothreitol and heated to 65°C for 10 min. This 
heating step substantially improved the resolution of exten-
sion products over background, as observed by Fornwald et 
al. (13). An equal volume of a solution containing deoxynu-
cleoside triphosphates (1 mM each), 750 U of RNasin per ml, 
and 40 1-Lg of actinomycin D per ml was added, and the 
primer extended with avian myeloblastosis virus reverse 
transcriptase (500 U/ml) at 42°C for 1 h. The reaction was 
terminated by the addition of EDT A to 10 mM, and the RNA 
was degraded by treatment with DNase-free RNase (50 
IJ.g/ml) at 40°C for 1 h. After ethanol precipitation, the 
reactions were suspended in formamide-dye buffer, dena-
tured by boiling for 3 min, and electrophoresed on a 6% 
polyacrylamide-8 M urea sequencing gel in Tris borate-
EDTA buffer. DNA sequencing reactions were used as size 
markers . Extended products were detected by autoradiogra-
phy of the dried gel. 
Exonuclease VII mapping. For exonuclease VII mapping, 
actin-gene-containing plasmid DNA fragments were isolated 
and labeled with either polynucleotide kinase and [-y-
32P)ATP (3,000 Cilmmol) for 5'-end mapping, or E. coli DNA 
polymerase I large fragment (Klenow) and [a32P)dCTP (400 
Cilmmol) for 3'-end mapping. 
DNA-RNA hybridization was performed as described 
above in the primer extension analysis by using 50 1-Lg of total 
RNA from a differentiated culture of BC3H-1 cell line and 
about 5 ng of labeled (ca. 106 cpm/IJ.g) DNA fragment. 
Hybridizations were carried out at 60 or 65°C for 3 h. Each 
hybridization mixture was diluted into 10 volumes of 30 mM 
KCI-10 mM Tris hydrochloride (pH 7.4}--10 mM EDTA, 
chilled on ice, and incubated at 45°C for 1 h with 10 U of E. 
coli exonuclease VII per ml (2). After ethanol precipitation, 
the exonuclease VII-resistant material was electrophoresed 
on a 5% polyacrylamide-8 M urea sequencing gel or alkaline 
agarose gel (24) and autoradiographed. 
In vitro transcription with SP6 RNA polymerase and RNase 
mapping. Synthesis of the complementary-strand SP6 probe 
and RNase mapping were carried out as described by Melton 
et al. (28). 
RESULTS 
Isolation and mapping of the mouse skeletal a-actin gene. A 
cosmid clone containing the skeletal a-actin gene was iso-
lated from a BALB/c genomic cosmid library as described in 
Materials and Methods. The location and orientation of the 
gene within a single 6.8-kb EcoRI fragment were established 
by restriction endonuclease mapping with 5' and 3' frag-
ments of the Drosophila actin-coding sequence and the rat 
a-actin 3' -untranslated sequence as probes. 
The 6.8-kb EcoRI fragment containing the entire skeletal 
a-actin-coding and flanking sequences was isolated from the 
41-kb insert of the cosmid clone (Fig. 1A) and subcloned into 
the EcoRI site of the plasmid vector pSP62 (Fig. 18). 
Subsequently , the putative promoter region of the gene was 
VoL 6, 1986 
localized to about 100 base pairs within the Smal-Ssti region 
(Fig. 1C and D) by hybridization with the 20-base oligonu-
cleotide probe containing the sequence of the CAA T pro-
moter homology which is highly conserved between the 
skeletal a-actin genes of chickens and rats (34) (data not 
shown). This result confirmed that the subcloned EcoRl 
fragment contained the 5 '-ftanking sequence of the gene. 
Also, it suggested that the position of the transcription 
initiation site should be close to the Ssti site . The detailed 
restriction endonuclease map of the actin-coding and 
flanking regions in Fig. 1C was used to choose the DNA 
fragments to be subcloned into M13 and mp18 and mp19 
vectors for sequencing. From these subclones we deter-
mined the linear sequence of 4,007 nucleotides, on both 
strands independently (Fig. 2). 
Amino-acid-coding region of the mouse skeletal a-actin 
gene. The complete nucleotide sequence of the mouse skel-
etal a-actin gene with the 5'- and 3'-ftanking regions is shown 
in Fig. 2. Exons within the protein-coding region and the 
introns separating them were initially assigned mainly by 
homology with the rat skeletal a-actin genomic sequence 
(54) and in part by comparison with the partial eDNA 
sequence for the carboxy-terminal portion of the mouse 
protein (29) . This assignment was supported by the fact that 
the sequences at the presumed exon-intron junctions are in 
accordance with the consensus sequence for splice sites (7) . 
In addition, the expected lengths of exons 2, 3, 4, and 5 were 
confirmed experimentally within an accuracy of ±3 nucleo-
tides by hybridizing an SP6 anti-sense transcript of a 
BamHI-EcoRI fragment (Fig. 18) to poly(A)+ RNA from 
differentiated 8C3H-1 cells and RNase mapping (data to be 
presented in the Ph.D thesis by M. C.-T. Hu at the Califor-
nia Institute of Technology) . The translated amino acid 
sequence for this interpretation of the structure of the mouse 
skeletal a-actin gene is identical to that of rats , rabbits , and 
chickens . (The amino acid sequence of mouse skeletal 
a-actin has not been directly determined .) 
The coding sequence begins with codons for two amino 
acids , Met and Cys , which are absent from the mature 
protein. They are followed by the codon for Asp (GAC), the 
known N-terminal residue of striated muscle actin . The same 
two codons preceding the codon specifying the N-terminal 
amino acids are found in the human (20) , rat (54), and 
chicken (13) skeletal a-actin genes and in the human (19) and 
chicken (8) cardiac a-actin genes. Interestingly , these two 
codons are also found in all six Drosophila actin genes (14) 
and sea urchin actin genes (10, 43), but the Cys codon is 
absent in vertebrate cytoskeletall3-actin genes (22, 33, 38). It 
has been suggested that the Met-Cys dipeptide is removed 
by posttranslational processing (54). 
Although the derived sequence of the primary skeletal 
a-actin is 377 residues, we have numbered the amino acids in 
Fig. 2 in conformity with the numbering system suggested by 
Lu and Elzinga (23) and Vandekerckhove and Weber (52), 
which yields 374 positions. Of the three additional positions , 
two are the Met-Cys dipeptide at the N-terminus , while the 
third is an " extra" serine residue between positions 234 and 
235 which has been designated 234a (23, 52). 
The coding region of the mouse skeletal a-actin gene is 
split by five introns (Fig. 1D) at codons specifying amino 
acids 41142 (IVS 2) , 150 (IVS 3), 204 (IVS 4) , 267 (IVS 5), and 
327/328 (IVS 6) . These intron positions are identical to those 
for the corresponding genes of chickens and rats (13, 54). 
The length and positions of the exons and introns may be 
deduced from Fig. 2. Previously, Zakut et al. (54) have 
reported that a potential splice site (CAG/GT A) is present 32 
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FIG. 4. Identification of the 5' end of the mouse skeletal a-actin 
mRNA by primer extension. The 5'-end-labeled, 42-base oligonu-
cleotide complementary to the coding sequence, from positions 1038 
to 1079 (Fig. 2), was hybridized with 5 11g of poly(A)+ RNA from a 
differentiated culture of BC3H-1 cells and extended by using reverse 
transcriptase as described in the text. The extension products were 
electrophoresed on a 6% polyacrylamide-8 M urea sequencing gel 
and autoradiographed . The diagram (lower panel) shows the product 
expected from full-length elongation of mRNA. Lanes: 1, primer 
extension products; 2 through 5, sequencing ladders used as size 
markers. nt, Nucleotide. 
base pairs downstream from the CG/GT splice site at codon 
150 in the rat skeletal a-actin gene . Our results do not reveal 
this potential splice site in the mouse gene. This is not 
surprising, because use of the extra splice site in the rat gene 
would produce an actin with an insert of 11 amino acids , and 
no such product has yet been detected. 
Sequence of the S' -untranslated region of the mouse skeletal 
a-actin gene. Although the actin amino acid sequence data 
and cloned eDNA partial sequence (29) could be used to 
identify the translated regions of the gene, independent 
means were required for delineating the 5'-untranslated 
region. The 5' borders of the first, untranslated, ex on and the 
second exon were approximately determined by exonucle-
ase VII mapping (Fig. 3A and 8). In addition, the precise 
assignment of the transcription initiation site, ACAC, was 
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FIG. 5. Percent homology profiles for the mouse , rat, and chicken skeletal a-actin genes. In this analysis, the sequence search string was 
25 nucleotide s, and gaps inserted in the sequences for alignment purposes were scored as regions of 0% homology. (A) Mouse versus rat 
skeletal a-actin genes: (B) mouse versus chicken skeletal a-actin genes. The structure of the mouse skeletal a-actin gene is shown between 
the two homology plot s. Vertica l arrows indicate two inverted duplications as described in the text. bp , Base pairs . 
confirmed by a newly developed mapping technique by using 
T4 DNA polymerase (M. C. T . Hu and N . Davidson, sub-
mitted for publication) and assigned to be nucleotides -111. 
This site was identified 1,031 nucleotides upstream from the 
initiator ATG codon (Fig. 2). We assigned the 5' border of 
the first intron to nucleotides 58/59 by matching the length of 
the primer extended product (Fig. 4) with the positions 
determined above for the 5' borders of the first and second 
A 
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MOUSE -2 tJ GGT'CCGGTttTAG CT ACCTGGGCCAGGG CAGTCCTCTCCTT -173 
RAT -206 TAG . . C . T . -165 
CHICK -22A G CG ATTATTTCGGCCC:CGGCCCGGGGGCCTCTAGACGCTCCTUTACGGCCCGGCCTCG . C GC CCA .U.GCAG -127 
B 
a a' 
2 2' 3 
MOUSE -172 CTTTGGTCAGTGCAGG &GACCCGGGCGGGACCC.t.GGCTGAGAACCAGCCGA.t.GGAAGGGACTCT .t.GTGCCCGAC.t.CCCAAA T A TGGCTTGGG AAGGGC.t. -7 • 
R.t.T -t6 • G G A -70 
CHICK • Jii!6 . C G CC G G NNCGCC.G . GC CCG __ TC ·8• 
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H\JMAN 
... ausE . .,
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MOUSE . ., 
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4' 
ACCGCAG CGGAC AGCGCCU.GTGUGCCTCGCTTCCCTCCCGCGGCG.t.CC A GGGCCCG AGCCGAGAGT .t.GC.t.GTTGT .t.GCT .t.CCCGCCCAG.t. 
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FIG. 6. Comparison of the nucleotide sequence of the 5'-flanking and the 5'-untranslated regions of vertebrate skeletal a-actin genes . (A) 
Alignment of the 5' -flanking region sequences of mouse , rat, and chicken skeletal a-actin genes. (B) Alignment of the 5' -untranslated region 
sequences of human, mouse , rat , and chicken skeletal a-actin genes . Dots indicate identity with the first sequence listed . Blanks indicate that 
gaps have been introduced during the alignment for maximal homology . The CAAAT box and TAT A box are highlighted with solid bars. A 
broken bar indicates the transcription initiation site, and an asterisk indicates the initiation codon ATG . Horizontal arrows above the 
sequences represent the adjacent inverted complementary sequences of rodents which are indicated numerically , whereas horizontal arrows 
underneath the sequences represent the adjacent repeats of chicken sequences, which are indicated alphabetically. 
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FIG. 7. Predicted inverted repeat structures in the 5'-flanking region and the 5'- and 3'-untranslated regions of the mouse, rat, and chicken 
skeletal a-actin genes . (A) Four potential configurations are shown in the 5'-flanking and the 5'-untranslated region of the mouse skeletal 
a-actin gene. Similar configurations can be found in the rat gene . (B) Three potential configurations are shown in the 5'-flanking and the 
5'-untranslated region of the chicken skeletal a-actin gene. (C) A potential stem-loop is demonstrated in the 3'-untranslated region of the 
mouse skeletal a-actin gene. A similar structure can be found in the rat gene. (D) A potential stem-loop is shown in the 3'-untranslated region 
of the chicken skeletal a-actin gene. The indicated free energy values for the base-paired regions were calculated by the method of Tinoco 
et al. (50). Note that the free energies for the base-paired regions in the 5'-flanking region were estimated by the same method . assuming that 
the stacking energies of DNA base pairs are similar to those of RNA base pairs. CAAAT, TATA, and putative polyadenylation signal 
ATTAAA are indicated by the boxes. 
exons. The sequences at the determined borders of the first 
intron are in agreement with the consensus splice site 
sequences (7). Thus, the first intron is 961 nucleotides long 
and interrupts the 5' -untranslated region 12 nucleotides 
upstream from the initiator ATG codon . 
A canonical promoter sequence TAT AT AAA (5) was 
identified at nucleotides -33 to -26 (Fig. 2) , and a CAAA T 
sequence (12) was located 91 nucleotides upstream from the 
transcription initiation site. The positions of these regulatory 
sequences in the promoter region correspond well with those 
of similar sequences found upstream from the 5' cap site of 
other eucaryotic genes (7). 
Sequence of the 3' -untranslated region of the mouse skeletal 
a-actin gene. The location of the polyadenylation site was 
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FIG. 8. Comparison of the nucleotide sequence of the 3'-untranslated regions of vertebrate skeletal a-actin genes. Alignment of the 
3'-untranslated region sequences of mouse , rat, chicken. and huma n (partial) skel etal a-actin genes. Symbols are as described in the legend 
to Fig . 6. The putative polyadenyla ti on signal ATTAAA is highlighted with a solid bar. and the termination codon TAG is indicated with an 
as teri sk. 
identified approximately at nucleotide 2944 (±5 nucleotides) 
of the sequenced gene (Fig . 2) by exonuclease VII mapping 
(Fig. 3C). The sequence A TT AAA was located 25 nucleo-
tides upstream from the polyadenylation site . In addition , 
the sequence TGTGTGTGG was found 4 nucleotides down-
stream from the polyadenylation site, in agreement with the 
suggestion that a G + T-rich stretch downstream from the 
polyadenylation site is required for the correct 3 '-end for-
mat ion of mRNA (16, 26). Another potential polyadenylation 
signal AA T AAA was also found at nucleotides 2942 through 
2947, about 22 nucleotides downstream from the end of the 
putative polyadenylation signal A TT AAA identified above. 
We have no evidence that thi s second potential signal 
function s in the mouse. 
Thus, the 3'-untranslated region of the mouse skeletal 
a-ac tin mRNA is about 245 nucleotides long [excluding the 
poly(A) tail] . It is about the same size as the 3 '-untranslated 
regions of the rat (241 nucleotides [54]) and human (253 
nucleotides [37]) skeletal a -ac tin mRNA but much shorter 
than that of rat cytoskeletal J3-actin mRNA (670 nucleotides 
[33]). The length of skeletal a -ac tin mRNA in mammal s is 
about 1,650 nucleotides (31 , 37, 44), including the poly(A) 
tail. Comparison with the total length of transcribed se-
quences in the mou se and rat genes (about 1.450 nucleotides) 
would suggest that the poly(A) tail is about 200 nucleotides 
long. 
Copy number of the mouse skeletal a-actin gene. Southern 
blot analysis of BALB/c genomic DNA digested with four 
different restriction endonucleases (Pst! , Bglll , Hindlll , and 
Sstl) demonstrated that genomic and cosmid fragment s 
hybridizing with the skeletal a 3 '-untranslated region-
specific probe comigrate (data not shown) . This result sug-
gests that the gene is present in single copy in the mouse 
genome , in agreement with previous repor:t s (29, 30). 
DISCUSSION 
Strong homology and interesting inverted repeat structures 
in the 5' -flanking region and both the 5'- and 3' -untranslated 
regions of vertebrate skeletal a-actin genes. We have aligned 
the nucleotide sequence of the mouse skeletal a-actin gene 
with those of the rat and chicken by using percent homology 
profiles (Fig. 5) . All alignments depend on introduction of 
gaps for maximal homology, and areas of high and low 
homology between two sequences are displayed as peaks 
and troughs, respectively . The coding sequences show a 
very high degree of homology (2:90%), as expected since the 
proteins themselves are identical. In comparison of rat with 
mou se, the intron sequences between coding exons are 
about 75% homologous, except for intron 3, for which the 
lengths differ by 49 nucleotides. The corresponding introns 
of the chicken are much more divergent in length and 
sequence . In comparing rat with mouse , the long intron 
following the 5' untranslated exon 1 shows sharp peaks of 
conserved and nonconserved regions. 
Figures 5 and 6A show very high conservation (-85%) in 
the 5' -flanking region between the cap site and 300 nucleo-
tides upstream of rat and mouse skeletal a-actin genes. The 
homology between chicken and mouse in the same region is 
also rather high (- 60%). Nude! et al. (32) have found a 
similar degree of homology between the rat and chicken 
skeletal a-actin genes. We have also found considerable 
homology in the 5'-untranslated region. By introducing gaps 
for best alignment (Fig. 6B) there is (i) a high degree of 
homology between rat and mou se in the 5' untranslated 
region , (ii) a rather high degree of homology between human 
and rodents , except for three long inserts in the human gene , 
and (iii) a moderate degree of homology between chickens 
and rodents. Conserved sequences between chickens and 
rat s around the CAA T box and about 46 to 59 nucleotides 
downstream from the cap site have been previously recog-
nized by Ordahl and Cooper (34). A similar comparison of 
the 5'-untranslated regions of nonmuscle J3-actins (human 
eDNA and rat genomic sequence) also shows a high degree 
of sequence conservation (38). We find , however, no cross-
homology between a- and J3-actin 5' -untranslated regions . A 
number of studies have suggested that the sequence and 
structure of the mRNA in the 5'-untranslated region have an 
important role in regulation of translation (11, 36, 40, 46). 
The fact that there are conserved sequences in the 5 '-
untranslated region in all of the vertebrate skeletal a-actin 
genes, but a different set of conserved sequences in the 
cytoskeletal J3-actin genes, suggests that there may be de-
velopmentally specific translational regulatory mechanisms 
in muscle versus nonmuscle cells . 
It is striking that a number of inverted repeat structures 
exist in the 5' -flanking and the 5' -untranslated regions of the 
rodent and chicken genes. These are indicated as inverted 
repeat s in Fig. 6 and as remarkably stable hairpin structures 
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for a single strand in Fig. 7A and B. Some of these inverted 
repeat structures have been conserved between chickens 
and rodents. The species compared (avian and mammalian) 
have been separated for more than 250 million years (12) , 
indicating a strong selective constraint to conserve these 
sequences and suggesting that the sequences may be biolog-
ically significant. If the primary transcripts actually initiate 
at the cap site, the structures shown in Fig. 7A and B would 
not occur in the RNA. These sequences could function as 
duplicated transcription factor binding sites. with the bound 
factors (presumably proteins) having opposite orientation at 
the two members of an inverted repeat as postulated by 
McKnight et al. (25) and by Giniger et al. (18). Alternatively, 
some single-strand DNA regions may be opened up during 
formation of a transcription bubble , and these hairpins could 
then form in the DNA as indicated in Fig. 7. Potential hairpin 
structures have also been found in the 5' -flanking region and 
the first untranslated exon in the rat cytoskeletal 13-actin 
gene (33) . They differ, however , from those found in the 
skeletal a-actin genes . For example , whereas the T ATA box 
is presented within a loop of the rat 13 gene, it is found 
between stem-loop structures in the a genes . The existence 
of such differences between the cytoskeletal and muscle-
specific actin genes raises the possibility that the conserved 
inverted repeats in the a genes are important for tissue-
specific expression. To our knowledge , this is the first 
description of inverted repeats and possible secondary struc-
ture formation among the highly conserved sequences in the 
5' -flanking and the 5' -untranslated regions of vertebrate 
skeletal a-actin genes . 
A long sequence of about 110 nucleotides, including the 
putative polyadenylation signal ATTAAA, is highly con-
served in the 3 '-untranslated region of vertebrate skeletal 
a-actin genes (Fig. 8). It is noteworthy that two blocks of 
these highly conserved sequences in the 3 '-untranslated 
region can form a stem-loop structure with estimated stabil-
ities of -8.4 kcaVmol for mice and rats (Fig. 7C) and -8.2 
kcaVmol for chickens (Fig. 7D). These structures are imme-
diately upstream from the A TT AAA polyadenylation signal. 
It has been suggested that the inverted repeat at the 3' end of 
sea urchin histone mRNA is important for the generation of 
the histone mRNA 3' termini (5 , 6). This putative structure 
does not act as a DNA cruciform. but exerts its function at 
the level of the RNA transcripts (4). It is conceivable that the 
potential hairpin structure upstream from the putative 
polyadenylation signal in skeletal a-actin plays a role in the 
correct 3'-end formation of skeletal a-actin mRNA. 
Interesting features in the first intron of vertebrate skeletal 
a-actin genes. Rat and mouse skeletal a-actin genes have a 
long first intron compared with chickens (i.e., 976, %1 , and 
111 nucleotides for rats, mice , and chickens , respectively). 
There are several highly conserved sequences in this intron 
between rats and mice, but the introns are quite divergent in 
other regions (Fig. 5A) . The chicken first intron is quite G+C 
rich (82%) compared with rat introns (53 .5%) and mouse 
introns (52%). We have been unable to find any sequence 
homology between the chicken and rodent introns. There are 
two inverted duplications within the rodent first intron. Both 
occur within the conserved sequences (arrows in Fig. 5A). 
Furthermore, an inverted repeat can also be found in the 
chicken first intron (shown as a hairpin in Fig. 9C). The 
remarkably stable hairpin structures in the vertebrate first 
intron (Fig. 9) may form in the primary transcript. If the 
splicing apparatus tracks along the intron in search of splice 
sites, it may be able to pass along the base of such hairpins. 
The hairpins would effectively shorten the intron , thereby 
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FIG . 9. Predicted inverted repeat structures in the first intron of 
rodents and chicken skeletal a-actin genes. (A) Two potential 
configurations in the first intron of mouse skeletal -actin gene. (B) 
Similar configurations in the first intron of rat skeletal a-actin gene. 
(C) One potential hairpin loop in the first intron of chicken skeletal 
a-actin gene. The indicated free energy values for the base-paired 
regions were calculated by the method of Tinococ et al. (50). 
Numbers within parentheses indicate the numbers of nucleotides 
downstream from the transcription initiation site. 
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expediting its excision by splicing. A similar mechanism has 
been proposed as one way to explain intermolecular splicing 
between two RNAs base paired through their intron se-
quences (47). Alternatively, we speculate that these inverted 
repeats may play a role of transcriptional enhancement in the 
regulation of tissue-specific gene expression because it has 
been proposed that a tissue-specific transcription enhancer 
element is located in the intron of a heavy-chain immuno-
globulin gene (17). In fact, the putative "core" sequence in 
the heavy-chain gene intron is present as an inverted repeat 
(17). 
In conclusion, we have found several conserved and 
inverted repeat sequences outside of the protein-coding 
region of the skeletal a-actin genes. It would be interesting to 
investigate whether these conserved inverted repeat se-
quences serve as regulatory elements in differentiated mus-
cle cells. 
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SUMMARY 
We have developed a precise and convenient mapping technique for determining transcription start points 
(tsp) on cloned genomic DNA using T4 DNA polymerase. This method uses single-stranded (ss) M 13 DNA 
and therefore is, unlike S I and Exo VII nuclease mapping methods, independent of the restriction endonuclease 
sites present in the insert. Essentially the protocol involves the following steps: (1) hybridizing an mRNA to 
an ss Ml3 vector containing an antisense genomic DNA sequence spanning the presumptive tsp (cap site); 
(2) annealing a DNA primer (MI3 sequencing primer) to the MJ3 DNA at a site on this DNA upstream from 
the 5 ' end of the mRNA on the template DNA; (3) extending the DNA primer with T4 DNA polymerase 
towards the 5 ' end of the mRNA. Since T4 DNA polymerase will not displace the mRNA: DNA hybrid, 
synthesis is blocked at the first nucleotide of the mRNA molecule. The length of the extended DNA products 
can then be determined with single nucleotide resolution on denaturing sequencing gels in parallel with a 
sequencing ladder. We have used this approach to map the tsp of the mouse skeletal ex-actin gene. The sensitivity 
of the method allows precise mapping of transcripts present as 0.02-0.05 % of the total RNA. This method 
is particularly valuable for mapping the tsp of genes which are known to contain a large intron between the 
first and second exons. It can also be applied to map the 5 ' border of any given exon of a gene in an M 13 vector 
or in other vectors that give ss DNAs. 
• To whom correspondence and reprint requests should be 
addressed. 
Abbreviations: BSA, bovine serum albumin ; eDNA, DNA 
complementary to mRNA ; dNTP, deoxynucleoside triphos-
phates; nt, nucleotide(s); PA, polyacrylamide; Pipes , piperazine-
N.N ' -bis[2-ethane sulfonic acid); Pollk, Klenow (large) fragment 
of£. coli DNA polymerase I; RNasin, ribonuclease inhibitor; ss, 
single stranded; TBE, Tris-borate-EDTA; tsp, transcriptional 
start point(s); u, units. 
INTRODUCfiON 
The study of individual genes from eukaryotes 
usually begins with the cloning of specific eDNA 
complementary to an mRNA or the cloning of a 
gene. The isolation and identification of genomic 
segments is then followed by transcriptional analysis 
to answer questions concerning development and 
gene regulation. 
0378-1119/86/$03.50 © 1986 Elsevier Science Publishers B.V. (Biomedical Division) 
Two of the most popular techniques for mapping 
the 5' ends of genes involve the use of ss-specific 
endonuclease S 1 or exonuclease Exo VII to map 
RNA transcripts hybridized to well characterized 
template DNA (Berk and Sharp, 1978a). Both of 
these mapping techniques require precise restriction 
maps. If the labeled end of the DNA restriction 
fragment is within 200 nt of the end of the RNA and 
within the most 5' exon, high-resolution mapping of 
the cap site can be obtained by S I mapping. How-
ever, it has been found that S I mapping can result in 
protected fragments several nt longer than corre-
sponding to the cap site, due presumably to pro-
tection by the cap structure (Weaver and Weiss-
mann, 1979). Exo VII data can be used to confrrm 
the S 1 mapping and are also useful for mapping 
short exons in which restriction sites have not been 
mapped (Berk and Sharp, 1978b). They are, how-
ever, not accurate for mapping the tsp of a gene 
which contains a large intron between the first and 
second exons, when the labeled site lies within the 
second exon. 
Here, we describe an accurate and convenient 
procedure for mapping tsp on cloned genomic DNA 
with single nt resolution . This method uses 
ss M 13 DNA and therefore is, unlike S 1 or Exo VII 
mapping methods, independent of the restriction 
sites present in the insert. Furthermore, the sensi-
tivity of the method makes possible precise mapping 
of moderately rare transcripts where sufficient RNA 
is available. It is particularly valuable for mapping 
the 5' termini of genes which are known to contain 
a large intron between the frrst and second exons. It 
also provides an alternative to S 1 and Exo VII 
mapping methods . We have successfully used this 
approach to map the tsp of the mouse skeletal 
a-actin gene. It should be possible to apply this 
method to map the 5' border of any given exon of a 
gene cloned into an M 13 vector or other vectors that 
give ss DNAs. 
MATERIALS AND METHODS 
(a) Materials 
T4 DNA polymerase, T4 polynucleotide kinase, 
and Pollk were purchased from Bethesda Research 
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Laboratories (BRL) or Boehringer-Mannheim. 
Radio-labeled nt were purchased from Amersham or 
New England Nuclear. Unlabeled nt were obtained 
from P-L Biochemicals, placental ribonuclease inhi-
bitor, RNasin, from Promega Biotech, and the 
Escherichia coli 16S- and 23S-ribosomal RNAs from 
Boehringer-Mannheim. 
(b) Preparation of DNA primer 
The hexadecadeoxynucleotide (5 ' -GGGTAAC 
GCCAGGGTT -3') was synthesized by S. Horvath, 
Caltech, on an automated DNA synthesizer 
(Hunkapiller et al., 1984). Purification of the oligo-
deoxynucleotide following synthesis was carried out 
using a 20 % PA-8 M urea preparative gel in 
TBE buffer (90 mM Tris, 90 mM borate, 3 mM 
EDTA, pH 8.3). The desired product was eluted 
from the gel by a crush-soak method (Maxam and 
Gilbert, 1980) using 0.5 M NH4 · acetate. An aliquot 
of the purified oligodeoxynucleotide was 5' end 
labeled to a specific activity of 1.0 x 108 cpm/Jlg 
with polynucleotide kinase and [ y-32P]ATP (approx. 
3000 Ci/mmol) for use as a primer. 
(c) Preparation of RNA and ss DNA 
Total cellular RNA was isolated from differen-
tiated cultures of the mouse myogenic cell line 
BC3H-1 (Schubert et al. 1974) using the guanidine 
thiocyanate-esC! procedure (Chirgwin et al., 1979). 
Poly(A) + RNA was isolated from total cellular 
RNA using two cycles of oligo(dT)-cellulose chro-
matography (Aviv and Leder, 1982). The ss DNA 
was prepared basically as described by Sanger et al. 
(1980). All nucleic acids were purified by two cycles 
of precipitation with 2.5 vols. of ethanol and 0.1 vol. 
of 3M Na ·acetate (pH 5.5). 
(d) RNA : DNA hybridization 
All hybridizations and subsequent extension 
reactions were carried out in capped 0.5-ml eppen-
dorf tubes. The dried RNA sample [ 10 or 5 Jlg of 
poly(A)+ RNA] was dissolved in 2.2 Jll diethylpyro-
carbonate-treated H20, heated to 65 °C for 10 min 
and 2.8 Jll of 9 x hybridization buffer (360 mM 
Na ·Pipes, pH 6.4 ; 3.6 M NaCI; 9 mM EDTA) was 
added. One Jll of Ml3 ss DNA (0.1 or 0.05 JlgfJll) 
with insert complementary to the 5' region of the 
mRNA of interest and 20 J.!l of deionized formamide 
were added to the RNA solution. The mixture was 
denatured by heating at 80 °C for 10 min and hybrid-
ized by incubation for 16 h at 37 °C. Nucleic acids 
were precipitated by the addition of 35 J.!l of 5 M 
NH4 • acetate and 250 J.!l of ethanol and chilled with 
dry ice for 30 min. The precipitate was collected by 
centrifugation at 4 o C for 15 min, briefly dried, redis-
solved in 0.3 M Na · acetate and precipitated with 
2.5 vols . of ethanol. The RNA : DNA pellets were 
washed with 75 % ethanol and dried under vacuum. 
(e) Primer extension with T4 DNA polymerase 
Each of the dried RNA: DNA pellets was sus-
pended in 9 J.!l of T4 DNA polymerase buffer 
[ 16.6 mM (NH4 hS04 ; 67 mM Tris · HCI, pH 8.8; 
6. 7 mM MgCI2 ; 10 mM P-mercaptoethanol; 6. 7 J.!M 
EDTA; 0.17 mg/ml BSA; 0.2 mM denatured 
salmon sperm DNA]. Note that the pellet should 
be dissolved directly in T4 DNA polymerase 
buffer rather than suspending in H20 and adding 
10 x T4 DNA polymerase buffer, subsequently. 
One J.!l (2.5 ng/ J.tl) of the [ 32 P]DNA primer 
(1.0 x 108 cpm/J.tg) was added and the annealing 
mixture was heated to 65 °C for 10 min and incu-
bated for 1 h at 3 7 o C. The synthesis reaction was 
carried out by adding 0.5 J.tl of 10 x T4 DNA poly-
merase buffer, 0.5 J.!l of RNasin (30 u/J.tl), 2 J.!l of 
2.5 mM dNTP (a mixture of equal volume of 10 mM 
dATP; dGTP; dCTP; dTTP), and 1.5 J.!l ofT4 DNA 
polymerase (5 ufJ.tl, BRL). The reaction mixture was 
incubated for 1 h at 37 °C. The reaction was then 
terminated by addition of EDTA to 10 mM and 
extraction with an equal volume of phenol-chloro-
form . 
After ethanol precipitation and drying under va-
cuum, the RNA: DNA pellets were suspended in 
2 J.!l of sterile distilled H2 0 followed by 10 J.!l of gel 
loading buffer (90% formamide; 10 mM EDTA; 
10 mM NaOH; 0.2% bromophenol blue; 0.2% 
xylene cyanol). The sample mixture was heated at 
95 o C for 3 min, quenched on ice, and electro-
phoresed on a 40 em 6% PA-8 M urea sequencing 
gel in TBE buffer in parallel with four dideoxy DNA 
sequencing reactions as size markers. Following 
electrophoresis, the gel was immediately dried for 1 h 
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on a BioRad gel dryer at 80 ° C and autoradiographed 
with Kodak XAR film at -70 o C overnight. 
(f) Primer extension with Pollk 
The dried RNA : DNA pellets were dissolved in 
10 J.!l of 50 mM NaCI, 7 mM Tris · HCI (pH 7.4), 
10 mM MgC12 , 3 mM dithiothreitol, containing 
2.5 ng of the labeled DNA primer (1.1 x 107 
cpm/J.tg) in a 0.5-ml eppendorf tube. The annealing 
mixture was heated to 65 °C for 10 min and 
incubated at 45 o C for 1 h, at which time an equal 
volume of the same annealing buffer, containing 
1 mM each dNTP and 750 ufml of RNasin, was 
added and the primer extended with Pollk 
(500 ufml) for 1 h at an appropriate reaction tem-
perature (14, 23, or 37 °C). The reaction was termi-
nated by addition of EDTA to 10 mM and the mix-
ture was extracted with phenol-chloroform. After 
ethanol precipitation and drying under vacuum, the 
sample was heated at 95 °C for 3 min in gel loading 
buffer (formarnidejdye mix) and analyzed on a 40 em 
6% PA-8 M urea sequencing gel and autoradio-
graphed. 
(g) Nucleotide sequencing 
The ss M13 templates were sequenced by the 
dideoxy chain termination procedure (Sanger et al., 
1977) using [cx-35S]dATP (500 Cijmmol) label 
(Biggin et al., 1983) with some modifications as 
described by Hu et al. (1986). 
(h) Ribonuclease digestion 
RNases A and T1 digestion of RNA: DNA 
hybrids to cleave off the overhanging ss RNA was 
performed as described by Melton et al. (1984). 
RESULTS 
(a) Mapping strategy 
The basic principle of the method for mapping a 
tsp on a genomic clone is illustrated in Fig. 1. mRNA 
hybridized to the antisense strand of ss template 





T4 DNA polymerase 
(and four dNTP) 
Analyze the size of the extension 
producl on sequencing gel 
Fig. I. Strategy for mapping transcription start points (tsp) on 
cloned genomic DNA. 
DNA polymerase of a primer hybridized to the M 13 
ss DNA. Poly{A)+ RNA is hybridized to the ss ge-
nomic sequence cloned in its antisense orientation 
into a phage M13 vector under conditions below the 
melting temperature {Tm) of the RNA: DNA hybrid 
(Casey and Davidson, 1977). Subsequently, a 
[ 
32P]DNA primer (M 13 sequencing primer) is an-
nealed to the Ml3 DNA, upstream from the 5' end 
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of the hybridized mRNA, and extended with T4 
DNA polymerase. The synthesis is blocked by the 
5' end of the RNA since T4 DNA polymerase does 
not catalyze strand displacement synthesis (Masa-
mune and Richardson, 1971). The length of the ex-
tended DNA products, determined with single nt re-
solution on a sequencing gel, can be compared with 
the result anticipated from the nt sequence. 
(b) Mapping the tsp of the mouse skeletal a-actin 
gene 
Fig. 2 shows the results of primer extension ana-
lyses of the tsp of the mouse skeletal a-actin gene. 
Poly{A)+RNA from differentiated BC3H-1 cells 
was hybridized to the ss a-actin genomic M 13 clone 
containing the antisense DNA strand tentatively 
identified as containing the tsp of the gene by 
Exo VII mapping and the identification of the puta-
tive promoter region (Hu et al., 1986). In panel A, a 
major reaction product of 103 nt demonstrates the 
presence of a strong stop for the T4 DNA poly-
merase at the first "A" base of the nt sequence 
ACAC. Weaker bands of 102 and 101 nt are also 
evident. In the comparable experiment in Fig. 2B, 
the predominant band is again at 103 nt, with a 
distinct but weaker band at 102 nt. We suggest that 
the cap site corresponds to termination at 103 nt and 
that the mRNA begins with the sequence ACAC ... 
In this interpretation, the band at 102 nt is due to 
premature termination of the primer extension pro-
duct resulting from steric interference by the 5' cap 
(m7G 5 'ppp). Alternatively, the mRNA actually be-
gins with the sequence CACAC ... The overall identi-
fication of the cap site is consistent with our lower 
resolution Exo VII mapping data (Hu et al., 1986) 
Fig. 2. Primer-extension mapping of the tsp of the mouse skeletai<X-actin gene. In the diagram in the lower part of the figure, the heavy 
line indicates the DNA primer and the dashed line indicates the bases added to the primer by T4 DNA polymerase; the lengths of the 
primer and of the anticipated extension (based on known sequence of the gene) are shown below. (A) Lane I [Extension], unlabeled 
DNA primer was hybridized to the template DNA in the presence of hybridized mRNA and extended with T4 DNA polymerase and 
[e~- 35 S]dATP (500 Ci/mmol) for I hat 37°C; lanes 2-5, sequencing ladders of the same template DNA in the absence of hybridized 
mRNA. The nucleotide sequence was shown on the right of the autoradiogram and the "cap" site and TAT A box are underlined and 
indicated. (B) The 32P-Jabeled primer was hybridized to: Janes 4-6, template DNA in the presence of hybridized mRNA and extended 
with Pollk; lanes 7-9, template DNA in the presence of hybridized mRNA and extended with T4 DNA polymerase. Controls : Janes J-3, 
template DNA only and extended with T4 DNA polymerase; Janes 10-13, sequencing ladders . Reaction temperatures are indicated 
above the autoradiogram. The numbers on the left margins of the autoradiograms (A and B) denote the sizes (in nt) determined from 
marker sequence in adjacent lanes . All RNA : DNA hybridizations were performed with 3 p.g of poly( A)+ RNA hybridized to I p.g of 
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and as noted in the DISCUSSION, with the assign-
ment for the rat !X-actin mRNA (Zakut et al., 1982). 
The extension products (including the high-M, 
smear on the autoradiogram) from the DNA without 
hybridization with RNA (Fig. 2B, lanes 1-3) suggest 
that there are several secondary structures existing in 
the ss template M 13 DNA which can block synthesis 
by T4 DNA polymerase. This interpretation is sup-
ported by the increasing intensity of these bands 
when the extension reactions were performed at 
lower temperatures. We estimate that the template 
DNA, in this experiment, was in about fourfold 
excess over the actin mRNA, so many template 
molecules are not hybridized to that RNA. There-
fore, it was not surprising that the intensity, on the 
autoradiogram, of the background products gene-
rated when the polymerase was hindered by the 
secondary structures in the template DNA was 
greater than that of the products obtained when the 
polymerase was blocked by the mRNA molecules on 
the DNA template. 
(c) Pollk can catalyze strand displacement synthesis 
at the RNA : DNA hybrid 
When primer extension was performed using 
Pollk (Fig. 2B, lanes 4-6), there was no discrete ex-
tension product even at low temperatures (14 °C). 
The overall background of the extension reaction 
was the same as that of the extension on the ss M 13 
template DNA without hybridization to RNA (not 
shown). These results indicate that this enzyme cata-
lyzes strand-displacement synthesis at the junction 
with an RNA: DNA hybrid segment and at the 
secondary structures existing in the ss template 
DNA. 
(d) Sensitivity of the primer-extension-mapping 
technique 
To test the potential of the method, we carried out 
a reconstruction experiment using BC3H-1 po-
ly(A) + RNA diluted with excess heterologous RNA, 
i.e., E. coli 16S- and 23S-ribosomal RNAs. In this 
experiment, we also titrated the amount of the 
ss DNA template to reduce the background pro-
ducts due to the secondary structures in the template 
DNA. Fig. 3 shows the pattern of the extension pro-
ducts from a serial dilution of poly( A)+ RNA vs. 
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0.1 J-Ig or 0.05 jlg template DNA, and of I 0 Jlg of 
total BC3H-1 RNA vs. 0.1 J-Ig template DNA. It is 
clear that the intensity of the mRNA-specific signal 
(the bands labeled "cap site") increases corre-
sponding to the amount of poly( A) + RNA used. As 
little as 0.1 J-Ig of poly( A) + RNA, vs. 0.1 J-Ig or 
0.05 Jlg template DNA, can be detected with expo-
sure time of 2 days without the aid of an intensifying 
screen using a [ 32P)DNA primer with a specific 
activity of 1.0 x 108 cpm/Jlg DNA. Although skele-
tal a-actin mRNA is thought to be an abundant 
transcript, its actual abundance in the po-
ly(A)+ RNA fraction is not known. If the skeletal 
rx-actin transcript is estimated to be present at 2 % to 
5% of the poly( A) + RNA from differentiated 
BC3H-l cells, the detection of a band with 0.1 jlg of 
BC3H-l poly(A) + RNA diluted with 5 jlg of heterol-
ogous RNA corresponds to the detection of an RNA 
of abundance 0.02 to 0.05 % in a sample. This calcu-
lation suggests that the method is sufficiently sensi-
tive to detect mRNA species present at levels of a 
few copies per cell (Affara et al., 1980). It is recom-
mended, however, that poly( A) + RNA should be 
used rather than total RNA because of the higher 
background products in the latter case (as shown in 
lane !). 
(e) Overhanging 3 ' RNA has no effect on the ex-
tension reactions 
As an additional control, the following experiment 
was performed to ensure that the observed extension 
products were not artifacts of the interaction of the 
long overhanging 3' portion ofthe bound RNA with 
the template DNA. The RNA: DNA hybridization 
was carried out as described above except that the 
antisense ss DNA was from an Ml3 subclone with 
a shorter insert which still contains the predicted tsp 
of the gene. Following hybridization, an aliquot of 
the mixture of the RNA : DNA hybrid was treated 
with RNases A and T1 to cleave off the overhanging 
RNA tail. The DNA primer was annealed to the 
ss template DNA of either the intact or the RNase-
treated RNA : DNA hybrid, and then extended with 
T4 DNA polymerase. Primer extension on the 
ss template DNA alone was performed as a control 
experiment. The experimental rationale was that if 
the primer extension reaction of the T4 DNA poly-
merase was indeed blocked specifically by the 5' end 
0 .11-'q DNA lemplale 0.051-'q DNA templa!e 
+ 
w~a~ Poly(A)'RNA A T G C Poly(A)' RNA 












Fig. 3. Sensitivity test of the primer extension mapping tech-
nique with T4 DNA polymerase. Equal amounts of RNA 
samples (BC3H-I poly( A) • RNA diluted with E . coli 16S and 
23S ribosomal RNAs to make up a total of 5 j.tg of RNA) were 
hybridized to either 0.1 j.tg or 0.05 j.tg ofM13 ss DNA containing 
the antisense strand of the mouse skeletal (X-actin genomic clone 
DNA. The amount of poly( A) + RNA in each hybridization was 
as indicated above each lane (except that in lanes I and 6, 10 j.tg 
of total RNA and 10 j.tg of poly( A) + RNA were used). In each 
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of the mRNA on the template DNA, the predigested 
RNA molecule on the template DNA should have 
the same blocking effect on the synthesis of the poly-
merase as that of the intact RNA molecule on the 
template DNA. Furthermore, the extension products 
from different template DNAs, containing the same 
region of the RNA: DNA hybrid, should produce 
the same result. The primer extension results showed 
that the stop point for the extension reaction was not 
influenced by the RNA tail on the 3' side of the exon, 
nor by slight changes in the position of the initiating 
primer relative to the tsp (not shown) . 
DISCUSSION 
We describe here a new mapping technique for 
identifying tsp on cloned genomic DNA. The method 
utilizes the features of T4 DNA polymerase which 
allow it to carry out primed DNA synthesis on a 
ss template but prevent it from carrying out a strand 
displacement reaction through an RNA : DNA du-
plex region. Our measurements indicate an apparent 
variability of one nt in the stop position. The major 
band observed by us corresponds to a 5' skeletal 
ex-actin mRNA sequence ofm7G(5 ' )ppp(5 ' )ACAC. 
The weaker band with a length one nt less 
would correspond to the mRNA sequence of 
m7G(5')ppp(5')CACAC. We suggest that the for-
mer assignment is correct because of the greater 
intensity of this band, but we do not have decisive 
proof of this point. If this interpretation is correct, 
the observed termination of the T4 DNA polymerase 
extension reaction to give a product one nucleotide 
shorter may be due to steric interference by the cap 
structure. We note that the conventional primer 
reaction, 2.5 ng of (32P]DNA primer (1.0 x 108 cpm/J.tg) was 
hybridized to the template DNA and extended with T4 DNA 
polymerase for I h at 37 • c. Following denaturation, equal 
amounts of radioactive counts of the primer extension samples 
were electrophoresed on a 6% PA-8 M urea gel. Lanes 7-10 
demonstrate sequencing ladders of the same template DNA in 
the absence of hybridized mRNA. An autoradiographic exposure 
developed without the aid of an intensifying screen was used to 
map primer extension products. The Mcap" site (tsp) and T A TA 
box are indicated on the right of the autoradiogram. 
extension and S I mapping methods usually show 
several bands differing in length by one or more nt, 
with corresponding uncertainties in the cap site 
(Hanauer et al., 1983, Kost et al., 1983 ; Luse et al., 
1981; Weaver and Weissmann, 1979). 
The present method has one very significant 
advantage in addition to its apparent accuracy. In 
many cases, mouse skeletal ex-actin being one of 
them, the first exon of a eukaryotic gene is quite 
short. It is then often difficult to find a useful restric-
tion site within this exon for primer extension or 
S I mapping. It is also frequently the case that the 
first intron is rather long, so that Exo VII mapping, 
using a restriction fragment labeled within the second 
exon, gives products which are too long to be 
measured with single nt accuracy. 
The current method requires only that the insert, 
cloned in M13 or other vectors that give ss DNAs, 
spans the cap site. Indeed, it can be used to deter-
mine whether or not the cap site or a splice acceptor 
site of an exon (see below) is contained in a given 
insert. If the available insert extends too far upstream 
for accurate length measurements using a primer 
which lies within the vector sequence, standard 
methods for reducing the insert size can be used 
(Henikoff, 1984; Dale et al., 1985). Alternatively, a 
special primer within the insert could be synthesized 
and used . 
In the conventional method of primer extension 
mapping of cap sites using reverse transcriptase and 
mRNA as template, secondary structures in the 
5 ' region of mRNA cause premature stops. 
Although secondary structures in the DNA sequence 
upstream from the cap site may cause similar prob-
lems in the present method, the lower thermal 
stability of DNA secondary structures compared to 
RNA secondary structures may provide some ad-
vantage for the present method. 
The sensitivity of this method should also recom-
mend it for a variety of studies. In the present appli-
cation, we have mapped the cap site of an abundant 
transcript. Nevertheless, the sensitivity test experi-
ment suggests that the experimental conditions used 
should work for a message present at only 0.02 % to 
0.05 % of the poly(A) + RNA. Furthermore, we 
believe that by using optimal ratios of template DNA 
to poly(A)+ RNA and by using a primer as close as 
possible to the presumptive cap site, thus minimizing 
the number of secondary structure stops, consider-
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ably greater sensitivity can be achieved. We further 
suggest that the method could be improved by adding 
T4 bacteriophage gene 32 protein in the primer ex-
tension reactions with T4 DNA polymerase to sti-
mulate this polymerase by removing inhibitory 
secondary structure from the template DNA (Hu-
berman et al., 1971). 
T4 DNA polymerase is uniquely suited to this 
method since it contains neither endonuclease nor 5' 
to 3' exonuclease activity. Moreover, it does not 
catalyze strand-displacement synthesis . In this 
report, we demonstrate that Pollk catalyzes strand-
displacement synthesis . While it has previously been 
shown that E. coli DNA polymerase I catalyzes 
strand-displacement synthesis at nicks (Masamune 
and Richardson, 1971 ), to our knowledge, this is the 
first experimental evidence to show that Pollk can 
displace RNA molecules from the DNA template at 
a junction with an RNA : DNA hybrid segment even 
at low temperature (14 o C). 
It should be noted that in the primer extension 
reactions with T4 DNA polymerase we used a new 
DNA sequencing primer as described in MATERIALS 
AND METHODS , section b. The synthetic universal 
primer 5' -CCCAGTCACGACGTT (Messing 




T4 DNA polymerase 
(and four dNTP ) 
Analyze the s1ze of the extenSIOn 
product on sequencing gel 
Fig. 4. Schematic representation of the proposed method for 
mapping the 5' border of any given ex on of a gene. 
et a!., 1981) has been found to hybridize to a second 
site on the M 13 template, in the gene II region of the 
phage at position 787 (Messing, 1983). Alternatively, 
the new universal M 13 sequencing primer 
5 '-AGTCACGACGITGT A (Norrander et al., 
1983) can be applied to this current method. 
Finally, we note that if one has an M 13 antisense 
insert spanning part of an exon and its upstream 
intron, the intron-exon border can be mapped. This 
proposed application is illustrated in Fig. 4. 
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APPENDIX A 
Ribonuclease mapping of exons of the mouse skeletal a-actin gene with 





0 "U ... 
Q_ Q) -lD en Q) 
Q_ 0'1 




SP6 309 - " 
-325(E3) 
Promoter 242 -.... . f ~ I 238 -" -DNA 217 - -201-- - - 195(E5) 190-- -anti-RNA 180-- -
~ 
160 - --161 (E4) 147 - -mRNA - 140(E2) + 
~ anti-RNA 122 - -110 - -~ RNases A+ T1 
mRNA 90 :: -
2 3 4 5 Protected RNA t1 76 - -
67 - -
·~ 
2 3 4 
74 
APPENDIX B 
Codon usage in actin genes. 
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Expression cloning of cDNAs encoding the p75 subunit of the high-
affinity interleukin-2 receptor by a new selection strategy. 
78 
ABSTRACT 
Interleukin-2 (IL-2) binds to both high- and low-affinity IL-2 
receptors on activated T lymphocytes. A critical question concerning 
the role of IL-2 receptors (IL-2-R) in the control of T-cell growth, is 
the mechanisms by which IL-2 bound to high-affinity membrane receptors 
can be internalized and transduce a growth signal to the cell nucleus . 
Current data are consistent with the view that high-affinity IL-2 
receptors are composed of p75 and p55 heterodimeric receptors, a p75 
subunit noncovalently linked to a p55 subunit, each of which is 
independently capable of binding IL-2 with much lower affinity. The IL-
2-R p75 subunit appears to be the biologically relevant moiety, whereas 
the p55 subunit seems to function merely as a helper binding protein, 
having no signaling capacity of its own. The IL-2-R p55 subunit has 
been extensively studied, and its eDNA clones have been isolated. 
However, the IL-2 -R p75 subunit has not been purified, nor have its 
eDNA clones been isolated . I therefore propose two major steps to 
directly isolate eDNA clones encoding the IL-2-R p75 subunit without 
prior purification of this protein. First, I will construct a selected 
eDNA library by using subtraction probes to enrich for IL-2-R p75 
cDNAs. Second, IL-2-R p75-specific eDNA clones will be isolated from 
this library using a new selection method- an indirect immunoselection 
protocol. If successful, this should contribute to an understanding of 
the molecular basis of signal transduction by the high-affinity IL-2 
receptor. Moreover, the proposed selection strategy may represent a 
powerful general approach for the isolation of genes encoding receptors 
for other growth factors. 
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INTRODUCTION 
The activation of a human T cell immune response to a foreign 
antigen is initiated by the interaction of the human T cell antigen 
receptor (for a review, see Allison and Lanier, 1987) with antigen 
presented on the cell surface in the context of products of the major 
histocompatibility locus. This activation also requires the macrophage-
derived interleukin-1 (for a review, see Oppenheim et al., 1986). 
Following this interaction, a subset of helper T cells express the gene 
encoding the T-cell growth factor interleukin-2 (IL-2) (Smith, 1980). 
To exert its biological effect, IL-2 must interact with specific high-
affinity membrane receptors. Activated lymphocytes with high-affinity 
receptors can proliferate in response to IL-2, resulting in the expan-
sion of T cells with specialized effector functions, including helper, 
suppressor, and cytotoxic activities. Elucidation of the mechanism of 
the interaction of IL-2 with IL-2 receptors is essential to understand-
ing the dynamics of IL-2 mediated T-cell growth and for the exploita-
tion of its therapeutic potential. A failure of the production of 
either the growth factor IL-2, or its receptor, results in failure of 
the T cell immune response. Although the interaction of an appropri-
ately presented antigen with its specific polymorphic receptor complex 
confers specificity for a given T-cell immune response, the interaction 
of IL-2 with IL-2 receptors determines its magnitude and duration. 
Activated T cells express two classes of IL-2 receptor (IL-2-R) 
that differ in their affinity for IL-2. In both normal activated 
lymphocytes and most IL-2-R expressing T-cell lines tested, only 1-10% 
of the receptors are high affinity (dissociation constant Kd~1o- 11M) 
80 
and appear to mediate the physiological response ofT cells to IL-2; 
the remaining receptors bind IL-2 with much lower affinity (Kd~lo- 8M) 
(Robb et al., 1981; Robb et al., 1984; Lowenthal et al., 1985). Current 
evidence suggests that only IL-2 bound to high-affinity receptors is 
internalized via receptor-mediated endocytosis (Weissman et al., 1986; 
Fujii et al., 1986). Both classes of receptors share the same Tac 
peptide (the IL-2-R p55 subunit) defined by the anti-Tac monoclonal 
antibody (Robb et al., 1984; Waldmann, 1986). The IL-2-R p55 subunit 
has been extensively studied, its eDNA clones have been isolated, and 
the structure of the gene determined (Leonard et al., 1984; Nikaido et 
al., 1984; Cosman et al., 1984; Leonard et al., 1985; Ishida et al., 
1985). However, the molecular basis for the distinction in affinity 
between high- and low-affinity receptors has not been elucidated. 
Recent reports from several laboratories provide strong evidence that 
there is a second IL-2 binding protein (p75 subunit) that interacts 
with the IL-2-R p55 subunit to form the high affinity IL-2 receptor 
(Sharon et al., 1986; Tsudo et al., 1986; Teshigawara et al., 1987; 
Tsudo et al., 1987; Robb et al., 1987; Dukovich et al., 1987). 
Several observations challenged the idea that the IL-2-R p55 
subunit was the only molecule involved in binding IL-2 and triggering a 
physiological response. First, transfection of nonlymphoid mouse cells 
with cDNAs encoding human IL-2-R p55 generated only low-affinity 
receptors (Greene et al., 1985) whereas similar transfection of two 
mouse T-cell lines displayed both high- and low-affinity human IL-2 
receptors (Hatakeyama et al., 1985; Kondo et al., 1986). These results 
suggested that T cells express a cell-specific component that either 
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directly contributes to the binding site of the high-affinity IL-2 
receptor or modulates the binding affinity of IL-2-R p55. Second, the 
deduced structure of the IL-2-R p55 predicts that only 13 amino acids 
form the cytoplasmic domain, raising questions as to the mechanism of 
signal transduction (Leonard et al., 1984; Nikaido et al., 1984; Cosman 
et al., 1984). In fact, IL-2 saturation of the low affinity binding 
sites expressed by normal T cells has no effect on the rate of cell 
proliferation, and non-T cells transfected solely with the IL-2-R p55 
eDNA can not respond to IL-2 (Smith, 1988). Third, some lymphocytes, 
including natural killer cells and precursors of lymphokine-activated 
killer cells, apparently do not express the IL-2-R p55 but still bind 
and respond to IL-2. 
The available data are consistent with the view that high-affinity 
IL-2 receptors consist of at least two subunits, each of which is 
independently capable of binding IL-2 with much lower affinity. It has 
been shown that each subunit interacts with a different region of the 
IL-2 peptide molecule, supporting the idea that both subunits directly 
contribute to the binding site of the high-affinity receptor (Robb et 
al., 1987). Recently, it has been demonstrated that IL-2 binds to and 
dissociates from the iL-2-R p75 subunit 102 to 103 times more slowly 
than it does to the p55 subunit, which takes place very rapidly (Wang 
and Smith, 1987). Furthermore, it has been indicated that the IL-2-R 
p75 subunit by itself is sufficient to signal T-cell proliferation 
(Sharon et al., 1986), suggesting that the IL-2-R p75 subunit is the 
biologically relevant moiety whereas the p55 subunit appears to 
function merely as a helper binding protein, having no signaling 
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capacity of its own. Nevertheless, the generation of an extremely high 
affinity receptor from two distinct low affinity binding proteins may 
be of even greater importance for regulation of IL-2 responses. 
The notion that high-affinity IL-2 receptors are p75/p55 
heterodimeric receptors has important implications. First, structural 
studies of the p75 subunit may help to elucidate signal transduction by 
the high-affinity IL-2 receptor to promote T-cell growth. Second, 
functional studies of this gene (p75 subunit) expression in normal T 
cells may help to explain the role of IL-2 during thymic differenti-
ation, since regulated IL-2-R expression is universally associated with 
mature T-cell immune competence. Therefore, understanding the mechanism 
of the interaction of IL-2 with its high-affinity receptors (p75/p55) 
is of fundamental importance in developing an overall picture of the 
operation of the T cell immune system. 
SPECIFIC AIMS 
The primary objectives of this proposal are to isolate cDNA(s) 
encoding the p75 subunit of the high-affinity IL-2 receptor, investi-
gate the structure of the peptide deduced from them, and study the 
regulation of this gene (p75) expression in normal human T cells. The 
research project proposed here represents a promising approach in which 
to study how the IL-2-R p75 subunit interacts with the pSS subunit to 
form the high-affinity IL-2 receptor and mediate the physiological 
response of T cells to IL-2. Ultimately, the results of this project 
will provide evidence as to how IL-2 specifically functions on T cells. 
This should lead, in the long term, to an understanding of the 
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molecular basis of signal transduction by the high-affinity IL-2 
receptor and thus contribute to the elucidation of the mechanisms 
governing the control of thymic differentiation and the development of 
the functional capacities of the T lymphocyte. 
METHODS AND PROCEDURES TO BE USED IN PROPOSED PROJECT 
I propose two major steps to directly isolate eDNA clones encoding 
the IL-2-R p75 subunit without prior purification of this protein. 
First, I will construct a selected eDNA library by using subtraction 
probes to enrich for IL-2-R p75 cDNAs as described (Hedrick et al., 
1984). Second, IL-2-R p75 subunit-specific eDNA clones will be isolated 
from this library by using a new method - an indirect immunoselection 
protocol (see below). Overall, this cloning approach is based on the 
following assumptions about the nature of the IL-2-R p75 gene(s): (1) 
That they should be expressed in YT-clone-2C2 cells, a human leukemic T 
cell clone that expresses solely the IL-2-R p75 (Teshigawara et al., 
1987), but not in MT-1 cells, a human leukemic T cell line that does 
not express the IL-2-R p75 subunit (Tsudo et al., 1987). (2) That the 
mRNAs for the IL-2 receptor proteins should be found on membrane bound 
polysomes, as one would expect the nascent receptor polypeptides to 
attach to the endoplasmic reticulum by a leader peptide (Blobel and 
Dobberstein, 1975). Therefore, by synthesizing 32P-labeled cDNAs of the 
membrane-bound polysomal RNA of YT-clone-2C2 cells and subtracting with 
those sequences also expressed in MT-1 cells, one should be left with a 
specific probe representing a small fraction of total YT-clone-2C2 cell 
gene expression and likely to include copies of the mRNAs that encode 
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the IL-2-R p75 subunit, but not the p55 subunit. (3) That the IL-2-R 
p75 subunit itself is capable of binding IL-2 specifically (Teshigawara 
et al., 1987; Tsudo et al., 1987a and b) . (4) That it is possible to 
obtain a non-blocking anti-IL-2 monoclonal antibody or a polyclonal 
antiserum to IL-2 (see below). 
The strategy to be used to isolate eDNA clones representing 
membrane-bound mRNAs expressed in YT-clone-2C2, but not in MT-1 cells, 
is shown in Figure lA (page 91). Membrane-bound polysomal poly(A)+ RNA 
will be prepared from YT-clone-2C2 cells as described (LaPolla et al., 
1984); total cellular poly(A)+ RNAs from YT-clone-2C2 and MT-1 cells 
will be prepared by the procedure as described (Chirgwin et al., 1979). 
(These two cell lines can be obtained from Dr. Kendall A. Smith, 
Dartmouth Medical School, Hanover, NH.) 32P-labeled eDNA and unlabeled 
eDNA will be synthesized from membrane-bound and total cellular 
poly(A)+ RNAs, respectively, using oligo(dT) and reverse transcriptase 
(Davis et al., 1984). YT-clone-2C2 eDNA synthesized from total cellular 
poly(A)+ RNA will be subtracted with MT-1 total poly(A)+ RNA and the 
subtraction products will be used to synthesize the second strand DNA 
with DNA polymerase I as described (Davis et al., 1984). [The separa-
tion of eDNA from RNA and from DNA:RNA hybrids will be carried out by 
using a CsCl gradient containing guanidine hydrochloride as described 
(Lubbert et al., 1987).] The double-stranded eDNA will then be cloned 
into the ~H3M vector as described (Seed and Aruffo, 1987), and the 
ligated DNA will be transformed into E. coli competent cells to 
generate a plasmid eDNA expression library. 32P-labeled eDNA probes of 
YT-clone-2C2 cells will be subtracted with MT-1 total cellular poly(A)+ 
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RNA, and used to screen the above eDNA library. After being screened 
with the YT-clone-2C2-specific probe, the selected eDNA library can be 
rescreened. 
The strategy of the indirect immunoselection protocol is depicted 
in Figure lB (page 91). Specifically, in this protocol a spheroplast 
fusion technique (Sandri-Goldin et al., 1981) will be used to introduce 
the library into COS cells, where it replicates and expresses its 
inserts. The cells in dishes will be treated with recombinant human IL-
2 from E. coli (Wang et al., 1984), which is commercially available, at 
a final concentration of Sxl0- 8M and incubated for 1 hour at 4 °C 
according to the method described by Tsudo et al. (1986). It is crucial 
here to assume that the IL-2-R p75 subunit expressed by itself in COS 
cells will bind IL-2 since it has been demonstrated that in some T 
cells the p75 subunit alone, without the pSS subunit, can bind IL-2 
specifically (Teshigawara et al., 1987; Tsudo et al., 1987a and b). 
After washing off the unbound IL-2, the cells will be harvested by 
detaching without trypsin, treated with monoclonal antibody specific 
for human IL-2 (Smith et al., 1983), and then distributed in dishes 
coated with affinity-purified antibody to mouse immunoglobulins as 
described (Seed and Aruffo, 1987). It should be noted that the anti-IL-
2 monoclonal antibody to be used here should be a non-blocking antibody 
(i.e . this antibody recognizes a site of IL-2 peptide that will not 
interfere with binding of IL-2 to its receptors). Alternatively, a 
polyclonal antiserum to IL-2 could be used. Probably, some of the 
antibodies therein will recognize epitopes on the surface of IL-2 that 
are not involved in binding to the receptors. (Some mouse monoclonal 
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antibodies and polyclonal antisera to human IL-2 may be obtained from 
Dr. Kendall A. Smith, Dartmouth Medical School, Hanover, NH.) The 
rationale of this indirect immunoselection protocol is that cells 
expressing IL-2-R p75 subunit will be bound with IL-2 which in turn 
will be recognized by the non-blocking anti-IL-2 monoclonal antibody or 
an anti-IL-2 antiserum so that these cells will adhere to dishes 
(coated with anti-mouse IgG antibody), and the remaining cells can be 
washed away. The adherent cells should express solely the IL-2-R p75 
but not the pSS subunit since the pSS subunit sequences have been 
depleted from the eDNA expression library as described above. Further, 
this can be verified by treating those cells with the anti-pSS (anti-
Tac) monoclonal antibody before performing IL-2 binding assay (Robb et 
al., 1981; Tsudo et al., 1986), and they should not be blocked. From 
the adherent cells, plasmid DNAs can be recovered by the "Hirt" 
procedure (Hirt, 1967) and transformed back into E. coli for further 
rounds of transfection and selection. Whether or not the positive cDNAs 
are derived from IL-2-R p75 mRNA will be determined by transfecting 
these plasmid DNAs into MT-1 cells, which constitutively express pSS 
but not p75 subunit (Tsudo et al., 1987), to reconstitute high-affinity 
IL-2 receptors. Moreover, the IL-2-R p75-producing cells can be 
confirmed by an IL-2 cross-linking study, as described (Tsudo et al., 
1986; Teshigawara et al., 1987), to see whether they have expressed the 
p75 peptide. It is important to reiterate that the strategy described 
above using the wH3M vector (Aruffo and Seed, 1987) for the expression 
eDNA library is chosen because of the following reasons: (1) That the 
eukaryotic transcription unit allows high-level expression in COS cells 
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of coding sequences placed under its control. (2) That the small size 
and particular arrangement of sequences in this vector permit high-
level replication as a plasmid in COS cells. 
The strategy described above using an indirect immunoselection 
procedure to isolate eDNA clones for the IL-2-R p75 subunit may prove 
useful in the isolation of clones for other membrane proteins. Specifi-
cally, in cases where it is difficult to purify membrane proteins, due 
to their low abundance and their hydrophobic nature, and/or to make 
antibodies, this approach requires only a second non-blocking antibody 
or a polyclonal antiserum reactive to the ligand which can directly 
bind to the specific membrane protein. For instance, this selection 
strategy should be applicable for the isolation of genes encoding 
receptors for other growth factors such as the human hematopoietic 
colony-stimulating factors, including granulocyte colony-stimulating 
factor (G-CSF), macrophage colony-stimulating factor (M-CSF), 
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Figure 1. Strategy of clone isolation. 
92 
PROPOSITION 2 
Cloning of cDNA(s) encoding the negative regulatory protein(s) that 
modulate expression of human c-myc by a new genetic approach. 
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ABSTRACT 
Regulation of transcription from the proto-oncogene c-myc appears 
to play an important role in normal cellular proliferation and the 
genesis of diverse tumors. A negative regulator has been identified 
within a DNA segment upstream of the human c-myc gene that can inhibit 
expression from its promoters. Moreover, a 15- to 20-bp sequence within 
this DNA segment binds a nuclear factor (or factors) from extracts of 
human Hela cell or mouse ID13 cell nuclei (Hay et al., 1987). It is 
therefore interesting to investigate this putative sequence-specific 
DNA-binding protein (or proteins) that binds to the negative element 
and represses the c-myc gene. I propose a new genetic approach to 
directly isolate eDNA clones encoding the negative regulatory DNA-
binding protein(s) of human c-myc without prior purication of the 
protein(s). If successful, this system would represent a powerful 
general approach for the isolation of genes for eukaryotic sequence-




Alterations in the structure and/or expression of the proto-
oncogene c-myc as a consequence of chromosome translocation are well 
studied in most murine plasmacytomas and human Burkitt lymphomas (for 
review, see Cory, 1986; Cole, 1986). The mechanisms that regulate the 
c-myc gene have become central to understanding the role of c-myc in 
cell transformation and in the response of cells to mitogens. Unlike 
the ras oncogenes, which are activated as the result of mutations 
within the protein-coding regions, no amino acid changes are required 
for c-myc activation. Many investigations, therefore, have pointed to 
quantitative differences in the levels of c-myc expression in tumor vs. 
normal cells. Expression of c-myc is increased during the response of 
cells to growth factors (Greenberg and Ziff, 1984; Greenberg et al., 
1985; Dean et al., 1986; Levine et al., 1986) and decreased during 
differentiation of cells to a nonproliferative state (Grosso and Pitot, 
1985; Bentley and Groudine, 1986; Endo and Nadal-Ginard, 1986; Ramsay 
et al., 1986; Yarden and Kimchi, 1986), suggesting that c-myc protein 
is an important component in the regulatory networks associated with 
normal cell proliferation. Since the c-myc protein has been shown to be 
a DNA-binding protein and associated with the cell nuclear matrix 
(Donner et al., 1982; Eisenman et al., 1985; Watt et al., 1985), it is 
also possible that c-myc is involved in the transcriptional control of 
other cellular genes which in turn regulate cell proliferation. 
The available data are consistent with the view that chromosomal 
translocations and proviral insertion lead to deregulation or constitu-
tive expression of the c-myc gene. Several models have been proposed to 
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explain how these DNA rearrangements disrupt normal c-myc regulation. 
First, the c-myc gene has been shown to be regulated at the tran-
scriptional level since serum or growth factors can stimulate quiescent 
cells to increase the c-myc transcription rate significantly (Greenberg 
and Ziff, 1984; Greenberg et al . , 1985; Dean et al., 1986; Levine et 
al., 1986), i . e. the positive transcriptional control model. Second, 
the c-myc gene has been proposed to be under negative transcriptional 
control via a putative repressor which binds to the 5'-flanking region 
or within the large first untranslated exon (Dunnick et al., 1983; 
Leder et al., 1983), i.e. the negative transcriptional control model . 
Third, it has been suggested that modulation of RNA stability plays an 
important role in the regulation of c-myc RNA level (Blanchard et al., 
1985; Dani et al. , 1985; Dony et al. , 1985; Knight et al . , 1985; 
Piechaczyk et al., 1985), i.e. the post-transcriptional modulation 
model . Fourth, c - myc has been postulated to regulate its own level of 
expression through a feedback mechanism, which would account for the 
suppression of the normal allele in tumor cells with activated c-myc 
genes (Dunnick et al . , 1983; Leder et al., 1983; Nishikura et al . , 
1983), i.e . the feedback regulation model. Fifth, Saito et al . (1983) 
have found that a region of the nucleotide sequences in the first exon 
was significantly complementary to a region of the second exon. The 
mRNA from the untranslocated c-myc gene could form a stable stem-loop 
structure where the AUG initiation codon would be located within the 
loop. They proposed that such a secondary structure could render the 
AUG initiator inaccessible for translation. Thus, displacement of the 
first exon from the translocated c-myc gene would produce higher levels 
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of protein from a given amount of RNA, i.e. the translational control 
model. Yet, there is no consensus model that can account for all of 
these findings and interpretations. 
It is clear that the expression of the c-myc gene is regulated in 
part at the transcriptional level. Recently, a negative transcriptional 
control element has been identified in the murine c-myc gene 5'-
flanking region, located 428-1188 bp 5' of the first c-myc promoter 
(Remmers et al., 1986). This element is likely to inhibit gene expres-
sion at the transcriptional level but not at the post-transcriptional 
level since it is located outside the transcription unit of the c-myc 
gene. Interestingly, this element can act, in either orientation, upon 
a heterologous promoter (the SV40 promoter in the pSV2CAT plasmid) at a 
distance of ~1.7 kb 3' of this promoter to inhibit gene expression 
(Remmers et al., 1986). Therefore, it has been proposed that there is a 
negative enhancer, termed as "dehancer", located upstream of the murine 
c-myc gene. Strikingly, a negative regulator for the human c-myc gene 
has also been identified very recently (Hay et al., 1987). This 
negative regulatory element of human c-myc resides within a segment (-
293 to -353) upstream of the gene that can inhibit expression from its 
promoters (Pl and P2), as shown in Figure lA (page 107). Furthermore, 
they have demonstrated that a 15- to 20-bp sequence within this DNA 
segment (the negative element) binds a nuclear factor (or factors) from 
extracts of human Hela cell nuclei. In addition, they found the same 
binding site was occupied when this DNA segment was exposed to nuclear 
extracts from a mouse cell line ID13, suggesting that a common nuclear 
factor (or factors) is involved in the inhibition of transcription from 
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the c-myc gene. 
A number of eukaryotic genes whose expressions correspond to 
extracellular inducing signals are under the control of juxtaposed 
transcriptional enhancers and the negative regulators. In each case, 
the negative regulators are effective only in cellular conditions where 
the putative negative trans-acting factors (repressor-like molecules) 
are active (Chambon et al., 1984; Gonzalez and Nebert, 1985; Goodbourn 
et al., 1986; Nir et al., 1986). One good example is the negative 
regulator that represses transcription from the human P-interferon gene 
in the absence of an inducing agent (Goodbourn et al., 1986). This 
negative regulatory mechanism has been further supported by genomic 
DNAase I footprinting experiments (Zinn and Maniatis, 1986). Similarly, 
there may be settings in which the positive regulators of the c-myc 
genes are controlled by the adjacent negative regulators. There are 
several similarities between these two negative regulators (p-
interferon and c-myc genes) described above. First, both negative 
regulatory elements reside downstream of enhancer elements and upstream 
of their promoters. Second, activation of these promoters may involve 
both the removal of a repressor (or repressors) and the stimulation of 
a positive regulatory factor (or factors) so that enhancer elements 
can override the negative elements in the induced state. Third, both 
negative regulatory elements can repress transcription from a heterolo-
gous promoter (for instance, the SV40 promoter). Fourth, evidently, the 
nucleotide sequences that bind nuclear factors within both negative 
elements are conserved (Figure lB, page 107). In light of these find-
ings, it seems likely that at least some of the negative transcription-
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al regulators in mammalian cells may share a common mechanism that a 
sequence-specific DNA-binding protein(s) directly binds to the negative 
element of the repressable genes and inhibits transcription. 
SPECIFIC AIMS 
The primary objectives of this proposal are to isolate cDNA(s) 
encoding the putative negative regulatory protein(s) responsible for 
the inhibition of transcription from the human c-myc gene, investigate 
the structure of the protein deduced from the cDNA(s), and further 
study the regulation of this gene (repressor) expression in normal 
mammalian cells. This should lead, in the long term, to an under-
standing of the molecular basis of regulation of transcription from the 
proto-oncogene c-myc and thus contribute to the elucidation of the 
mechanisms governing the control of normal cellular proliferation and 
in the genesis of diverse tumors . 
METHODS AND PROCEDURES TO BE USED IN PROPOSED PROJECT 
I propose two major steps to directly clone eDNA clones encoding 
the c-myc-specific negative regulatory protein(s) by a new genetic 
approach without prior purification of the protein(s). First, I will 
construct a eDNA library from human Hela cells by using a redesigned 
Agtll system (see below). Second, I will develop a genetic circuit in 
E. coli to serve as an in vivo DNA-binding assay (see below). The 
expression vector Agtll will be modified by replacing the entire lacZ 
gene with the trpE expression cassette of the expression vector pSHNB6, 
a derivative of the expression vector pATHl, as described (Tanese et 
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al., 1985). There are several reasons for redesigning this expression 
vector. In the Agtll system, the foreign amino acid sequences are 
fused to the carboxyl terminus of the very large P-galactosidase 
protein. There is some danger that any segments of the exogenous 
protein that can recognize DNA will be buried. I therefore propose to 
use the trpE expression cassette (Tanese et al., 1985). In this case, 
the fusion protein will contain only the first 18 amino acids of trpE, 
then the foreign protein. Therefore, the probability of functional 
domains in the foreign protein sequence being available for reaction 
with a DNA sequence will be enhanced. It has been demonstrated that the 
trpE expression cassette of the expression vector pSHNB6 can express 
high levels of enzymatically active reverse transcriptase that closely 
resemble the authentic enzyme and are stable in E. coli (Roth et al., 
1985; Tanese et al., 1985). Furthermore, the trpE expression cassette 
can be induced in the absence of tryptophan by the addition of indole-
acrylic acid so that this system can be applied to enrich sequence-
specific DNA-binding proteins in E. coli. 
The proposed in vivo DNA-binding assay is designed as follows. I 
will install the human c-myc negative regulatory element (termed NRE) 
sequence (as shown in Figure lB, page 107) into the promoter region, 
between the Pribnow box and the transcription start site, of the lacZ 
gene in the exact position normally occupied by the lac operator. The 
c-myc NRE DNA fragment will be prepared by oligonucleotide synthesis on 
both strands. I anticipate that the expression of P-galatosidase will 
then be under the control of the putative NRE-binding protein(s) (see 
below). Lac+ bacterial colonies or phage plaques are blue in the 
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presence of X-gal (5-bromo-4-chloro-3-indolyl-fi-D-galactoside). The 
rationale of this expression system is that, in a bacterial host 
containing the plasmid with the modified lacZ gene, if the ~/trpE 
vector containing the eDNA encodes and expresses a functional NRE-
binding protein, then this protein will recognize the NRE sequence in 
the promoter region of the lacZ gene and inhibit the transcription of 
this gene just as the lacZ gene is repressed by the operator-bound 
repressor in the lac operon. This ~/trpE plaque will then be colorless 
(clear plaque) in the presence of X-gal whereas other ~/trpE plaques 
without NRE-binding proteins will be blue. Therefore, I could readily 
screen ~/trpE plaques by the color indication and pick up colorless 
plaques . Whether or not a large scale lysate from this phage plaque 
contains NRE-binding activity will be tested by biochemical analyses 
such as gel-mobility - shift assays or DNAase I footprints. It is impor-
tant to reiterate that the strategy described above using the ~jtrpE 
expression eDNA library is to express the putative NRE-binding proteins 
at a high level so that they will be able to block most or all of the 
NRE sequence in the lacZ expression vectors . Therefore, the background 
level of fi-galatosidase due to insufficient blocking of NRE-binding 
proteins can be minimized . 
Overall, this system consists of one phage ~ expression vector 
containing a eDNA library and one plasmid expression vector containing 
the lacZ indicator gene; therefore, they should be compatible in an 
E . coli host. Moreover, this system retains the advantage of the high 
efficiency in vitro packaging of the ~gtll system for the generation of 
a representative eDNA library. If successful, this system would 
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represent a powerful general approach for the isolation of genes for 
eukaryotic sequence-specific DNA-binding proteins, such as tissue-
specific transcription factors. 
It should be noted that there are several potential difficulties 
in this approach. First, it will be hard to clone full length eDNA in 
the Agtll like vector if the mRNA encoding the DNA-binding protein is 
greater than approximately 3 kb. It has been shown very recently, 
however, that transcription factor SPl synthesized in E. coli from a 
partial eDNA clone is still functional for sequence-specific DNA 
binding in vivo and in vitro (Kadonaga et al., 1987), suggesting that 
in all cases it may not be strictly necessary to have a full length 
eDNA for a functional assay to work. Second, it will be difficult to 
retain DNA-binding activity with a polypeptide from a single eDNA if 
the functional protein comprises multiple different subunits. However, 
most (if not all) of the prokaryotic sequence-specific DNA-binding 
proteins characterized so far are encoded by single genes, such as the 
A and lac repressors (Miller and Reznikoff, 1980), araC (Miller and 
Reznikoff, 1980) and lexA (Brent and Ptashne, 1984) proteins. This is 
also true for most of the known eukaryotic sequence-specific DNA-
binding or regulatory proteins, including the Gal4 transcriptional 
regulatory protein (Johnston and Hopper, 1982), the mating type 
regulatory proteins al and a2 (Johnson and Herskowitz, 1985) in yeast; 
the SV40 large T antigen (Hansen et al., 1981), glucocorticoid 
receptors in mammals (Miesfeld et al., 1986); and the transcription 
factors SPl (Briggs et al., 1986; Kadonaga and Tjian, 1986), CTF 
(Jones et al., 1987), AP-1 (Lee et al., 1987), nuclear factor 1 (NFl) 
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(Rosenfeld and Kelly, 1986), and the adenovirus MLTF (Chodosh et al., 
1986) from human Hela cells; heat shock HSTFs from Drosophila and yeast 
(Wiederrecht et al., 1987). These results suggest a single eDNA will 
probably encode a functional NRE-binding protein. Third, a bacterial 
synthesized polypeptide may not work if the functional DNA-binding 
protein requires eukaryotic-specific post-translational modifications. 
However, in a Xenopus oocyte microinjection assay, the human 
adenovirus ElA protein synthesized in E. coli is functional (Ferguson 
et al., 1984). Also, in a protoplast fusion experiment, the human T-
cell leukemia virus type I (HTLV-1) P40x protein, a trans-activator 
(tat-1) protein, synthesized in E. coli is functional (Giam et al., 
1986). I therefore assume that post-translational modifications may not 
be a problem for this system. 
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Figure 1. Elements that control transcription from the human c-myc 
gene. (A) Location of the negative and positive regulatory elements . 
Horizontal arrowheads indicate the sites for initiation of transcrip-
tion controlled by the promoters Pl and P2. The first untranslated exon 
is shown as a solid box. Two regions where nuclear factor 1 (NFl) might 
bind are marked by diagonal hatching boxes. (B) Similarities between 
the nucleotide sequences in the negative regulatory elements for the 
human c-myc and P-interferon genes . Nucleotides contributing to dyad 
symmetry are underlined. Asterisks (*) denote identities between the 
two sequences. (The details of this figure have been taken from Hay et 
al., 1987, and the pertinent literature.) 
108 
PROPOSITION 3 
Interferon may induce a negative regulatory protein (or proteins) that 
is responsible for transcriptional repression of interferon-inducible 
genes in human cells. 
109 
ABSTRACT 
Interf erons (IFNs) are cell-secreted protein factors that are not 
only involved in the defense against virus infections, but play a key 
role in the regulation of cell proliferation and differentiation . Many 
cellular genes have now been identified as being specifically activated 
by IFNs and, therefore, they are possible mediators of the complex 
biological function of IFNs. In human fibroblasts, the induction of 
some of these genes by IFN (type I) is followed by a decline in the 
transcript i on rate of the genes and accompanied by an inability of 
further IFN exposure to reinduce transcription (Larner et al . , 1986). 
This negat i ve regulatory event is probably due to the synthesis of an 
IFN-induced regulatory protein (or proteins) that is responsible for 
transcript i onal repression of these genes . I propose a biochemical 
approach to isolate the putative IFN-induced negative regulatory 
protein(s) and clone the gene(s) coding for them. If successful, this 
should contribute to the elucidation of the mechanisms governing the 
control of IFN-inducible gene regulation. 
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INTRODUCTION 
One of the central issues in modern biology is the control of gene 
expression. An important question in this regard is how various control 
molecules, such as specific polypeptides, act on cell surface receptors 
to control the expression of specific genes which in turn regulate 
cell growth and function. The interferons (IFNs) are a group of poly-
peptides that exert potent growth inhibitory and antiviral activities 
on cells with which they interact (for a review, see Lengyel, 1982). 
The binding of IFNs to specific high-affinity cell surface receptors 
results in an induction of particular mRNAs and of the corresponding 
proteins (Revel and Chebath, 1986). The transcriptional response to 
interferon is rapid; at least seven genes (namely, 1-8; IND-1; ISG-15, 
-54 and 56; MT-1 and -2) achieve maximum transcription rates within two 
hours of IFN exposure (Friedman et al., 1984; Larner et al., 1986; Levy 
et al., 1986; Morris and Huang, 1987; Reich et al., 1987). In human 
fibroblasts, the induction of IND-1 and ISG-54 genes by interferon is 
followed by a programmed decline in the transcription rate of IND-1 and 
ISG-54 genes and accompanied by an inability of further IFN exposure to 
reinduce transcription (Larner et al., 1986). A similar transient 
transcriptional induction has also been found for the ISG-15, -54, and 
-56 genes (Levy et al., 1986; Reich et al., 1987). This negative regu-
latory event, termed desensitization, requires the continuous synthesis 
of highly labile proteins because it can be reversed by cycloheximide 
(Larner et al., 1986; Levy et al., 1986). Although desensitization is 
known to occur after treatment of many cell types with a variety of 
hormones and neurotransmitters (Mukherjee et al., 1975; Terasaki et 
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al., 1978), this is the first instance of desensitization shown to act 
at the tran-scriptional level for defined mRNA products. Larner et al. 
(1986) have recently shown that desensitization of transcription of the 
two IND genes requires newly synthesized protein(s) and is not based 
solely on a loss of surface IFN receptors. Furthermore, it has been 
previously claimed that there are no large scale changes in cytoplasmic 
alkalini-zation, ca2+ flux, and phosphoinositide turn-over during early 
(0-30 min) treatment of human cells with IFN (Mills et al., 1985). 
These mechanisms have been variously implicated in the generation of 
second messengers mediating the mitogenic activation of cells by growth 
factors (Macara, 1985; Majerus et al., 1984). Therefore, Larner et al. 
(1986) have proposed the straightforward explanation that an IFN-
induced regulatory protein is responsible for negative autoregulation. 
What might be the mechanism of transcriptional repression by the 
negative regulatory protein(s)? The negative regulatory protein(s) may 
be either an enzyme (for instance, a kinase) or a protein directly 
involved in transcription. Two IFN-induced enzymes have been character-
ized (Baglioni, 1979; Lengyel, 1982; McMahon and Kerr, 1983). First, a 
double-stranded RNA-dependent protein kinase that phosphorylates the a-
subunit of protein synthesis initiation factor 2 (eiF2) and blocks 
translation. This kinase does not appear to be the right candidate 
since desensitization requires continuous protein synthesis. A second 
enzyme, 2' ,5'-oligoadenylate (2-5A) synthetase, is activated by double-
stranded RNA, and its product activates a latent endoribonuclease, the 
2-5A-dependent RNAase (Wreschner et al., 1981). It has been shown that 
inhibiting the RNAase by the inhibitor CH3Sp(A2'p) 2A2'pp3'0CH3 (Watling 
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et al., 1985), a 2-5A analogue capable of inhibiting the activation of 
the 2-5A-dependent RNAase, has no major effect on the turnover of 
rapidly induced mRNAs in the mitogenically stimulated mouse 3T3 and L 
cells (Porter et al., 1986). This implies that the putative negative 
regulatory protein(s) is probably not a sequence-specific RNAase. While 
it is still possible that some other enzymatic activity causes negative 
regulation, we think it more likely that negative regulation is due to 
a sequence-specific DNA-binding protein(s) that directly binds to cis-
acting sequences of the repressible genes, just as the lac repressor 
binds to its cognate operator (Miller and Reznikoff, 1980), and blocks 
transcription. Similarly, it has been shown that the tissue specificity 
of the immunoglobulin heavy-chain (IgH) enhancer is negatively con-
trolled (Imler et al., 1987). Blocking protein synthesis with cyclo-
heximide in fibroblasts, in which the IgH gene is normally inactive, 
stimulates transcription of an integrated IgH gene, suggesting that 
these cells contain highly labile repressor-like proteins (Ishihara et 
al., 1984). Furthermore, a number of eukaryotic genes have been shown 
to be negatively regulated, including those from the cellular genes rat 
insulin 1 (Laimins et al., 1986; Nir et al., 1986), human P-interferon 
(Goodbourn et al., 1986), murine and human c-myc (Remmers et al., 1986; 
Hay et al., 1987), and from the SV40 (Borrelli et al., 1984; Velcich 
and Ziff, 1985), polyomavirus (Borrelli et al., 1984; Cremisi and 
Babinet, 1986), and murine sarcoma virus (Gorman et al., 1985). In 
light of these results, it seems reasonable that negative regulation of 
eukaryotic gene expression may be a common mechanism. It has been pro-
posed that these negative regulatory elements function by interfering 
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with the interaction of enhancers with ubiquitous stimulatory trans-
acting factors. Moreover, once the cis-acting sequence responsible for 
the putative IFN-induced negative regulator(s) has been identified (see 
below), I should be able to verify whether the nature of the negative 
regulator(s) is a sequence-specific DNA-binding protein(s) by bio-
chemical analyses such as gel-mobility-shift assays, or DNAase I 
footprinting. 
SPECIFIC AIMS 
The primary objectives of this proposal are to isolate the 
putative IFN-induced negative regulatory protein(s), clone the gene(s) 
coding for them, and further study the regulation of this gene 
expression in mammalian cells. This should lead, in the long term, to 
an understanding of the molecular basis of IFN-dependent transcription-
al desensitization and thus contribute to the elucidation of the 
mechanisms governing the control of IFN-inducible gene regulation. 
METHODS AND PROCEDURES TO BE USED IN PROPOSED PROJECT 
1. Delineation of cis-acting sequences responsible for the 
putative negative regulator(s). Three IFN-inducible human genes have 
been previously isolated and characterized (Levy et al., 1986; Reich et 
al., 1987). These genes, termed ISG-15, -54, and -56, are inducible by 
human type I IFN (-Q and -P) and subject to desensitization. The 5' 
portion of the gene ISG-54 can drive a heterologous gene lacking an 
active promoter in the same IFN-dependent manner as that of the gene 
ISG-54, indicating that the regulatory elements for both the positive 
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and negative arms of IFN-mediated transcription lie within the 5' 
portion of ISG-54 (Levy et al., 1986). Recently, the positive 
regulatory region of the ISG-54 gene has been shown to reside within 
122 nucleotides upstream of the transcription initiation site (the cap 
site) (Levy et al., 1988). Further, an IFN-inducible enhancer element 
has been recently identified in the 5' flanking region of the ISG-15 
gene, close to the CCAAT box. This element is highly conserved between 
the ISG-15 and -54 genes (Reich et al., 1987). 
It should now be possible, using either deletions or saturation 
mutagenesis, to identify the cis-acting sequence responsible for the 
negative regulation of these genes. I will use ISG-54 as a working 
system for this purpose. The reported ISG-54/ElB fusion vector (Levy 
et al., 1986) can be used as an expression system. Alternatively, this 
promoter can be fused to the bacterial chloramphenical acetyltrans-
ferase (CAT) gene which is a widely used reporter gene for expression 
studies (Gorman et al., 1982). Sequential deletion mutants of the 5' 
flanking DNA of ISG-54 will be constructed in vitro. In addition, the 
conserved region between ISG-15 and -54 (which has been shown by D. 
Levy to be the site of a protein footprint after IFN-induction) will be 
subjected to multiple base-pair changes to alter it and to construct 
plasmids that differ in positive or negative regulation. Previously, 
Levy et al. (1986) have described an assay system for determining both 
the tran-scriptional efficiency and specificity of the recombinant 
vector ISG-54/ElB in human cells. In a similar fashion, I propose to 
introduce the mutant plasmids into human fibroblast (FS2) cells by a 
standard DNA-mediated gene transfer technique (for instance, the DEAE-
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dextran procedure which I have already used). Subsequently, transfected 
cells will be treated with IFN-o in the absence or presence of 
cycloheximide. Cytoplasmic RNA will be extracted and analyzed by the 
RNAase protection assay as described (Levy et al . , 1986; Melton et al., 
1984). Alternatively, the IFN-induced desensitization (or repression) 
of transcription in transfected cells could be analyzed by nuclear 
runoff assays (Larner et al., 1986) using the ElB DNA of the plasmid to 
monitor the transcription signal. This approach will probably lead us 
to identify not only the negative sequence element but also the 
positive element responsible for transcriptional induction. In order to 
examine the mechanism by which the negative element functions, the 
identified cis-acting negative element could be fused to the HSV-1 tk 
gene (McKnight and Gavis, 1980) containing its native promoter. Thus, I 
could examine whether the cis-acting negative element functions on a 
heterologous promoter in an IFN-dependent manner. As a positive con-
trol, the 5' flanking DNA of ISG-54 (approximately from -800 to -34 bp) 
would be fused to the HSV-1 tk gene containing its native promoter. 
2. Molecular clonin& of the &ene(s) encodin& the ne&ative 
re&ulatory protein(s). Once the cis-acting interferon-inducible 
negative element (termed INE) has been identified, it should be 
possible to isolate the protein(s) that binds to the INE by using the 
radioactive-labeled INE sequence as a probe (see below). Previous 
results indicate that the putative INE-binding protein(s) is inducible 
by type I IFN and causes IFN-dependent desensitization (McMahon and 
Kerr, 1983). An important question therefore is what role theINE-
binding protein(s) plays in initiating the decline in the IFN-induced 
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transcription of these genes (ISG-15, -54, -56). Moreover, since these 
genes (ISG-15, -54, -56) can be induced by type I IFN but not type II 
IFN (-1), does the putative INE-binding protein(s) only respond to type 
I IFN? Finally, how is this INE-binding protein(s) induced by IFNs 
(type I)? Does this induction also require other IFN-regulated tran-
scription factors, such as the positive transcription regulator(s)? 
One approach to answering these questions is the molecular cloning 
and characterization of the gene(s) coding for INE-binding protein(s). 
I propose to clone the gene(s) by a biochemical approach. One of the 
most effective modern biochemical approaches for purifying DNA-binding 
proteins is sequence-specific DNA affinity chromatography. A purifi-
cation procedure for the putative INE-binding protein(s) will be 
designed by analogy with that used for the successful isolation of 
transcription factors SPl and CTF (Briggs et al., 1986; Kadonaga and 
Tjian, 1986; Jones et al., 1987). I propose to prepare nuclear extracts 
from the IFN (type I) treated human fibroblast (FS2) cells in the 
presence of protease inhibitors. The several enrichment and purifi-
cation steps will include ammonium sulfate precipitation, gel filtra-
tion (Briggs et al., 1986), ion exchange chromatography (if needed), 
but especially DNA affinity chromatography (in the presence of excess 
poly d(I-C]), with tandem copies of the double-stranded INE DNA 
sequences covalently affixed to Sepharose (Kadonaga and Tjian, 1986). 
Purification will be monitored by gel-mobility shift assays and/or 
DNAase I footprints. The highly purified preparation of INE-binding 
proteins can be analyzed by SDS gel electrophoresis and the molecular 
weight of the predominant protein determined. The question of whether 
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the purified INE-binding proteins can induce transcription repression 
of an IFN-inducible gene will be examined by in vitro transcription 
analysis using the ISG-54/ElB fusion vector as a template. It has been 
determined that constitutive transcription of the ISG-54 gene takes 
place with extracts from uninduced cells (Levy et al., 1986). 
Once the putative INE-binding protein(s) has been purified to near 
homogeneity by sequence-specific DNA affinity chromatography, it should 
be possible to obtain a partial amino acid sequence and prepare appro-
priate oligonucleotide probes which will allow us to clone the gene 
from a human fibroblast cell ~gtlO eDNA library (Huynh et al., 1985). 
Alternatively, purified INE-binding protein(s) will allow us to gener-
ate antibodies against this protein, in order to clone the gene from a 
human fibroblast cell ~gtll eDNA library (Huynh et al., 1985). 
Of course, isolation of a protein that binds to a cis-acting 
regulatory sequence permits the inference, but not the rigorous 
conclusion that the protein functions as a regulator. If the cis-acting 
sequences for positive and negative (INE) regulation overlap, then we 
may not have a strong inference as to whether we have isolated the 
positive or negative trans-acting regulator. To settle these questions, 
we will have to set up functional assays based on expression systems 
for the cloned gene. These may be either an in vitro transcription 
system or based on gene transfer into cells in culture. These are 
important problems, but they are far enough into the future so that I 
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PROPOSITION 4 
The use of a biotin-streptavidin complex to probe the mechanism of 
transcriptional enhancer function. 
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ABSTRACT 
Transcriptional enhancers were originally identified as long-range 
activators of gene transcription in many viral genomes and near or 
within cellular genes of higher eukaryotes. These cellular enhancers 
were the first DNA sequences found to confer tissue specificity. The 
available data are consistent with the view that enhancer function is 
mediated by sequence-specific trans-acting factors (presumably 
proteins) that bind to enhancer elements and stimulate transcription 
from nearby promoters, in vivo and in vitro. However, the mechanism by 
which enhancer elements interact with specific binding factors and lead 
to the long-range activation of transcription from promoters is not 
understood for any enhancer. Although many models have been postulated 
to account for the mechanism of enhancer action, current experimental 
data could not exclusively distinguish one model from the others 
(especially between the looping model and the scanning model). I 
propose to construct a biotin-streptavidin-biotin bridge between an 
enhancer and an enhancerless promoter and ask whether the enhancer can 




One of the central problems in eukaryotic molecular biology is to 
understand the control of gene expression. Essentially, two DNA 
sequence elements (namely, promoters and enhancers) are required for 
the regulation of gene transcription in eukaryotes. Promoters are 
required for accurate and efficient initiation of transcription from 
genes, whereas enhancers are needed to increase the rate of transcrip-
tion from promoters. Promoters are located immediately upstream of the 
start site of transcription (for reviews, see Dynan and Tjian, 1985; 
McKnight and Tjian, 1986), whereas enhancers can act on cis-linked 
promoters at great distances (a few kilobases away) in an orientation-
independent manner and can also function downstream from the transcrip-
tion unit (for a review, see Serfling et al., 1985). Enhancers have 
been identified in many viral genomes (for reviews, see Gluzman, 1985; 
Serfling et al., 1985) and near or within a variety of cellular genes 
of higher eukaryotes (Banerji et al., 1983; Walker et al., 1983; 
Gillies et al., 1984; Ott et al., 1984; Picard and Schaffner, 1984; 
Deschamps et al., 1985; Goodburn et al., 1985; Haslinger and Karin, 
1985; Theisen et al., 1986; Kawamoto et al., 1988). These cellular 
enhancers often potentiate transcription in a tissue-specific, and 
sometimes inducible, fashion. 
The available data are consistent with the view that enhancer 
function is mediated by sequence-specific trans-acting factors 
(presumably proteins) that bind to enhancer elements and stimulate 
transcription from nearby promoters, in vivo (Scholer and Gruss, 1984; 
Ephrussi et al., 1985; Mercola et al., 1985; Schlokat et al., 1986) and 
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in vitro (Sassone-Corsi et al., 1985; Wildeman et al., 1984; Sen and 
Baltimore, 1986; Wildeman et al., 1986; Sealey and Chalkley, 1987; 
Speck and Baltimore, 1987; Kawamoto et al., 1988). This stimulation has 
been implicated in increasing density of RNA polymerase II molecules on 
actively transcribed genes under enhancer control (Weber and Schaffner, 
1985; Treisman and Maniatis, 1985). There are generally multiple 
binding sites for nuclear factors within an enhancer, and enhancers are 
often present in two or more copies. Although enhancer sequences have 
been extensively characterized and their binding factors found, the 
mechanism by which they interact with protein factors and lead to the 
long-range activation of transcription from promoters is not understood 
for any enhancer . Many models have been postulated to account for the 
mechanism of enhancer function, including the looping model; the 
scanning model; the chromatin structure model; the site-specific gyrase 
model; and the nuclear address model (Courey et al., 1986; Ptashne, 
1986). In light of numerous experiments, the current view of enhancer 
function is that enhancers act as entry sites for transcription factors 
that communicate with other promoter-specific components of the tran-
scriptional machinery, including RNA polymerase II, to initiate tran-
scription . This communication could occur mainly in two distinct ways. 
First, the enhancer binding factors could scan along the DNA double-
helix chain until a promoter and/or its transcriptional machinery is 
encountered (the scanning model) . Second, the intervening DNA double-
helix chain could loop out to bring the enhancer and associated protein 
factors into direct contact with the promoter and/or its transcription-
al machinery (the looping model). Yet, current experimental data do not 
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decisively distinguish between these two models. 
SPECIFIC AIMS 
The goal of this proposal is to design a simple experimental 
approach to determine the correct or the most suitable model for the 
mechanism of enhancer function. This should contribute to an under-
standing of the mechanism(s) governing the control of gene expression. 
METHODS AND PROCEDURES TO BE USED IN PROPOSED PROJECT 
I propose to measure the transcription activity of a composite 
transcription unit in which a DNA fragment containing a transcriptional 
enhancer element will be linked to another DNA fragment containing 
solely a promoter and a reporter gene, but no enhancer, by a non-DNA 
molecule. If this linkage is completely non-DNA like and sufficiently 
bulky (for instance, a big protein), a scanning mechanism would become 
improbable to account for any transcriptional activation, whereas a 
looping mechanism should not be significantly impeded by the structure 
of the connecting bridge. I therefore propose to introduce a biotin-
streptavidin-biotin bridge between the enhancer and promoter sequences 
as a linkage. A positive result, i.e. observation of an enhancing 
effect, will be strong evidence for a "through-space" model (the 
looping model). A negative result will suggest that enhancers operate 
via a "through-the-chain" model (the scanning model). 
Streptavidin is a nonglycosylated 60,000-dalton protein, composed 
of four identical subunits, isolated from Streptomyces avidinii (Chaiet 
and Wolf, 1964) . This protein is extremely similar in function to egg 
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white avidin and binds four biotin molecules per tetramer with a very 
high affinity (dissociation constant Kd-lo- 15M) (Green, 1975). Unlike 
egg white avidin, however, streptavidin exhibits minimal nonspecific 
binding to biological samples at physiological pH (Haeuptle et al., 
1983). 
The bacterial chloramphenicol acetyltransferase (CAT) coding 
sequence that is transcribed under the control of the SV40 early pro-
moter and the SV40 3' RNA processing signals will be used as a tran-
scription unit which is a widely used reporter gene for an expression 
study (Gorman et al., 1982a). The proposed construction of the compos-
ite enhancer/transcription units are depicted in Figure 1 (page 135). 
Primarily, the DNA molecule containing the CAT gene with the enhancer-
less SV40 promoter (SV-CAT) and the DNA molecule containing the en-
hancer segment will each be labeled with biotin at one end (see below), 
cross-linked with streptavidin, and the complex transfected into mamma-
lian culture cells. CAT enzyme activity will then be assayed with 
extracts from the transfected cells. Control experiments will be per-
formed as follows: (1) The two biotinylated DNA molecules (the enhancer 
molecule and the SV-CAT molecule) without streptavidin will be simul-
taneously transfected into the same culture cells and assayed for CAT 
enzyme activity. (2) The biotinylated or non-biotinylated DNA molecule 
with the SV-CAT gene only (without streptavidin nor enhancer) will be 
transfected into culture cells and assayed for the basal level of CAT 
gene expression. (3) The biotinylated DNA molecule with the SV-CAT gene 
alone (without the enhancer molecule) will be incubated with streptavi-
din and transfected into culture cells, and thus assayed for the effect 
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of streptavidin itself on CAT gene expression. 
Specifically, the commonly used plasmid pA10cAT, which contains 
the SV40 promoter elements but no enhancer sequences (Gorman et al., 
1982b), will be linearized by digestion with Sali and Pstl restriction 
endonucleases so that a DNA fragment (~2 kb Sali-Psti segment) 
consisting of the SV40 promoter/CAT gene (SV-CAT) only can be isolated 
and purified after fractionating by agarose gel electrophoresis. In the 
same manner, a DNA fragment (~0.6 kb Sali-Sphi segment) containing 
solely the Moloney murine sarcoma virus (MSV) enhancer will be isolated 
from the plasmid pSM12 (Laimins et al., 1984) and used as a tran-
scriptional enhancer element. This particular enhancer is chosen 
because the effect of the MSV enhancer in augmenting expression by 
insertion into pA10cAT has already been studied. The ends (Sal! sites) 
of these two specific DNA fragments that contain the SV-CAT gene and 
the MSV enhancer will be repaired individually with E. coli DNA 
polymerase I large fragment (Klenow enzyme) in the presence of nucleo-
tides dCTP, dGTP, biotin-11-dUTP, and 2' ,3'-dideoxyadenosine 5'-tri-
phosphate (see below for an explanation). 32P-labeled-dCTP will also be 
included in the end-filling reaction to monitor the percentage of 
incorporation of biotin-11-dUTP. The biotinylated DNA will be separated 
from unincorporated biotin-11-dUTP by chromatography on Sephadex G-50 
or by a G-50 spun column (Maniatis et al., 1982). (Note that phenol 
extractions should be avoided during DNA preparation as biotinylated 
DNA will partition to the interface or into the phenol layer.) The 
purified biotin-end-labeled DNA fragment containing the SV-CAT gene 
will be incubated with an excess of streptavidin (the molar ratio will 
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be around DNA:streptavidin- 1:2), separated from unbound streptavidin 
by chromatography on Sepharose CL-2B, and then incubated with the 
purified biotin-end-labeled DNA fragment containing the MSV enhancer 
element . The final enhancer/streptavidin/SV-CAT complex (~2.6 kb in 
length) can be separated and isolated from the other DNA mixtures, 
including any enhancer/streptavidin/enhancer complex (~1.2 kb in 
length), or SV-CAT/streptavidin/SV-CAT complex (~4 kb in length) and 
other unbound DNA fragments, after fractionating by agarose gel elec -
trophoresis. Although streptavidin has four biotin-binding sites, the 
available evidence is that they are grouped into two non-interacting 
sets of two each (Green et al., 1971). It is therefore probable that 
the above manipulations will lead to a linear DNA-biotin-streptavidin-
biotin- DNA configuration. Subsequently, the purified composite 
enhancer/streptavidin/SV-CAT molecule will be transfected into mamma-
lian cells in culture (for example, mouse Ltk- cells or the rat XC 
cells) using the DEAE-dextran transfection protocol that is sufficient-
ly effective for transient expression with linear DNA in these culture 
cells (Hu and Davidson, unpublished data) or the electroporation method 
(Chu and Berg, 1987). After 48-72 hours incubation, CAT enzyme activi-
ties will be assayed with extracts from these transfected cells as 
described (Gorman et al . , 1982a). In the meantime, DNA samples for the 
various control experiments as described above will be prepared, with 
or without streptavidin, transfected into culture cells using the same 
transfection protocol, and CAT enzyme activities will be assayed with 
extracts from the transfected cells in the same fashion. (All of the 
materials described above are commercially available.) 
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It should be noted that the restriction endonucleases Sal! (which 
will generate 5'-protruding ends), Pstl and Sphl (both of which will 
generate 3'-protruding ends) are used to linearize the DNA because only 
the 5'-protruding ends can be repaired with Klenow enzyme in the 
presence of 4 dNTPs. Therefore, they will be filled in with biotin-11-
dUTP and leave the other 3'-protruding ends (Pstl and Sphl sites) 
unlabeled . Moreover, the terminus of each repaired Sal! site 
( 5' oo o G""TCGAC 00 03 ' ) will be a dideoxy nucleotide (ddATP) which will not 
3' o o o C A G C T,.G o o o 5' 
be capable of ligating with other DNA blunt ends. It will therefore 
rule out the possibility of ligation between the enhancer and the SV-
CAT gene fragments in the transfected cells if some of the ends of the 
biotin-labeled DNA are not stably bound with streptavidins (see below) . 
This design also prevents the self-ligation between the two free ends 
of the composite enhancer/ streptavidin/SV-CAT molecule in the 
transfected cells since it is unlikely to join the Pstl site on the one 
end, with the Sphl site on the other end (Figure 1, page 135). However, 
one might imagine that it is possible to form a big circular DNA 
molecule in which two copies of the composite enhancer/streptavidin/SV-
CAT molecule might join together via the ligation of Pstl to Pstl sites 
and Sphl to Sphl sites . Should this happen in the transfected cells, 
the enhancer elements and the transcription units (SV-CAT) are still 
physically separated by streptavidins so that this peculiar molecule 
should not distort the proposed experiments. Nevertheless, the physical 
structure (i.e. circular or linear) of the DNA molecule in the 
transfected cells will be examined after the DNA transfection (see 
below) . 
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It is crucial to consider the stability of the streptavidin-linked 
molecules since variation in the stability of this composite molecule 
will significantly interfere with the interpretation of transcriptional 
enhancement. Fortunately, because of the extraordinarily high-affinity 
interaction between biotin and streptavidin [Kd-lo-15M, (Green, 1975)], 
it seems reasonable to assume that the biotin-streptavidin linkage will 
be stable in culture cells and in an in vitro transcription system (see 
below). Furthermore, the configuration of the composite enhancer/ 
streptavidin/SV-CAT molecule in transfected cells will be confirmed by 
extracting the DNA molecules from transfected cells' nuclei by the Hirt 
procedure (Hirt, 1967), and analyzing the length and the physical 
structure of the DNA molecule by electrophoresis on agarose gels. 
Alternatively, the transcription activity of this composite 
enhancer/streptavidin/SV-CAT DNA molecule and the various control DNA 
constructions can be determined in an in vitro transcription system in 
which the composite DNA molecule presumably would be stable since cell-
free transcription extracts have become well defined (Reinberg et al., 
1987; Reinberg and Roeder, 1987a and b). Although the in vitro 
enhancing effect of a transcriptional enhancer (SV40 enhancer) has been 
shown to be limited somewhere between 5- to 15-fold (Scholer and Gruss, 
1985), the advantage of using such a highly characterized transcription 
system justifies the attempt to study the mechanism of enhancer 
function. Yet, there is no proof that the mechanism of transcriptional 
stimulation of an enhancer in vitro is the same as that in vivo . It is 
still debatable whether the full enhancer function can be achieved in 
vitro with cell-free transcription extracts, or whether some higher-
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order nuclear structures are also required. Nevertheless, the first 
approach I propose to use here is an in vivo transcription system and 
the rest of the problems are far enough into the future so that I will 
not describe in detail the approach of using an in vitro transcription 
system . 
Finally, all of the procedures described above are standard 
molecular and cellular biology techniques . It does not require any 
particular reactions or difficult techniques to carry out the proposed 
project. If the transcription activity (CAT enzyme activity) of such a 
composite enhancerjstreptavidin/SV-CAT DNA molecule is significantly 
higher than those of the control experiments as described above, it 
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Figure 1. Schematic diagram of the construction of the composite 





During development of the vertebrate nervous system, nerve growth 
factor (NGF) plays an essential role in the survival and maintenance of 
sympathetic and sensory neurons (Levi-Montalcini and Angeletti, 1968). 
NGF was the first and is the only neurotrophic growth factor identified 
so far that has been shown to be responsible for neuronal survival in 
vivo . NGF exerts its effects on NGF-dependent neurons by interacting 
with specific, high-affinity receptors located on the neuronal cell 
surface . The human NGF receptor has been purified (Puma et al., 1983, 
Grob et al., 1985), its eDNA clones have been isolated (Johnson et al., 
1986), and the structure of the gene determined (Chao et al., 1986). 
However, the molecular basis for the mechanism of NGF action is not 
understood. The deduced amino acid sequence of the human NGF receptor 
(Johnson et al., 1986) reveals several features that distinguish it 
from other receptors for growth factors. First, the NGF receptor has no 
sequence homology with the family of genes encoding either serine/ 
threonine or tyrosine specific protein kinases. It is thus unlike a 
variety of other growth factors including epidermal growth factor (EGF) 
(Ushiro and Cohen, 1980), platelet-derived growth factor (PDGF) (Ek et 
al., 1982), colony-stimulating factor (CSF-1) (Sherr et al., 1985), and 
fibroblast growth factor (FGF) (Thomas et al., 1984). Second, there is 
no sequence homology between NGF and insulin receptors, whereas se-
quence homology between NGF and insulin has been reported (Frazier et 
al., 1972). Third, although NGF stimulates serine/threonine phospho-
rylation of specific nuclear and cytoskeletally associated proteins (Yu 
et al., 1980; Landreth and Rieser, 1985), the protein kinase activities 
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responsible for these phosphorylation reactions apparently may not be 
intrinsic to the receptor since the NGF receptor lacks significant 
sequence homology with known serine/threonine protein kinases. 
Therefore, understanding the mechanism of the interaction of NGF with 
its receptor is of fundamental importance in the NGF-receptor signal 
transduction mechanism and in developing an overall picture of the 
development of NGF-dependent neurons. 
Characterization of the cell surface NGF-receptor by kinetic and 
equilibrium binding parameters has revealed two apparent affinity 
states (Sutter et al., 1979; Landreth and Shooter, 1980; Schechter and 
Bothwell, 1981; Buxser et al., 1983). The first NGF-receptor state has 
a high affinity for 1251-NGF (dissociation constant Kd~3xlo- 10M), and 
the second state has a lower affinity for 1251-NGF (Kd~3xl0- 9M). Photo-
affinity cross-linking of 1251-NGF experiments indicated that two NGF-
binding proteins existed in membrane preparations (Buxser et al., 1983; 
Grob et al., 1983). Furthermore, analysis of highly purified NGF-
receptor revealed two proteins with molecular weight of 80- and 200-
kilodalton (kDa) (Puma et al., 1983). A model for binding of NGF to its 
receptor has been proposed according to the dimeric structure of NGF 
and binding properties of NGF to its receptor (Buxser et al., 1985). 
The biologically active form of NGF is composed of two identical 13-kDa 
peptides which are noncovalently associated to form a 26-kDa molecule 
(Greene and Shooter, 1980). The dimeric structure of NGF suggests that 
each 13-kDa monomer may be able to bind to one NGF-receptor. As shown 
in Figure 1 (page 149), when a dimeric NGF binds to a single 80-kDa 
receptor molecule it forms a low affinity complex. When each monomer of 
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NGF associates with a separate receptor molecule it will form a high 
affinity complex that is a dimeric receptor structure bridged by the 
dimeric NGF (200-kDa complex). Simultaneous dissociation of NGF from 
two receptors is significantly less probable than dissociation from a 
single receptor . Apparently, with two receptors there is a slower 
dissociation rate and higher affinity. This model is supported by the 
evidence that the NGF-receptor exists, at least partially, as a 
disulfide-linked dimer (Grob et al., 1985). 
Several years ago, Geisler and Weber (1977) developed a method for 
directly assessing the role of the amino terminus of lac repressor in 
operator binding. They found that, in 1.0 M Tris-HCl, pH 7 . 5/ 30% (V/V) 
glycerol, tryptic cleavage is limited to only two sites in the lac 
repressor arginine-51 and lysine-59. Cleavage under these conditions 
yielded the tetrameric trypsin-resistant core and approximately equal 
amounts of two amino-terminal "headpieces" which could bind specifi-
cally to the lac operator (Ogata and Gilbert, 1978 ). Similarly, using 
papain digestion of the A phage repressor, Pabo et al. (1979) 
demonstrate that the amino-terminal domain binds DNA, and the carboxyl-
terminal domain oligomerizes. Moreover, Simmons (1988) has identified 
very recently the regions of the simian virus 40 (SV40) large T antigen 
that make strong, intermediate, and weak bindings to the viral origin 
of DNA synthesis after digestion with various concentrations of Pronase 
E , a nonspecific protease . It should be possible therefore to apply the 
proteolytic dissection technique in a similar way to identify the 
functional domains of the human NGF receptor. 
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SPECIFIC AIMS 
The goal of this proposal is to design an experimental approach to 
identify the functional domains of the human NGF receptor, and further 
to determine their conformation under physiological conditions. This 
should lead, in the long term, to an understanding of the structure of 
the NGF-binding sites in the receptor protein, and ultimately to an 
elucidation of the mechanism of NGF action. 
METHODS AND PROCEDURES TO BE USED IN PROPOSED PROJECT 
I propose to use the proteolytic dissection technique to identify 
the functional domains of the human NGF-receptor. First, I will 
determine the proper conditions for digestion of the NGF/NGF-receptor 
complexes with Pronase E. Affinity chromatography-purified NGF-receptor 
(Puma et al., 1983) will be incubated with 125I-labeled-NGF and then 
digested with various concentrations of Pronase E. The size of the 
digested peptides will be analyzed by electrophoresis in sodium dodecyl 
sulfate (SDS) 15% polyacrylamide gels (Laemmli, 1970) in the presence 
of dithiothreitol. Alternatively, a time course of Pronase E digestion 
of the NGF/NGF-receptor complexes can be performed and monitored by the 
same gel electrophoresis. Second, purified NGF will be coupled to CNBr-
activated Sepharose 4B (Pharmacia) for 16 hours at 4 °C in 0.5M NaCl, 
O.lM borate, pH 8.5 buffer as described (Puma et al., 1983). After 
coupling is completed, the gel will be washed and equilibrated in equi-
libration buffer (lOmM Na-phosphate, pH 7.2, 136mM NaCl, SmM KCl, 1.2% 
octylglucoside and phosphatidylcholine). This column will be used as an 
affinity matrix for NGF receptors. Purified NGF receptors will be 
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passed over the column and incubated for 1 hour at 22 °C. The column 
will then be extensively washed with equilibration buffer. Subsequent-
ly, Pronase E (in equilibration buffer) at the proper concentration as 
determined above will be passed through the column and incubate for a 
certain time as determined in the first step. Third, after an extensive 
wash step, any NGF-receptor fragments still bound to the column will be 
eluted with buffer of O.lSM NaCl, pH 11.0, containing 1.2% phospha-
tidyl-choline. The origin of the eluted fragments (i.e. the NGF-binding 
domains) on NGF receptor will be determined by automated Edman degrada-
tion and amino acid analysis as described (Hunkapiller et al., 1984). 
As a control , nonspecific binding of the NGF receptor to Sepharose-4B 
will be determined by parallel incubation in the column not containing 
any NGF. In addition, other "amino acid-specific" proteases may be used 
in the digestions as described above. For instance, trypsin which 
cleaves after arginine and lysine, chymotrypsin which cleaves after 
phenylalanine, endoproteinase Lys-C which cleaves lysine and endo-
proteinase Arg-C which cleaves arginine specifically (Levy et al., 
1970), and endonuclease Glu-C (V8 protease) which hydrolyzes peptides 
specifically at the carboxyl-terminal of glutamate residues (Houmard 
and Drapeau, 1972) can all be used. 
Since the high affinity NGF receptor exists as a disulfide-linked 
dimer, it can be determined whether or not the NGF -binding domains 
still retain the dimeric conformation. In order to rapidly determine 
molecular weights of "native", undissociated proteolyzed protein 
fragments, I therefore propose a new gel permeation chromatography . The 
basic idea of this method is to perform gel filtration on a glass plate 
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as thin-layer chromatography rather than carrying out column chromatog-
raphy (see below) . Several advantages of this proposed method justify 
the attempt to develop it. First, the separated peptides can be 
transferred from the gel layer to nitrocellulose filter membrane (see 
below), therefore , they can be detected by not only the conventional 
gel-staining methods such as coomassie blue and silver staining (Merril 
et al . , 1979), but also with radioactively labeled antibodies specific 
to sample proteins. By contrast, in column chromatography or gel fil-
tration HPLC (high performance liquid chromatography), the separated 
proteins usually can be detected only by the ultraviolet (VU) ab-
sorbance. Thus, one can use more sensitive detecting methods in this 
proposed chromatography technique than in the conventional column chro-
matography or gel filtration HPLC. Second, many experimental samples 
and molecular weight standards can be easily applied on a single gel-
plate and compared because it is a two dimensional gel filtration (see 
below) . By contrast, only one unknown sample, with or without molecular 
weight standards, can be applied on a column chromatography or gel 
filtration HPLC. Third, the conditions of filtration should be very 
constant from sample to sample in this proposed chromatography since 
all of the samples are present simultaneously on the same gel-plate. 
Fourth, unlike column chroma-tography, there is no need to determine 
the void volume of the gel-plate beforehand in this proposed chromatog-
raphy. Moreover, the filtration data by the proposed method may provide 
the elution condition for column chromatography or gel filtration HPLC. 
Fifth, although estimation of molecular weights of "native", undissoci-
ated proteins may be achieved by disc gel electrophoresis (Hendrick and 
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Smith, 1968; Kempe et al., 1974), it is generally more cumbersome than 
gel filtration. 
The detailed procedures for this proposed chromatography are 
described as the following. The preparation of Sephadex G-100 (super-
fine grade) will be the same as that for column chromatography. After 
swelling, the gel particles will be allowed to settle and the super-
natant removed by decantation. The gel slurry will be poured onto a 
glass plate horizontally, spread out evenly on the plate, and allowed 
to settle undisturbed for 2 or more hours in a humid chamber until it 
forms a thin-layer of gel (still moist) on the glass plate. Then, the 
gel-plate will be set up as Figure 2A (page 150). The buffer has to be 
run over the plate by descending chromatography. The bridges carrying 
the eluant to and from the plate have to be thick filter paper (e.g. 
Whatman 3 MM) in order to have sufficient capacity. Note that the 
filter paper should be covered with plastic wrap to avoid evaporation. 
The flow rate through the gel can be regulated by the angle of the 
plate to the horizontal. 
Before the run is started, the plate has to be equilibrated by 
allowing the sovent to flow through the gel for several hours. After 
equilibration, the sample (2-5 ~1) will be applied through a micro-
pipette as a round spot (ca. 2-4 mm in diameter). Sample application 
should be carried out with the plate horizontal and with care not to 
disturb the gel layer. The flow rate over the plate can be measured by 
the use of a colored reference substance, e.g. blue dextran. After 
completion of the run, as shown in Figure 2B (page 150), the separated 
peptides will be transferred from the gel layer by absorption into a 
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superimposed sheet of nitrocellulose filter membrane as the Southern 
transfer procedure for DNA samples (Southern, 1975). This step should 
be performed with the plate horizontal and with care not to disturb the 
gel layer. It is important that air bubbles not be trapped between the 
membrane and the gel layer with this procedure. After about 6-12 hours 
of transfer, the nitrocellulose membrane will be removed and then air 
dried and stained according to conventional methods, e.g. coomassie 
blue or silver staining (Merril et al., 1979). Alternatively, it can be 
probed with radioactively labeled antibodies specific to sample pro-
teins after the membrane has pre-hybridized with the blocking solution 
to eliminate the nonspecific binding of antibodies. 
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Figure 1. A model for binding of NGF to NGF-receptor to form low and 
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Figure 2. A set-up for the proposed gel permeation chromatography (A), 
and the "Southern"-like protein transfer (B). 
